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1.1 Glycosidases 
1.1.1 Introduction 
Glycosidases, or glycosyl hydrolases (GH; EC 3.2.1.-), are a widespread 
group of enzymes that hydrolyse the glycosidic bond between two 
carbohydrates in a disaccharide or polysaccharide moiety or between a 
carbohydrate and an aglycon.1 To date, the GHs have been classified into 108 
families on the basis of amino acid sequence similarities (see the CAZYs 
database at www.cazy.org).  
Due to the large number of proteins included in this family, a broad 
structural diversity is covered, but generally these enzymes have a size of 
approximately 500 residues and a general structure based on a barrel of β 
sheets surrounded by α helices (Figure 1.1). In addition to this minimum unit, 
glycosidases can form oligomers or have other domains that provide additional 
features such as molecular recognition or anchoring to membranes. 
 
Figure 1.1. Structure of Human Cytosolic β-glucosidase1 
Due to the function and the large number of metabolic processes in 
which they are involved, these enzymes are found in bacteria and prokaryotes 
and in higher organisms and have many different roles. In bacteria and 
                                                            
1
 Tribolo, S.; Berrin, J. G.; Kroon, P. A.; Czjzek, M.; Juge, N. J. Mol. Biol. 2007, 370, 
964. 
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prokariotes glycosidases are involved in the acquisition of nutrients, in both 
intra- and extracellular medium; in higher organisms they are present in Golgi 
apparatus and in the endoplasmic reticulum, in which they are involved in 
processes of maturation of glycoproteins, and in the lysosomes where they 
carry-out the degradation of carbohydrate-based structures. Another 
fundamental process in which these enzymes are involved is the digestion in 
the digestive tract, where they degrade nutrients as lactose, sucrose, trehalose 
or starch, and the disappearance of these enzymes in the intestine, for 
example, leads to lactose intolerance in humans.  
Glycosidases are involved in many metabolic pathways, from the most 
obvious such as the intestinal digestion of carbohydrates to complex processes 
of cell-cell and virus-cell recognition (Figure 1.2). 
 
Figure 1.2. Molecular recognition 
In a general scheme for the mechanism of hydrolysis (Scheme 1.1) 
cleavage of the glycosidic bond is achieved by attack of a water molecule 
catalysed by the enzyme. 
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Scheme 1.1. Glycosidic bond hydrolysis 
The hydrolysis of the glycosidic bond is performed by two catalytic 
residues of the enzymes: a general acid (proton donor) and a nucleophile 
(base); depending on the peculiar position of these catalytic residues, 
hydrolysis occurs via overall retention or overall inversion of the anomeric 
configuration (Scheme 1.2). 
 
Scheme 1.2. General glycosidase mechanisms for (a) an inverting β-glycosidase and (b) a 
retaining β-glycosidase2 
Both mechanisms involve oxocarbenium-ion-like transition states and a 
pair of carboxylic acids at the active site. In inverting glycosidases, these two 
residues are located approximately 10 Å (+/- 2 Å) apart on average3,4 and the 
                                                            
2
 Rye, C. S.; Withers, S. G. Curr. Opin. Chem. Biol. 2000, 4, 573. 
3
 McCarther, J.; Withers, S. G. Curr. Opin. Struct. Biol. 1994, 4, 885. 
Chapter 1 
6 
 
reaction occurs via a single-displacement mechanism by a water molecule 
where one carboxylic acid acts as a general base and the other as a general 
acid (Scheme 1.2a). In retaining enzymes, the two carboxylic residues are 
approximately 5.5 Å apart3,4 and the reaction proceeds via a double 
displacement mechanism (Scheme 1.2b). 
1.1.2 How to inhibit glycosidases 
The cleavage of the glycosidic bond is so general that glycosidases are 
involved in a large number of metabolic and catabolic processes, from the 
most obvious like the intestinal digestion of carbohydrates to the complex 
processes of cell-cell or virus-cell recognition. Here we present some 
important examples. 
1.1.2.a Intestinal digestion: treatment of type II diabetes 
The intestinal di- and oligosaccharidases are fixed components of the 
cell membrane of the brush border region of the small intestine wall. These 
enzymes digest dietary carbohydrates to monosaccharides which are absorbed 
through the intestinal wall. This group of enzymes include sucrase, maltase, 
isomaltase, lactase, trehalase and hetero-β-glucosidase. In the late 1970s, it 
was realized that inhibition of all or some of these enzymes could regulate the 
absorption of carbohydrates and such inhibitors could be used therapeutically 
in the oral treatment of non-insulin-dependent diabetes mellitus (NIDDM or 
type II diabetes).5 
                                                                                                                                                     
4
 Wang, Q.; Graham, R. W.; Trimbur, D.; Warren, R. A. J.; Withers, S. G. J. Am. Chem. 
Soc. 1994, 116, 11594. 
5
 Schmidt, D. D.; Frommer, W.; Müller, L.; Truscheit, E. Naturwissenschaften 1979, 
66, 584. 
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1.1.2.b Post translational processes 
The biosynthesis of the oligosaccharide chains of all the N-linked 
glycoproteins is initiated by the cotranslational transfer of a common 
oligosaccharide precursor (consisting of two N-acetylglucosamines, nine 
mannose and three glucose units) to the glycosylation site of newly 
synthesized polypeptides in the endoplasmic reticulum.6 The N-glycan chain is 
modified by a series of reactions within the endoplasmic reticulum and the 
Golgi’s apparatus, including trimming by the action of specific processing 
glycosidases. The final oligosaccharide structures depend on the polypeptides 
and on which processing glycosidases and glycosyltransferases are expressed 
in the cells. Endoplasmic reticulum glycosidases are essential for the 
maturation and endoplasmic reticulum quality control of glycoproteins 
containing N-glycans and for the normal development of cells, because they 
define the correct protein synthesis.7 
1.1.2.c Degradation mechanisms: treatment of genetic disorders 
Recent experimental data show that some human genetic diseases are 
due to mutations in proteins which influence their folding and lead to retaining 
of mutant proteins in the endoplasmic reticulum and subsequent degradation. 
The degradative function is carried out by more than 50 acid-dependent 
hydrolases contained within the lumen. Lysosomal enzymes are all N-
glycosylated glycoproteins.8 The glycosphingolipid (GSL) storage diseases are 
genetic disorders in which a mutation of one of GSL glycohydrolases blocks GSL 
degradation, leading to lysosomal accumulation of undegraded GSL.9 The only 
                                                            
6
 a) Elbein, A. D. Ann. Rev. Biochem. 1987, 56, 497. b) Elbein, A. D. FASEB J. 1991, 5, 
3055. 
7
 a) Herscovics, A. Biochim. Biophys. Acta 1999, 1473, 96. b) Parodi, A. J. Biochem. J. 
2000, 348, 1. 
8
 Kornfeld, S.; Mellman, I. Annu. Rev. Cell Biol. 1989, 5, 483. 
9
 Neufeld, E. F. Annu. Rev. Biochem. 1991, 60, 257. 
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successful treatment for such diseases to date is the enzyme replacement 
therapy for patients with type I Gaucher disease10 and Fabry disease.11 
1.1.2.d Molecular recognition 
Molecular recognition occurs when two molecules interact in a specific, 
and non covalent way (such as hydrogen bridges, hydrophobic interactions, 
Van der Waals forces, etc.). In the biological systems there are a lot of 
interaction processes based on molecular recognition, as represented in Figure 
1.2. The common feature for most of the recognition processes is that they are 
carried out by interaction of oligosaccharide chains. Therefore, the synthesis of 
oligosaccharides, as well as glycoproteins or glycolipids, is a fundamental step 
for molecular recognition and therefore for the functions of biological systems. 
It was shown that inhibitors of glycosidases bear interesting antiretroviral 
activities due to their interference with the correct glycosylation of viral 
envelope glycoproteins.12 
  
                                                            
10
 Barton, N. W.; Furbish, F. S., Murray, G. J.; Garfield, M.; Brady, R. O. Proc. Natl. 
Acad. Sci. USA 1990, 87, 1913. 
11
 Schiffmann, R.; Murray, G. J.; Treco, D.; Daniel, P.; Sellos-Moura, M.; Myers, M.; 
Quirk, J. M.; Zirzow, G. C.; Borowsky, M.; Loveday, K.; Anderson, T.; Gillespie, F.; 
Oliver, K. L.; Jeffries, N. O.; Doo, F.; Liang, T. J.; Kreps, C.; Gunter, K.; Frei, K.; 
Crutchfield, K.; Selden, R. F.; Brady, R. O. Proc. Natl. Acad. Sci. USA 2000, 97, 365. 
12
 Greimel, P.; Spreitz, J.; Stütz, A. E.; Wrodnigg, T. M. Curr. Top. Med. Chem. 2003, 
3, 513. 
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1.2 Iminosugars: Glycosidases Inhibitors 
1.2.1 Introduction  
Iminosugars are structural analogues of ‘true’ sugars in which the ring 
oxygen atom is replaced by a nitrogen atom (Figure 1.3). 
 
Figure 1.3. structure of iminosugars 
The presence of nitrogen in the ring provides a charged site under 
physiological conditions which is largely responsible for their very strong 
interaction with glycosidases enzymes. Indeed, the protonated nitrogen atom 
is able to mimic the oxocarbenium ion involved in the transition state of the 
hydrolysis catalyzed by these enzymes. For this reason iminosugars are very 
potent inhibitors of glycosidases, and since these enzymes are involved in a 
number of essential physiological processes, they possess an immense 
potential as therapeutic agents and many of such applications are starting to 
emerge. In addition, as a result of similarities between the mechanisms of 
glycoside hydrolysis and glycosyl transfer, novel applications of iminosugars in 
the control of biological glycosylation are being uncovered which considerably 
extend the scope of interest of these carbohydrate mimics. 
A lot of iminosugars were discovered in plants known for their 
therapeutic action against diarrohea, dysentery and colic, cancers, diabetes 
and bacterial infections and some of these have been already developed as 
drugs. For example, Acarbose (Figure 1.4) was introduced on the market under 
the name GlucobayTM in the 1990s, for the treatment of type II diabetes and N-
butyl-DNJ, under the name Zavesca® (Figure 1.4), was released for the 
treatment of Gaucher’s disease. 
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Figure 1.4. Glucobay (acarbose) and Zavesca (N-butyl-DNJ) 
1.2.2 Classification 
Iminosugars belong to the polyhydroxylated alkaloid super-family of 
natural products. They can be classified in several ways: according to their 
carbon structure, to the functional groups they contain, to the activities in 
which they are involved, for their therapeutic applications, or to their natural 
sources, etc. The systematic and intuitive classification is based on their 
structure. 
They are present in an enormous amount of biological systems, such as 
plants or microorganisms. Undoubtedly the most numerous are monocyclic 
derivatives such as piperidines and pyrrolidine, which may also contain various 
substituents or functional groups to form disaccharides or oligosaccharides. 
Among the bicyclic iminosugars, within all the existing possibilities in nature 
are three basic types: pyrrolizidines, indolizidines and nortropanes. They all 
have at least a pyrrolidine ring.  
Here we present a few examples of natural iminosugars, classified 
according to their structure. 
Glycosidases inhibitors 
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1.2.2.a Piperidines 
In 1966, Inouye et al.13 discovered the first natural polyhydroxylated 
alkaloid, nojirimycin (NJ, Figure 1.5). Isolated from a Streptomyces filtrate, it 
was shown to actively inhibit α- and β-glucosidases and was therefore the first 
natural glucose mimic. Nojirimycin B (commonly called mannonojirimycin, 
Figure 1.5)14 and galactostatin (galactonojirimicyn, Figure 1.5)15 were isolated 
soon after. 
 
Figure 1.5. Piperidine iminosugars 
Azasugars bearing a hydroxyl group at C-1 were found to be relatively 
difficult to isolate and handle due to their instabillity. The first report of the 
synthesis of an iminosugar was the synthesis of 1-deoxynojirimicin (DNJ, Figure 
1.5) by Paulsen and co-workers in 196616 and after by Inouye et al., which was 
achieved through the reduction of the anomeric hydroxyl group.17 However, 
                                                            
13a) Inouye, S.; Tsuruoka, T.; Niida, T. J. Antibiot. 1966, 19, 288. b) Inouye, S.; 
Tsuruoka, T.; Ito, T.;Niida, T. Tetrahedron. 1968, 24, 2125 
14
 Niwa, T.; Tsouruoka, T.; Goi, H.; Kodama, Y.; Itoh, J.; Inouye, S.; Yamada, Y.; 
Niida, T.; Nobe, M.; Ogawa, Y.; J. Antibiot. 1984, 37, 1579. 
15
 Miyake, Y.; Ebata, M. Agric. Biol. Chem. 1988, 52, 661. 
16
 Paulsen, H. Angew. Chem. Int. Ed. Engl. 1966, 78, 495. 
17
 Inouye, S.; Tsuruoka, T.; Ito, T.; Niida, T. Tetrahedron 1968, 24, 2125. 
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DNJ was soon afterwards isolated from Mulberry trees18 as well as 
Streptomyces cultures.19 A further DNJ analogue is the 1,2-dideoxynojirimycin, 
fagomine (figure 1.5). Initially found in the seeds of Fagopyrum escuelentum 
(Polygonaceae) seeds,20 it was later discovered in the leaves and roots of 
Xanthocercis zambesiaca (Leguminosae) together with other fagomine 
analogues and derivatives.21 
In 1984, Cenci di Bello et al. extracted from the seeds of Baphia 
racemosa the first naturally occurring azaglucuronic acid, (2S)-carboxy-
(3R,4R,5S)-trihydroxypiperidine (Figure 1.5), which was found to inhibit the 
human liver β-D-glucuronidase and α-L-iduronidase.22 
1.2.2.b Pyrrolidines 
The five-membered pyrrolidine family of iminosugars is as important as 
the piperidine derivatives. As a matter of fact, five-membered ring iminosugars 
have been the object of extensive biological and chemical investigations.  
The first natural pyrrolidine alkaloid isolated was (2R,3R,4R,5R)-2,5-
dihydroxymethyl-3,4-dihydropyrrolidine (DMDP, Figure 1.6), as a mimetic of β-
D-fructofuranose, from Derris elliptica23 and after found in a lot of 
microorganisms24 like a common metabolite. 
                                                            
18
 Yagi, M.; Kouno, T.; Aoyagi, Y.; Murai, H. Nippon Nogei Kagaku Kaishi 1976, 50, 
571. 
19
 Murao, S. Miyata, S. Agric. Biol. Chem. 1988, 52, 661. 
20
 Koyama, M.; Sakamura, S. . Biol. Chem. 1974, 38, 1111. 
21
 Kato, A.; Asano, N.; Kizu, H.; Matsui, K.; Watson, A. A.; Nash, R. J. J. Nat. Prod. 
1997, 60, 312. 
22
 Cenci di Bello, I.; Dorling, P.; Fellows, L. E.; Winchester, B. FEBS Lett. 1984, 176, 
61. 
23
 Welter, A.; Jadot, J.; Dardenne, G.; Marlier, M.; Casimir, J. Phytochem. 1976, 15, 
747. 
24
 Watson, A. A.; Fleet, G. W. J.; Asano, N.; Molyneux, R. J.; Nash, R. J. Phytochem. 
2001, 56, 265. 
Glycosidases inhibitors 
13 
 
Figure 1.6. Pyrrolidine iminosugars 
In fact there are many natural derivatives with a structure very similar to 
DMDP, in which one or more different groups or carbon atoms are removed; 
for instance, 6-deoxy-DMDP (Figure 1.6) or 1,4-dideoxy-1,4-imino-D-arabinitol 
(DAB-1, Figure 1.6)25 or unsatured systems like nectrisine.26 
Pyrrolidine, although structurally different from natural enzyme 
substrates, are generally very good inhibitors because they are also able to 
mimic the transition state of the enzymatic reactions.27 
1.2.2.c Indolizidines 
Indolizidines are bicyclic alkaloids where the azapyranose ring is fused to 
a pyrrolidine ring via N-bridge.  
 
Figure 1.7. Indolizidine iminosugars 
                                                            
25
 Nash, R. J.; Bell, E. A.; Fleet, G. W. J.; Jones, R. H.; Williams, J. M. J. Chem. Soc.-
Chem. Commun. 1985, 738. 
26
 Shibata, T.; Nakayama, O.; Tsurumi, Y.; Okuhara, M.; Terano, H.; Kohsaka, M. J. 
Antibiot. 1988, 41, 296. 
27
 a)Tschamber, T.; Gessier, F.; Dubost, E.; Newsome, J.; Tarnus, C.; Kohler, J.; 
Neuburger, M.; Streith, J. Bioorg. Med. Chem. 2003, 11, 3559. b) Chevrier, C.; Defoin, 
A.; Tarnus, C. Bioorg. Med. Chem., 2007, 15, 4125. 
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The first example is swainsonine (Figure 1.7), isolated in 1979 from the 
leaves of Swainsona canescens (Leguminosae).28 Other indolizidine alkaloids 
are lentiginosine and castanospermine, the bicyclic equivalent of DNJ having 
an ethylene bridge between the hydroxymethyl group and the nitrogen atom 
(Figure 1.7). 29 
There have been extensive studies on the toxicity of swainsonine28 and 
castanospermine30 containing legumes S. canescens and C. australe, 
respectively. In fact swainsonine was also found in locoweeds (Astragalus spp. 
and Oxytropis spp.), which causes the disorder ‘locoism’ in Western United 
States.31 
1.2.2.d Pyrrolizidines 
Pyrrolizidine structure is composed by two fused pyrrolidines with a 
bridgehead nitrogen atom. 
The first natural polyhydroxylated pyrrolidine was alexine (figure 1.8) 
from the seeds of Alexa leiopetala.32 Subsequently, australine (Figure 1.8), the 
7a-epimer of alexine, was isolated from Castanospermum australe. These two 
pyrrolizidines present a pattern of substitution, on one of the two pyrrolidine 
rings, that is repeated in a large number of other pyrrolizidines and which 
reminds the structure of DMDP and castanospermine. 
                                                            
28
 Colegate, S. M.; Dorling, P. R.; Huxtable, C. R. Aust. J. Chem. 1979, 32, 2257. 
29
 Asano, N.; Nash, R. J.; Molyneux, R. J.; Fleet, G. W. J. Tetrahedron: Asymmetry 
2000, 11, 1645.  
30
 Hohenschutz, L. D.; Bell, E. A.; Jewess, P. J.; Leworthy, D. P.; Pryce, R. J.; Arnold, 
E.; Clardy, J. Phytochem. 1981, 20, 811.  
31
 Molyneux, R. J.; James, L. F. Science 1982, 216, 190. 
32
 Nash, R. J.; Fellows, L. E.; Dring, J. V.; Fleet, G. W. J.; Derome, A. E.; Hamor, T. 
A.; Scofield, A. M.; Watkin, D. J. Tetrahedron Lett. 1988, 29, 2487. 
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Figure 1.8. Pyrrolizidine iminosugars 
Another very interesting pyrrolizidine is casuarine (Figure 1.8). This 
molecule was found, with its 6-O-α-glucoside, in the barks of Casuarina 
equisetifolia,33 a plant used in traditional medicine in Samoa for the treatment 
of cancer, or in the leaves of Eugenia jambolana.34  
A series of pyrrolizidines with highly diversified structures were isolated 
from Hyacinthoides non-scripta and Scilla campanulata (both from 
Hyacinthaceae family) and called hyacinthacines (for instance, hyacinthacine 
C1 or hyacinthacine A2, Figure 1.8).
35,36 
                                                            
33Nash, R. J.; Thomas, P. I.; Waigh, R. D.; Fleet, G. W. J.; Wormald, M. R.; de Q. 
Lilley, P. M.; Watkin, D. J. Tetrahedron Lett. 1994, 35, 7849. 
34
 Wormald, M.; Nash, R.; Watson, A. A.; Bhadoria, B. K.; Langford, R.; Sims, M.; 
Fleet George, W. J. Carbohydr. Lett. 1996, 2, 169. 
35
 Nash, R. J.; Fellows, L. E.; Dring, J. V.; Stirton, C. H.; Carter, D.; Hegarty, M. P.; 
Bell, E. A. Phytochem. 1988, 27, 1403. 
36
 Asano, N.; Kuroi, H.; Ikeda, K.; Kuzu, H.; Kameda, Y.; Kato, A.; Adachi, I.; Watson, 
A. A.; Nash, R. J.; Fleet, G. W. J. Tetrahedron: Asymmetry 2000, 11, 1. 
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Finally an important example is 7a-epialexaflorine (Figure 1.8), extracted 
from Alexa grandiflora, in which the castanospermine hydroxymethyl group 
has been replaced with a carboxy group. This is the first example of a natural 
aminoacid in which the carboxy group is in position 3 of a pyrrolizidine.37 
1.2.2.e Nortropanes 
Nortropanes are a relatively new class of polyhydroxylated alkaloids that 
contain an azapyranose ring, which are isolated primarily from the Atropa 
belladonna (Solanaceae) and Convolvulus arvenis (Convolvunaceae) but also 
from Moraceae families.38  
 
Figure 1.9. Nortropane iminosugars 
These iminosugars analogues, called calystegines are interesting 
because they contain a tertiary hydroxyl group at the bridgehead carbon 
atom29 with the exception of calystegine N1 (Figure 1.9).
24 Based on 
electrophoresis separation they were divided into two groups, calystegines A 
and calystegines B.39 The major component of the A group was calystegine A3 
(Figure 1.9) and of the group B was calystegine B1 (Figure 1.9). 
                                                            
37
 Pereira, A. C. D.; Kaplan, M. A. C.; Maia, J. G. S.; Gottlieb, O. R.; Nash, R. J.; Fleet, 
G.; Pearce, L.; Watkin, D. J.; Scofield, A. M. Tetrahedron 1991, 47, 5637. 
38
 Asano, N.; Oseki, K.; Tomioka, E.; Kizu, H.; Matsui, K. Carbohydr. Res. 1994, 259, 
243. 
39
 Tepfer, D.; Goldmann, A.; Pamboukdjian, N.; Maille, M.; Lepingle, A.; Chevalier, 
D.; Denarie, J.; Rosenberg, C. J. Bacteriol. 1988, 170, 1153. 
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2.1 The PhD Thesis 
Due to the therapeutic properties of natural iminosugars, this work is 
aimed to the total synthesis of some natural pyrrolizidine and pyrrolidine 
alkaloids and their unnatural analogues. The natural iminosugars synthesized 
were chosen on the basis of their biological activity, and the unnatural ones 
were targeted for the purpose of molecular modelling studies. 
The most important family studied is based on the casuarine structure: 
the total synthesis of casuarine and the first total synthesis of its 6-O-α-
glucoside and of a series of unnatural derivatives, were accomplished. 
Two different synthetic strategies were used, in order to afford the 
same or different iminosugars. In all cases the common building block was a 
carbohydrate derived nitrone (see chapter 2.2.2) previously used in our 
research group for the synthesis of hyacinthacine A2 (Scheme 2.1), a related 
pyrrolizidine alkaloid (See Chapter 3.2.2). 
Scheme 2.1. Sintheses of Hyacinthacine A2 by Goti and co-workers and by Py and co-workers 
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The same nitrone, with a different synthetic approach based on a 
pinacol-type coupling, was used shortly after by Py and co-workers40 to obtain 
the same target. 
While the synthesis developed in our group was based on a 1,3-dipolar 
cycloaddition approach, the Py’s synthetic strategy used the inversion of the C-
N bond polarity in nitrones which represent the donor partner in presence of 
SmI2.
40 The key step was stereoselective reductive coupling of the nitrone with 
ethyl acrylate, which allowed the assembly of the bicyclic core of the target 
molecule (Scheme 2.1).  
Starting from this nitrone, our first synthetic strategy to casuarine type 
targets was based on the 1,3 dipolar cycloaddition reaction between a chiral 
nitrone and suitably substituted cis-alkenes (Scheme 2.2). 
Scheme 2.2. 1,3-dipolar cycloaddition reaction based synthetic strategy 
The alternative strategy was based on the addition of organometal 
derivatives to the chiral nitrone to give pyrrolidine or pyrrolizidine alkaloids 
(Scheme 2.3). 
Scheme 2.3. Organometallic addition synthetic strategy  
                                                            
40
 Desvergnes, S.; Py, S.; Vallée, Y. J. Org. Chem. 2005, 70, 1459. 
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2.2 Nitrones 
As previously mentioned, the key intermediate for both the envisaged 
synthetic strategies was a nitrone. Here are briefly outlined the features of 
nitrones with particular emphasis on their reactivity. 
2.2.1 Nitrones and their reactivity 
Nitrones are dipolar compounds, i.e. “electrically neutral molecules 
carrying a positive and a negative charge in one of their major canonical 
descriptions”.41 In particular, they are best represented by the two limit 
structures A and B (Figure 2.1), with the negative charge mostly located on the 
oxygen atom and the positive charge delocalized at the nitrogen atom 
(structure A) and at the C-1 carbon atom (structure B). 
 
Figure 2.1. Nitrone charge delocalization 
Nitrones (or azomethine oxides) were first prepared by Beckmann in 
189042 and named after a shortening of “nitrogen-ketones” by Pfeiffer in 1916 
to emphasize their similarity to ketones.43 
To date various methods are known for the synthesis of nitrones, 
starting from different substrates, as described in Scheme 2.4: 
                                                            
41
 McNaught, A. D.; Wilkinson, A. In IUPAC Compendium of Chemical Terminology 
2nd Edition, 1997. 
42
 a) Beckmann, E. Ber. Dtsch. Chem. Ges. 1890, 23, 3331. b) Beckmann, E. Ber. 
Dtsch. Chem. Ges. 1894, 27, 1957. 
43
 Pfeiffer, P. Annalen 1916, 72. 
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Scheme 2.4. Synthetic strategies for the obtainment of nitrones 
The main methods for nitrone synthesis are: oxidation of 
hydroxylamines, amines and imines; N-alkylation of oximes on 
nitrocompounds; condensation of carbonyl compounds with hydroxylamines 
and are widely described in the literature.44 
As mentioned before, nitrones are extremely versatile compounds and 
they have found wide application in organic synthesis; in particular they are 
very useful tools for the construction of structurally complex molecules and 
particularly nitrogen-containing biologically active compounds. 
Their chemistry is hugely varied and frequently reviewed, but is 
dominated by their use as 1,3-dipoles (Scheme 2.5, route I) for cycloaddition 
                                                            
44
 Revuelta, J.; Cicchi, S.; Goti, A.; Brandi, A. Synthesis 2007, 4, 485. 
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reactions45 and in reaction with nucleophiles (Scheme 2.5, route II)46 because 
of their highly polarized C=N bond. 
 
Scheme 2.5. Nitrones reactivity 
Furthermore, the synthetic applications of nitrones have recently been 
extended to a novel reductive cross-coupling process (pinacol-type coupling) 
between nitrones and carbonyl compounds (Scheme 2.5, routes III and IV), 
                                                            
45
 a) Tufariello, J. J. In 1,3-Dipolar Cycloaddition Chemistry; Padwa, A. Ed; John 
Wiley & Sons: New York 1984. b) Confalone, P. N.; Huie, E. M. Org. React. 1988, 36, 
1. c) Torssell, K. B. G. Nitrile Oxides, Nitrones, and Nitronates in Organic Synthesis; 
Feuer, H., Ed.; VCH Publishers: New York 1988. d) Frederickson, M. Tetrahedron 
1997, 53, 403. e) Gothelf, K. V.; Jørgensen, K. A. Chem. Rev. 1998, 98, 863. f) Jones, 
R. C. F.; Martin, J. N. In Synthetic Applications of 1,3-Dipolar Cycloaddition Chemistry 
Toward Heterocycles and Natural Products; Padwa, A.; Pearson, W. H., Eds.; John 
Wiley & Sons: New York 2002. g) Osborn, H. M. I.; Gemmell, N.; Harwood, L. M. J. 
Chem. Soc. Perkin Trans. 1 2002, 2419. h) Desimoni, G.; Tacconi, G.; Barco, A.; 
Pollini, G. P. Natural Products Synthesis Through Pericyclic Reactions; ACS 
Monograph n. 180; Caserio, M. C., Ed.; American Chemical Society: Washington 1983. 
i) Annunziata, R.; Cinquini, M.; Cozzi, F.; Raimondi, L. Gazz. Chim. Ital. 1989, 119, 
253. 
46
 a) Bloch, R. Chem. Rev. 1998, 98, 1407. b) Enders, D.; Reinhold, U. Tetrahedron: 
Asymmetry 1997, 8, 1895. c) Lombardo, M.; Trombini, C. Synthesis 2000, 759. d) 
Merino, P. In Science of Synthesis; Padwa, A., Ed.; Thieme: Stuttgart 2004. e) Merino, 
P.; Franco, S.; Merchan, F. L.; Tejero, T. Synlett. 2000, 442. f) Lombardo, M.; 
Trombini, C. Curr. Org. Chem. 2002, 6, 695. 
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promoted by samarium diiodide, and other metal-mediated reactions.47 The 
reactions produce vicinal amino alcohols48 or β-amino acids,49 thereby 
enhancing the synthetic versatility of these reagents. Likewise, the use of 
nitrones as free-radical traps (spin traps) is well established, as they have been 
designed to react with oxygen radicals to lengthen their half-lives and allow 
their detection in EPR studies.50 Nitrones have also been used in vivo as 
protective agents against radicals generated by oxidative stress.51  
                                                            
47
 Cardona, F.; Goti, A. Angew. Chem. Int. Ed. 2005, 44, 7832. 
48
 Masson, G.; Py, S.; Vallée, Y. Angew. Chem. Int. Ed. 2002, 41, 1772. 
49
 a) Masson, G.; Cividino, P.; Py, S.; Vallée, Y. Angew. Chem. Int. Ed. 2003, 42, 2265. 
b) Riber, D.; Skrydstrup, T. Org. Lett. 2003, 5, 229. 
50
 Janzen, E. G.; Haire, D. L.; In Advances in Free-Radical Chemistry; Tanner, D. D., 
Ed.; JAI Press: Greenwich 1990. 
51
 a) Floyd, R. A.; Hensley, K. Ann. N. Y. Acad. Sci. 2000, 899, 222. b) Floyd, R. A. 
Proc. Soc. Exp. Biol. Med. 1999, 222, 236. 
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2.2.2 The key intermediate 
As already mentioned all the products synthesized derive from a 
common nitrone key intermediate (scheme 2.6): 
 
Scheme 2.6. The key intermediate 
Nitrone 1 has the correct stereochemistry of the pyrrolidine alkaloids 
and of ring A of the pyrrolizidine alkaloids depicted in Scheme 2.6. 
Nitrone 1 can be obtained from products of the chiral pool by a “one-
pot” strategy starting from tribenzyl L-xylose,52 or stepwise from tribenzyl D-
arabinose (Scheme 2.7).53 
                                                            
52
 Cicchi, S.; Marradi, M.; Vogel, P.; Goti, A. J. Org. Chem. 2006, 71, 1614. 
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Scheme 2.7 Synthesis of nitrone 1 
The best synthetic strategy, thanks to the greater accessibility of the 
starting material and the best overall yield, is that from tribenzyl D-arabinose 
(4, Scheme 2.8).  
Scheme 2.8. Synthesis of nitrone 1 from D-arabinofuranose 
Reaction conditions: a) NH2OH
.HCl, py, rt, 24 h, 100%; b) TBDPSCl, py, rt, 18 h, 100%; c) I2, 
PPh3, Im, toluene, 60 °C, 2 h, 85%; d) TBAF, THF, rt, 18 h, 96% 
 
The key feature of this synthetic strategy is the double inversion of 
configuration at C-4 of tribenzyl D-arabinose (4), obtained through iodination 
                                                                                                                                                     
53
 a) Cardona, F.; Faggi, E.; Liguori, M.; Cacciarini, M.; Goti, A. Tetrahedron Lett. 
2003, 44, 2315. b) Cramona, A. T.; Wightman, R. H.; Robina, I.; Vogel, P. Helv. Chim. 
Acta 2003, 86, 3066. c) Ref. 40 
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of alcohol 7 followed by cyclization of 5 to give 1 (Scheme 2.8).53a The two-fold 
inversion of configuration at C-4 of the carbohydrate that occurs in this 
sequence ensures the access to nitrones in wich the absolute configuration, 
with respect to the starting carbohydrate derivative, is overall retained at all 
stereocenters. Nitrone 1 has the correct relative and absolute stereochemistry 
at C-1, C-2 and C-3 of all the pyrrolizidine and at C-2, C-3 and C-4 of all the 
pyrrolidine target molecules. 
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2.3 Experimental Section 
2.3.1 General 
Commercial reagents were used as received. All reactions were 
magnetically stirred and monitored by TLC on 0.25 mm silica gel plates (Merck 
F254) and column chromatography was carried out on Silica Gel 60 (32-63 µm). 
Yields refer to spectroscopically and analytically pure compounds unless 
otherwise stated. NMR spectra were recorded on Varian Mercury-400, Varian 
INOVA-400 (1H, 400 MHz; 13C, 100 MHz), or Varian Gemini-200 (13C, 50 MHz) 
spectrometers. Infrared spectra were recorded with a Perkin-Elmer Spectrum 
BX FT-IR System spectrophotometer. Mass spectra were recorded on a QMD 
1000 Carlo Erba instrument by direct inlet; relative percentages are shown in 
brackets. ESI mass spectra were recorded by direct inlet on a ThermoScientific 
LCQ Fleet Ion Trap spectrometer with Surveyor Plus LC System; relative 
percentages are shown in brackets. ESI full MS were recorded on a Thermo 
LTQ instrument by direct inlet; relative percentages are shown in brackets. 
Elemental analyses were performed with a Perkin-Elmer 2400 analyzer. Optical 
rotation measurements were performed on a JASCO DIP-370 polarimeter. 
(1E)- and (1Z)-2,3,5,-Tri-O-benzyl-D-arabinose-O-oximes (6).54 2,3,5-Tri-
O-benzyl-D-arabinose (4, 12.5 g, 29.7 mmol) and hydroxylamine hydrochloride 
(8.29 g, 119 mmol) were dissolved in dry pyridine (60 mL), and 30 g of 3Å 
pellets molecular sieves were added under nitrogen atmosphere. The reaction 
mixture was left stirring at rt, under nitrogen atmosphere for 24 h. Then, the 
molecular sieves were filtrated and washed several times with toluene. 
Evaporation under reduced pressure afforded an oil that was subsequently 
partially dissolved in Et2O. After filtration, evaporation under reduced pressure 
of the filtrate afforded oxime 6 as a yellow oil, enough pure to be used for the 
                                                            
54
 Julina, R.; Vasella, A.. Helv. Chim. Acta 1985, 68, 819-830. 
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next step. Both diastereoisomers (E and Z) are formed (12.9 mg, quantitative 
yield). 1H-NMR (200 MHz, CDCl3) δ 7.60 (d, J=7.8 Hz, 1 H, H-1 (E)) 7.40-7.24 (m, 
15 H (E) + 15 H (Z)), 7.20 (d, J=7.0 Hz, 1 H, H-1 (Z)), 4.71-4.37 (m, 7 H (Z) + 7 H 
(E)), 4.13-4.08 (m, 1H (E) + 1 H (Z)), 3.78-3.68 (m, 3 H (E) + 3 H (Z)). 
(1E)-and(1Z)-2,3,5,-tri-O-benzyl-D-arabinose-O-[(tert-butyl)diphenylsilyl] 
oximes (7). To a cooled (0 °C) solution of 6 (12.9 g, 29.7 mmol) in 70 mL of dry 
pyridine, TBDPSCl (7.73 mL, 29.7 mmol) was added dropwise under nitrogen 
atmosphere. The mixture was left stirring at rt under nitrogen atmosphere for 
18 h. After filtration over Celite® and washing with toluene, the mixture was 
evaporated under reduced pressure to afford 7 as a yellow oil (20 g, 
quantitative yield), enough pure to be used for the next step. An analytically 
pure sample was obtained by filtration over a short pad of silica gel (eluent 
petroleum ether/ Et2O 3:2, Rf = 0.26). [α]D
24 = – 24.4 (c 1.32, CHCl3). 
1H-NMR 
(200 MHz, CDCl3) δ 7.92-7.76 (m, 10 H, Ar), 7.52-7.26 (m, 16 H, Ar, H-1), 4.77-
4.56 (m, 6 H, Bn), 4.38-4.32 (m, 1 H), 4.15-4.06 (m, 1 H), 3.76-3.69 (m, 3 H), 
1.26 (s, 9 H, tBu).  13C-NMR (50 MHz, CDCl3) δ 153.7 (d, C=N), 137.3, 136.6 (s, 
Ar), 135.0-134.3 (d, 10 C, Ar), 132.8-132.5 (s, 3 C, Ar), 129.3-124.8 (d, 15 C, Ar), 
79.2 (d, 1C), 77.3 (d, 1 C), 76.6 (t, 1 C), 73.3 (t, 1 C), 72.8 (t, 1 C), 70.4 (t, 1 C), 
69.5 (d, 1 C), 26.6 (q, 3 C, tBu), 18.8 (s, tBu). IR (CDCl3): 3571, 3071, 2931, 2859 
cm-1. MS (EI): m/z 616 (M+-tBu, 5), 508 (5), 402 (5), 199 (100), 181 (45), 91 
(100). Anal. Calcd. For C42H47NO5Si (673.90): C, 74.84; H, 7.04; N, 2.08. Found: 
C, 74.45; H, 7.06; N, 2.26. 
(1E)- and (1Z)-2,3,5-Tri-O-benzyl-4-deoxy-4-iodo-L-xylose-O-[(tert-Butyl) 
diphenylsilyl]oximes (5). To a stirred solution of 7 (9.8 g, 14.5 mmol) in dry 
toluene (100 mL), I2 (5.53 g, 21.8 mmol), PPh3 (4.95 g, 18.9 mmol) and 
imidazole (3.05 g, 44.9 mmol) were added under nitrogen atmosphere. The 
brown mixture was heated at 60-65 °C for 2 h. A saturated aqueous solution of 
NaHCO3 and Na2S2O3 (60 ml) was added and the mixture was left stirring at rt 
for 15 minutes. Then, it was extracted with CH2Cl2 (3×80 mL). The combined 
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organic phases were washed with a saturated aqueous solution of NaCl, dried 
over Na2SO4, filtered and concentrated under reduced pressure to afford 5 as a 
colourless oil, that was quickly filtered over a short pad of silica gel (eluent 
petroleum ether/EtOAc 10:1, Rf = 0.9) to afford pure 5 (9.6 g, 85 % yield). [α]D
24 
= + 16.2 (c 1.39,CHCl3). 
1H-NMR (200 MHz, CDCl3) δ 7.78-7.62 (m, 10 H, Ar), 
7.55 (d, J=7.6 Hz, 1 H, H-1), 7.40-7.10 (m, 15 H, Ar), 4.86 (d, J=11.7 Hz, 1 H), 
4.66 (d, J=11.3 Hz, 1 H), 4.45 (d, J=11.3 Hz, 1 H), 4.30-4.20 (m, 5 H), 4.15-4.07 
(m, 1 H), 3.74-3.69 (m, 1 H), 3.60-3.48 (m, 1 H), 1.09 (s, 9 H, tBu). 13C-NMR (50 
MHz, CDCl3) δ 152.8 (d, C=N), 138.3-133.1 (s, 5 C, Ar), 129.7-127.5 (d, 25 C, Ar), 
80.9 (d, 1 C), 77.4 (d, 1 C), 74.7 (t, 1 C), 72.8 (t, 1 C), 72.6 (t, 1 C), 71.3 (t, 1 C), 
31.3 (d, CH-I), 27.1 (q, 3 C, tBu), 19.3 (s, tBu); IR (CDCl3): 3069, 2930, 2858, 
1710, 1589, 1453, 1117 cm-1. MS (EI): m/z 657 (M+-I, 0.3), 508 (4), 309 (20), 199 
(44), 91 (100). Anal. Calcd. For C42H46NO4ISi (783.86): C, 64.35; H, 5.93; N, 1.79. 
Found: C, 64.16; H, 6.04; N, 2.10. 
(3R,4R,5R)-3,4-dibenzyloxy-5-benzyloxymethyl-1-pyrroline-N-oxide (1). 
To a stirred solution of 5 (7.7 g, 9.82 mmol) in dry THF (50 mL) a 1 M solution 
of TBAF in THF (10.2 mL, 10.2 mmol) was added under nitrogen atmosphere. 
The mixture was left stirring at rt under nitrogen atmosphere for 18 h. The 
solvent was evaporate under reduced pressure afforded a yellow solid. 
Purification by flash column chromatography on silica gel (EtOAc /petroleum 
ether 5:1), afforded pure nitrone 1 as a yellow solid (3.94 g, 96% yield), mp 80-
82 °C. [α]d
19 = - 41.7 (c 1.00, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.41-7.30 (m, 
15 H, Ar), 6.92 (br s, 1 H, H-2), 4.70 (dd, J=2.1, 1.8 Hz, 1 H, H-3), 4.65 (d, J=12.0 
Hz, 1 H, Bn), 4.61-4.58 (m, 4 H, Bn), 4.55 (d, J=12.0 Hz, 1 H, Bn), 4.41 (dd, J=3.4, 
2.2 Hz, 1H, H-4), 4.10-4.02 (m, 2 H, Ha-6, H-5), 3.81 (dd, J=9.9, 2.6 Hz, 1 H, Hb-
6). 13C NMR (50 MHz, CDCl3) δ 137.7, 137.2, 137.1 (s, Ar), 132.9 (d, C-2), 128.6, 
128.5-127.7 (d, 15 C, Ar), 82.7 (d, C-3), 80.3 (d, C-4), 77.4 (d, C-5), 73.9 (t, Bn), 
71.9 (t, Bn), 71.6 (t, Bn), 66.1 (t, C-6). IR (CDCl3): 3090, 3067, 3033, 2933, 2868, 
2247, 1584, 1455, 1095 cm-1. MS (EI): m/z 285 (6), 234 (3), 176 (6), 132 (19), 91 
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(100). Anal. Calcd. for C26H27NO4 (417.50): C, 74.80; H, 6.52; N, 3.35. Found: C, 
74.51; H, 6.78; N, 3.01. 
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3.1 The synthetic strategy 
Nitrones can be conveniently used in 1,3-dipolar cycloaddition reactions. 
The 1,3-dipolar cycloaddition reaction of nitrones to alkenes as dipolarophiles 
forms an isoxazolidine adduct. The synthetic utility of this reaction is 
demonstrated by the variety of attractive compounds which are available from 
isoxazolidines. 
The general synthetic strategy followed for the synthesis of the 
pyrrolizidine alkaloids is outlined in Scheme 3.1.  
 
Scheme 3.1. Synthetic strategy for the synthesis of pyrrolizidines 
We took advantage of a stereocontrolled cyclic nitrone cycloaddition 
strategy55 employing polyfunctionalyzed nitrone 1 and suitable (Z) - 
configurated dipolarophiles 8, which latter were then converted into 
pyrrolizidinone derivatives 10 by reductive ring opening/cyclization. 
Intermediates 10 bear a free hydroxyl group on C-6 of the pyrrolizidine ring, 
thus allowing selective glucosylation in this position. A good choice of the 
dipolarophile is crucial for the success of the strategy. 
                                                            
55
 Brandi, A.; Cardona, F.; Cicchi, S.; Cordero, F. M.; Goti, A. Chem. Eur. J. 2009, 15, 
7808. 
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The most favoured approach of alkenes to nitrone 1 occurs through exo-
anti transition states:  
 
Figure 3.1. Favourite transition state of cycloaddition 
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The substituents at C-3 and C-5 allow to obtain exclusively anti 
cycloadducts and the steric bulk of substituent at C-4 ensures an excellent exo 
selectivity. 
The complete stereoselectivity of the 1,3-dipolar cycloaddition, which 
allowed the selective installation of the three new stereocenters 
(corresponding to C-6, C-7 and C-7a in the target molecules) in one step with 
the required configuration, may be ascribed to the peculiar all-trans 
disposition of the benzyloxy groups in nitrone 1, which hampered any endo or 
syn approaches.44,53a 
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3.2 Casuarine and its unnatural derivatives 
3.2.1 Introduction 
Casuarine, (1R,2R,3R,6S,7S,7aR)-3-(hydroxymethyl)-1,2,6,7-tetrahydroxy 
pyrrolizidine (11, Figure 3.2), has been isolated from the bark of Casuarina 
equisetifolia L. (Casuarinaceae) and from the leaves of Eugenia jambolana 
Lam. (Myrtaceae),33,34 two plants well known for their therapeutic action 
against diarrhoea, dysentery and colic,56 breast cancer,1 diabetes and bacterial 
infections.2,57 Compound 11 is a strong inhibitor of the fungal glucoamylase 
from Aspergillus niger, with very high IC50 values (IC50 = 0.7 μM).
58 
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Figure 3.2. Casuarine and acarbose 
Isolation and purification of 11 from natural sources are very difficult 
and expensive and afford only minute amounts of compound. Furthermore, 
very few total syntheses of casuarine (11) have been reported to date.59,60 The 
                                                            
56
 Chopra, R. N.; Nayar, S. L.; Chopra, I. C. Glossary of Indian Medicinal Plants, 
Council of Scientific and Industrial Research (India), New Dehli, 1956, p.55; b) Nair, 
R. B.; Santhakumari, G. Ancient Science of Life 1986, 6, 80. 
57
 a) Grover, J. K.; Yadav, S.; Vats, V. J. Ethnopharmacol. 2002, 81, 81; b) Mentreddy, 
S. R. J. Sci. Food. Agric. 2007, 87, 743. 
58
 Kato, A.; Kano, E.; Adachi, I.; Molyneux, R. J.; Watson, A. A.; Nash, R. J.; Fleet, G. 
W. J.; Wormald, M. R.; Kizu, H.; Ikeda, K.; Asano, N. Tetrahedron: Asymmetry 2003, 
14, 325. 
59
 a) Denmark, S. E.; Hurd, A. R. Org. Lett. 1999, 1, 1311; b) Denmark, S.; Hurd, A. R. 
J. Org. Chem. 2000, 65, 2875; c) Izquierdo, I.; Plaza, M. T.; Tamayo, J. A. Tetrahedron 
2005, 61, 6527; d) Nash, R. J.; Fleet, G. W. J.; Van Ameijde, J.; Horne, G. PCT Int. 
Appl. (2006), WO2006008493. 
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highly complex and challenging structure of casuarine, as it is the most highly 
hydroxylated pyrrolizidine alkaloid and possesses six contiguous carbon 
stereocenters, is presumably responsible for the limited number of synthetic 
approaches described. 
We decided to approach the synthesis of casuarine (11), hyacinthacine 
A2 (13), (-)-uniflorine A (18) (another natural product with inhibition 
properties) and some unnatural derivatives like 7-deoxycasuarine (14) and its 
lactam 15, 7-homocasuarine (16), and 7-epiaustraline (17) (Figure 3.3) by the 
1,3-dipolar cycloaddition strategy. Then, with these molecules in hand, we 
performed molecular modelling and inhibition studies. 
 
Figure 3.3. Natural and unnatural pyrrolizidine alkaloids 
3.2.2 Synthesis of hyacinthacine A2 and 7-deoxycasuarine 
The 1,3-dipolar cycloaddition of nitrone 1 to dimethylacryl amide (19) is 
the first key-step for the synthesis of hyacintacine A2 (13), 7-deoxycasuarine 
(14) and its lactam derivate 15 (Figure 3.3). 
                                                                                                                                                     
60
 Casuarine has also been obtained as a side-product during the synthesis of targeted 3-
epi-casuarine: a) Van Ameijde, J.; Horne, G.; Wormald, M. R.; Dwek, R. A.; Nash, R. 
J.; Jones, P. W.; Evinson, E. L.; Fleet, G. W. J. Tetrahedron:Asymmetry 2006, 17, 2702. 
For related syntheses of casuarine diastereoisomers, see also: b) ref. 59d; c) Izquierdo, 
I.; Plaza, M. T.; Tamayo, J. A. J. Carbohydr. Chem. 2006, 25, 281; d) Ritthiwigrom, T.; 
Pyne, S. G. Org. Lett. 2008, 10, 2769. 
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Scheme 3.2. Synthesis of 7-deoxycasuarine lactam 
Reaction conditions: a) DCM, rt, 3 d, 85%; b) Zn, AcOH/H2O, 50 °C, 4 h, 80%; c) H2, Pd/C, EtOH, 
3 d, 88%. 
The cycloaddition reaction gave regio- and stereo-selectively 
isoxazolidine 20 with 85% yield. N-O bond cleavage of 20 was then achieved by 
treatment with Zn in acetic acid, affording lactam 21 with 80% yield. 
Compound 21 was the key intermediate for the total syntheses of all the three 
target molecules. Hydrogenation in EtOH catalyzed by Pd/C afforded lactam 15 
with 88% yield (Scheme 3.2).  
 
Scheme 3.3. Synthesis of hyacinthacine A2 and 7-deoxycasuarine 
Reaction conditions: a) LiAlH4, THF, reflux, 1.5 h, 75%; b) H2, Pd/C, HCl, EtOH, 3 d, 88%; c) MsCl, 
NEt3, DCM, rt, 2 h, 100%; d) LiAlH4, THF, reflux, 1.5 h, 80%; e) H2, Pd/C, HCl, MeOH, 3 d, 72%. 
Reduction of the C=O bond with LiAlH4 in refluxing THF gave compound 
22 with 75% yield which, after catalytic hydrogenation in EtOH, afforded 7-
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deoxycasuarine (14) in 88% yield (Scheme 3.3). Deoxygenation at C-6 was 
obtained through mesylation of 21 followed by treatment of mesylate 23 with 
LiAlH4 in refluxing THF, which gave 24 with 80% yield over 2 steps. Finally 
catalytic hydrogenation provided hyacinthacine A2 (13) with 72% yield (Scheme 
3.3). 
3.2.3 Synthesis of 7-homocasuarine  
For the synthesis of unnatural 7-homocasuarine (16), dimethyl maleate 
(25) was chosen as the suitable dipolarophile. Cycloaddition reaction of 
nitrone 1 to 25 in dichloromethane at room temperature afforded 
stereoselectively adduct 26 in 78% yield (Scheme 3.4). 
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Scheme 3.4. Synthesis of 7-homocasuarine 
Reaction conditions: a) DCM, rt, 4 d, 78%; b) Zn, AcOH/H2O, 50 °C, 3 h, 90%; c) LiAlH4, THF, 
reflux, 2 h, 100%; d) H2, Pd/C, HCl, EtOH, rt, 4 d, 89%. 
Treatment with Zn in acetic acid at 50°C for 3 h gave lactam 27 in 90% 
yield. Then, reduction of both C=O bonds, the ester and lactam moiety, with 
excess of LiAlH4 in refluxing THF provided diol 28 quantitatively. Finally, 
catalytic hydrogenation with Pd/C in the presence of HCl gave unnatural 7-
homocasuarine (16) in 89% yield.  
Chapter 3 
42 
 
3.2.4 Syntheses of Casuarine and 7-epiaustraline  
The major and most challenging problem in the synthesis of casuarine 
(11) is to install an OH group at the position 7 of the pyrrolizidine. A plausible 
retrosynthetic analysis suggested lactam 29 such direct precursor of casuarine 
(11) by the synthetic equivalence R3Si = OH using a Tamao-Fleming reaction, 
commonly occurring with complete retention of configuration. The lactam 
with the silylated group at position 7 can derive from the silylated isoxazolidine 
30, inturn accessible by a cycloaddition reaction of nitrone 1 with an 
appropriated silylated alkene (Scheme 3.5): 
 
 
Scheme 3.5. Retrosynthetic analysis for casuarine synthesis 
For this reason the chosen alkene for the cycloaddition reaction was the 
silylated alkene 31 (Scheme 3.6). 
Scheme 3.6. Alkene 31 synthesis 
Reaction conditions: a) 1) BuLi, THF, -78°C, 15 min.; 2) ClC=OCO2Et, THF, -78°C, 3 h, 88% over 
two steps; b) H2, Lindlar cat., 4 h, rt, 94%. 
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Alkyne 33 was obtained from (dimethylphenylsilyl)-acetylene (32) by 
reaction with BuLi and subsequent addition of ethyl chloroformate in 88% 
yield and then was hydrogenated with Lindlar catalyst and H2 in toluene. The 
reaction was controlled every 30 minutes via 1HNMR, and after 4 h, alkene 31 
was obtained in 94% yield (Scheme 3.6). 
The obtained Z-alkene 31 was used in the 1,3-dipolar cycloaddition 
reaction with nitrone 1. Although no close example was reported, we were 
confident that Z-disubstituted alkene 31 could provide the correct 
regioselectivity in the cycloaddition step on the basis of related nitrone 
cycloaddition reactions with vinyl silanes.61  
Scheme 3.7. Casuarine synthesis 
Reaction conditions: a) DCM, rt, 36 h, 79%; b) Zn, AcOH/H2O, 60-65°C, 5 h, 93%; c) Hg(CF3CO2)2, 
TFA, AcOH, AcOOH, CHCl3, rt, 76%; c) LiAlH4, THF, reflux, 78%; e) H2, Pd/C, MeOH, HCl, rt, 
100%. 
Indeed, the desired adduct 34 was obtained with high regio- and 
stereoselectivity in 79% yield (Scheme 3.7). The regiochemistry and relative 
stereochemistry of 34 were firmly established on the basis of COSY and NOESY 
experiments, which confirm the preference for an exo-anti transition state.  
                                                            
61
 DeShong, P.; Leginus, J. M.; Lander Jr, S. W. J. Org. Chem. 1986, 51, 574. 
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Reductive cleavage of the N-O bond53a,62,63 with Zn in acetic acid 
followed by spontaneous N-cyclization afforded lactam 35 in 93% yield. Then, 
the Tamao-Fleming reaction64 allowed oxidation of the C-Si bond with 
retention of configuration and 76% yield of diol 36. Oxidation of the C-Si bond 
to C-OH with retention of configuration was confirmed by NOESY experiments 
performed on the diacetyl derivative of 36. Finally, reduction of 36 with LiAlH4 
in refluxing THF (78% yield), followed by catalytic hydrogenation of 
pyrrolizidine 37, occurred quantitatively which provided casuarine (11) as a 
white solid, mp 180-182 °C (Scheme 3.7). The spectroscopic data and physico-
chemical properties of the synthesized compound were identical to those of 
natural casuarine.33 Synthetic 11 showed a specific optical rotation ([α]20D = 
+14.4 (c 0.52, H2O)) in good agreement with those reported for the natural and 
for the previously synthesized compound ([α]24D = +16.9 (c 0.80, H2O);
19 [α]27D = 
+10.8 (c 1.02, H2O),
59a respectively). In conclusion, this total synthesis 
furnished casuarine in 5 steps and 44% overall yield from nitrone 1, which 
compares well with the previously reported syntheses. 
 
Starting from the same isoxazolidine 34, through a 
protection/deprotection sequence on lactam 35, we can also obtain 7-
epiaustraline (17) (scheme 3.8). Treatment with zinc in acetic acid/water of 
product 34 and in situ protection with acetic anhydride in presence of pyridine 
afforded 38 with 93% yield overall 2 steps, then Tamao-Fleming reaction gave 
product 39 in 88% yield. Lactam 39 was protected at C-7 as benzyloxy 
                                                            
62
 Goti, A.; Cicchi, S.; Cacciarini, M.; Cardona, F.; Fedi, V.; Brandi, A. Eur. J. Org. 
Chem. 2000, 3633. 
63
 For our related work on the synthesis of necine bases, see: a) Goti, A.; Fedi, V.; 
Nannelli, L.; De Sarlo, F.; Brandi, A. Synlett 1997, 577; b) Goti, A.; Cacciarini, M.; 
Cardona, F.; Cordero, F. M.; Brandi, A. Org. Lett. 2001, 3, 1367. 
64
 a) Tamao, K.; Ishida, N.; Tanaka, T.; Kumada, M. Organometallics 1983, 2, 1694; b) 
Tamao, K.; Ishida, N. J. Organomet. Chem. 1984, 269, C37; c) Fleming, I.; Henning, 
R.; Plaut, H. E. J. Chem. Soc. Chem. Commun. 1984, 29; d) Fleming, I.; Henning, R.; 
Parker, D. C.; Plaut, H. E.; Sanderson, P. E. J. J. Chem. Soc. Perkin Trans 1 1995, 317. 
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derivative and then OH in position 6 was deprotected to give compound 40 in 
which only the OH in position 6 is deprotected (75% yield over 2 steps). 
Mesylation of the free OH at C-6, using mesylchloride in DCM and TEA, gave 
product 41 in 84% yield, which can be opportunately manipulated to obtain 7-
epiaustraline (17) (Scheme 3.8). 
Scheme 3.8. Synthesis of 7-epiaustraline 
Reaction conditions: a) Zn, AcOH/H2O, 60-65°C, 2 h; b) Ac2O, py, rt, 18 h, 93% over 2 steps; c) 
Hg(CF3CO2)2, TFA, AcOH, AcOOH, CHCl3, rt, 82%; d) BnOC(=NH)CCl3, CF3SO3H, Et2O, rt, 3 h, 
Ambersep 900 OH, MeOH, 75% over two steps; e)MsCl, DCM, TEA, rt, 4 h, 84%. 
 
7-epiaustraline (17) remains an important goal to achieve in our 
research group together with australine (42), 6-7-diepicasuarine (43), 7-
epicasuarine (44) and 5-methylcasuarine (45)(Figure 3.4).  
All these products might be achieved starting from the same 
cycloaddition reaction described for the synthesis of casuarine (11), and the 
same protection/deprotection procedure illustrated before and their synthesis 
is studying in our laboratories. 
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Figure 3.4. Australine (42), 6-7-diepicasuarine (43), 7-epicasuarine (44) and 5-methylcasuarine 
(45) 
3.2.5 (-)-Uniflorine A: synthesis and structural determination 
The leaves of Eugenia uniflora L. (Myrtaceae), an evergreen tree widely 
distributed in Paraguay, Uruguay, Argentina, and Brazil, furnish a natural 
Paraguayan medicine named Nangapiry. Infusions prepared from Nangapiry 
are used in folk medicines as antidiarrhoeic, diuretic, antirheumatic, 
antifebrile, and antidiabetic preparations.65 Water-soluble extracts obtained 
from the leaves of E. uniflora were found to inhibit the α-glucosidases maltase 
and sucrase, thus accounting for the antidiabetic effect induced by Nangapiry 
preparations.65 Two iminosugar alkaloids have been isolated from the water-
soluble, namely uniflorine A and B, for which the structures of 
pentahydroxyindolizidines 46 and 47, respectively, were proposed on the basis 
of NMR analyses (Figure 3.5). 
Uniflorine A and B were found to inhibit rat intestinal maltase (IC50 
values of 12 and 4.0 μM, respectively) and sucrase (IC50 values of 3.1 and 1.8 
μM, respectively).65 
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 Matsumura, T.; Kasai, M.; Hayashi, T.; Arisawa, M.; Momose, Y.; Arai, I.; 
Amagaya, S.; Komatsu, Y. Pharm. Biol. 2000, 38, 302. 
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Figure 3.5. Originally proposed and revised structure of (-)-uniflorine A and uniflorine B 
In 2004, Pyne and coworkers reported the total synthesis of putative 
uniflorine A (46) from L-xylose.66 However, the NMR spectroscopic data for 
synthetic 46 did not match those reported for natural uniflorine A, thus 
proving that the original structural assignment to uniflorine A was incorrect. 
Other total syntheses of 46 from the group of Dhavale67 and of 
diastereoisomers of 4668,69,70,71 showed that the NMR data of 1,2,6,7,8-
pentahydroxyindolizidines differ significantly from those of the natural product 
named uniflorine A. Pyne and coworkers also recognized that the NMR data 
reported for uniflorine B and its optical rotation were in good agreement with 
those of the known alkaloid casuarine 11,70 a known inhibitor of α-
                                                            
66
 Davis, A. S.; Pyne, S. G.; Skelton, B. W.; White, A. H. J. Org. Chem. 2004, 69, 3139. 
67
 Karanjule, N. S.; Markad, S. D.; Dhavale, D. D. J. Org. Chem. 2006, 71, 6273. 
68
 1-Epi-42 and 1,2-di-epi-42: Zhao, Z.; Song, L.; Mariano, P. S. Tetrahedron 2005, 61, 
8888. 
69
 1,2-Di-epi-42: Bell, A. W.; Pickering, L.; Watson, A. A.; Nash, R. J.; Griffiths, R. C.; 
Jones, M. G.; Fleet, G. W. J. Tetrahedron Lett. 1996, 37, 8561. 
70
 1,2-Di-epi-42 and 2-epi-42: Davis, A. S.; Ritthiwigrom, T.; Pyne, S. G. Tetrahedron 
2008, 64, 4868. 
71
 8a-Epi-42 and 1,2,8a-tri-epi-42: see ref. 67. 
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glucosidases.38, 72 Thus, they suggested that uniflorine B was actually the 
known alkaloid casuarine and that uniflorine A could possess a similar 1,2,6,7-
tetrahydroxy-3-hydroxymethylpyrrolizidine structure, most likely being 6-
epicasuarine 18, on the basis of the greatest difference of the chemical shifts 
at C-6 in the NMR spectra of uniflorine A and B.70  
For these reasons we decided to embark in the total synthesis of the 
compound proposed to be (-)-uniflorine A (18) by Pyne, namely 6-
epicasuarine, by exploiting a strategy that allowed the recent total synthesis of 
casuarine (11).72 While our work was in progress, Pyne and Ritthiwigrom 
reported a total synthesis of the unnatural enantiomer of 18, (+)-uniflorine A, 
which supported their structural hypothesis.73 Their synthesis started from D-
xylose and involved a boronic acid-Mannich reaction (Petasis reaction), a ring-
closing metathesis (RCM) followed by osmium catalyzed syn-dihydroxylation 
and cyclization of the intermediate dihydroxy pyrrolidine derivative as key 
steps (Scheme 3.9).73  
 
Scheme 3.9. Pyne’s synthetic strategy 
                                                            
72
 Cardona, F.; Parmeggiani, C.; Faggi, E.; Bonaccini, C.; Gratteri, P.; Sim, L.; Gloster, 
T. M.; Roberts, S.; Davies, G. J.; Rose, D. R.; Goti, A. Chem. Eur. J. 2009, 15, 1627. 
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The pyrrolizidine obtained (ent-18 ([α]22D +6.6 (c 0.35, H2O) (lit.
65 for (-)-
uniflorine A, [α]D -4.4 (c 1.2, H2O)) displayed spectroscopic data in good 
agreement with those of natural uniflorine A, thus confirming the postulated 
structural assignment as 6-epicasuarine 18. 
Our first total synthesis of (-)-uniflorine A (18) proceeded via inversion 
of configuration of the OH group at C-6 achieved through a Mitsunobu 
reaction with benzoic acid on the key intermediate 40 (Scheme 3.10) 
previously synthesized in the synthesis of 7-epiaustraline (17).73, 74  
Indeed, the intermediate 40 bears a free OH group at C-6 which can be 
further manipulated independently from the other OH groups. In order to 
access (-)-uniflorine A, a Mitsunobu reaction was performed on 40 using THF 
as solvent, benzoic acid (BzOH) as the nucleophile, triphenylphosphine and, 
alternatively, diisopropylazodicarboxylate (DIAD) or diethylazodicarboxylate 
(DEAD). 
 
Scheme 3.10. Synthesis of (-) uniflorine A 
Reaction conditions: a) BzOH, PPh3, DIAD, THF, rt, 75%; b) LiAlH4, THF, reflux, 45%, H2, Pd/C, 
MeOH, HCl, rt then dowex 50WX8, 6% NH4OH, 71%. 
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 For other syntheses of casuarine, see: a) Ref. 59a; b) Ref. 59b; c) Ref. 59c; d) Ref. 
60a; e) Bell, A. A.; Pickering, L.; Watson, A. A.; Robert, J. N.; Pan, Y. T.; Elbein, A. 
D.; Fleet, G. W. J. Tetrahedron Lett. 1997, 38, 5869. 
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Reaction of 40 with 1.2 equiv of BzOH, 1.2 equiv of PPh3 and 1.2 equiv of 
DIAD at room temperature for 2 h allowed no conversion of starting material. 
When the mixture was heated at 50 °C for 4 h a complex mixture was 
obtained, but isolation of the desired product was unsuccessful. The use of 
DEAD rather than DIAD and the same reaction conditions for 18 h gave 
compound 48 in 63% yield. However, the best yield (75% of isolated product 
after purification on silica gel) was achieved performing the reaction with DIAD 
at room temperature for 18 h (Scheme 3.10). Inversion of configuration at C-6 
was confirmed by 1D NOESY experiments performed on compound 48. Indeed, 
irradiation of H-6 gave NOE enhancement at H-7 and irradiation of H-7 gave 
NOE at H-1 (Figure 3.6). 
 
Figure 3.6. Compound 48; irradiation of H-6 gave NOE enhancement at H-7 and irradiation of 
H-7 gave NOE at H-1 
Concomitant reduction of C=O bond and deprotection of the OH group 
at C-6 with LiAlH4 in refluxing THF gave compound 49 in 45% yield. Finally, 
catalytic hydrogenation of 49 using 10% Pd on activated carbon in methanol in 
the presence of 0.1 ml of conc. HCl (37%), followed by absorption on an acidic 
resin and elution of the free base with 6% aqueous ammonium hydroxide, 
afforded (-)-uniflorine A (18) in 71% yield (Scheme 3.10). The observed NOEs 
are consistent with the configuration assigned to 18, as shown in Figure 3.7. 
Indeed, irradiation of H-6 gave nOe at H-7 and H-1 and irradiation of H-7 gave 
nOe at H-1. 
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Figure 3.7. Compound 18; irradiation of H-6 gave NOE at H-7 and H-1 and irradiation of H-7 
gave NOE at H-1 
The 1H NMR spectra (D2O) of 18 and those of natural uniflorine A were 
essentially identical (Δδ = 0.01 - 0.13 ppm). All of the 13C NMR signals of 18 (in 
D2O with MeCN as an internal reference at δ 1.47) were 1.6 - 3.0 ppm upfield 
compared to those reported for the natural product; however, a similar 
difference has been previously noted also for synthetic (+)-uniflorine by Pyne 
and coworkers, who attributed this systematic error to a different reference 
(not reported) in the spectrum of the isolated natural product. Indeed, the 13C 
NMR chemical shifts obtained for the compound synthesized by us were in 
good agreement with those reported for ent-18 synthesized by Pyne (Δδ = ± 1 
ppm).73 The specific optical rotation of synthetic 18 ([α]D
21 - 6.9 (H2O, c 0.42)) 
was essentially identical in absolute value to that reported for synthetic ent-18 
([α]D
21  + 6.6 (H2O, c 0.35)) and matched in sign that of the natural product 
([α]D
21 - 4.4 (H2O, c 1.2)). Further confirmation that natural (-)-uniflorine A is 
actually 6-epicasuarine 18, was furnished by the melting point of synthetic 18 
(177-180 °C) which was a near match to that reported for natural (-)-uniflorine 
A (174-178 °C).65 
In conclusion, we reported the first total synthesis of (-)-uniflorine A in 
9 steps and 11% overall yield, and we confirmed that (-)-uniflorine A is 6-
epicasuarine. 
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3.3 Casuarine 6-O-α-D-glucoside and its unnatural 
analogues 
3.3.1 Introduction  
Trehalose is well known as a storage carbohydrate, and trehalases play 
the essential role in the transport of glucose in insects and fungi.75 Trehalases 
inhibitors are potentially nontoxic to human, and the mode of action of these 
enzymes gives them a favourable biological selectivity because vertebrates do 
not depend on the hydrolysis of trehalose. 
All powerful trehalase inhibitors reported to date are the 
pseudodisaccharide type of inhibitors, such as casuarine-6-O-α-D-
glucopyranoside (50, Figure3.8).58  
 
Figure 3.8. Casuarine-6-O-α-D-glucopyranoside 
These compounds are powerful competitive inhibitors of porcine kidney 
trehalase. The extremely high affinity of pseudodisaccharide inhibitors derives 
from the synergistic interactions of an alkaloid unit and a sugar unit with two 
enzyme’s subsites.76 Trehalose is a blood sugar in insects and a major storage 
sugar in fungi and yeast. Therefore trehalases inhibitors are considered to have 
high potential as insecticides or fungicides. 
Isolation and purification of 50 from natural sources are very difficult 
and expensive and afford only minute amounts of compound. As a matter of 
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 a) Elbein, A. D. Adv.Carbohydr. Chem. Biochem. 1974, 30, 227. b) Elbein, A. D.; 
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fact, 50 has never been obtained in a chemically pure form and no total 
synthesis of 50 has been described before. 
A problematic issue in the synthesis of casuarine-6-O-α-glucoside (50) 
lies in the selectivity of glucosylation of the hydroxy group at C-6. Carefully 
planned extraction procedures have discovered recently more examples of 
glycosyl iminosugars isolated from natural sources, thus indicating that their 
occurrence in Nature is not uncommon.77 In contrast, few syntheses of glycosyl 
iminosugars are reported in the literature,78,79 and they all reflect some 
difficulties in targeting the final compounds with good yields and selectivities, 
particularly in the glucosylation step. Interestingly, their inhibitory properties 
differ substantially from those of the parent iminosugar, with the linked 
carbohydrate moiety usually generating higher selectivity. This can be due, in 
principle, to a different arrangement within the catalytic site or to some 
interactions with different subsites. 
3.3.2 Syntheses of 7-deoxycasuarine and 7-homocasuarine 
glucosides and their derivatives 
Before targeting the synthesis of casuarine-6-O-α-glucoside (50), we 
proceeded to synthesize the two unnatural analogues 7-deoxycasuarine and 7-
homocasuarine glucosides (51, 52, Figure 3.9). 
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Figure 3.9. 7-Deoxycasuarine glucoside and 7-homocasuarine glucoside 
For the synthesis of 7-deoxycasuarine glucoside (51) the glucosylation 
step was performed on lactam 21 with the glucosyl donor (53) in diethyl ether 
in the presence of TMSOTf, which gave 54 with 88% yield (Scheme 3.11). 
Scheme 3.11. Synthesis of 7-deoxycasuarine glucoside 
Reaction conditions: a) TMSOTf, Et2O, rt, 1 h, 88%; b) LiAlH4, THF, rt, 1 h, 58%; c) H2, Pd/C, HCl, 
MeOH, rt, 18 h, 77%. 
Reduction of the C=O bond with LiAlH4 afforded 55 with 58% yield. 
Finally, catalytic hydrogenation of 55 gave 51 in 77% yield. Catalytic 
hydrogenation was performed in the presence of some drops of HCl, as usual, 
in order to increase the reaction rate, since no reaction occurred under neutral 
conditions. Despite our concerns on carrying out the hydrogenation in acidic 
media, due to the presence of the hydrolytically cleavable glucosidic bond, this 
linkage was not affected under the standard conditions. The free amine 51 was 
obtained after elution trough a ionic exchange resin (Scheme 3.11). 
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For the synthesis of unnatural 7-homocasuarine glucoside (52) and of its 
lactam derivatives 57 and 60 the procedure was similar: glucosylation with the 
glucosyl donor 53 on lactam 27 in presence of TMSOTf afforded compound 56 
in 75% yield (Scheme3.12). 
Scheme 3.12. Synthesis of glucoside 56 
Reaction conditions: a) TMSOTf, Et2O/DCM, rt, 1 h, 75%. 
Intermediate 56 could be differently manipulated in order to obtain all 
the glucosyl derivatives 52, 57 and 60. 
Catalytic hydrogenation of 56 afforded 57 in 96% yield. Compound 57 
maintained the ester moiety at C-7 and the C=O bond at C-5 (Scheme 3.13). 
Scheme 3.13. Syntheses of 7-homocasuarine glucoside unnatural analogue 57 
Reaction conditions: a) H2, Pd/C, MeOH/EtOAc, rt, 4 d, 96%. 
Treatment of 56 with an excess of LiBH4 and BH3
.THF (see below) 
afforded complete reduction at both the C=O bonds affording 58 in 98% yield; 
then catalytic hydrogenation, performed as usual, gave glucosyl derivative of 
7-homocauarine 52 in 79% yield. Selective reduction of the ester moiety was 
achieved by treatment of 56 with LiBH4 in THF at room temperature for 1 h, 
which gave 59 in 62% yield. Finally, catalytic hydrogenation provided glucosyl 
derivative 60 in 72% yield (Scheme 3.14). 
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Scheme 3.14. Synthesis of 7-homocasuarine glucoside and its unnatural analogue 60 
Reaction conditions: a) LiBH4, BH3
.THF, THF, rt, 11 d, 98%; b) H2, Pd/C, HCl, MeOH, rt, 12 h, 
79%; c) LiBH4, THF, rt, 18 h, 62%; d) H2, Pd/C, MeOH, 24 h, 72%. 
3.3.3 Casuarine-6-O-α-D-glucopyranoside and its unnatural 
lactam 
The main problem in the synthesis of casuarine-6-O-α-D-
glucopyranoside (50) was the selective glucosylation in position 6. We needed 
to carry out the Tamao-Fleming oxidation prior to glycosylation as the 
glycosidic bond did not tolerate the harsh reaction conditions of Tamao-
Fleming oxidation. The problem was solved by a protection/deprotection 
sequence (Scheme 3.15) carried out on compound 35, also used in the 7-
epiaustraline and (-)-uniflorine A synthetic strategy, that afforded 40, which 
bears the free hydroxy group at C-6 suitable to be linked to the glucose 
moiety.  
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Scheme 3.15. Protection/deprotection sequence 
The glucosylation reaction on 40 was carried out with the 
trichloroacetimidate 53 and catalytic TMSOTf in diethyl ether and afforded 
selectively the α-anomer 61 in 72% yield. Only traces of the β-anomer, which 
could not be isolated, were detected in the crude reaction mixture. Reduction 
of C=O double bond of 61 was not a trivial task. LiAlH4, Red-Al, BH3-SMe2 or 
LiBH4 in refluxing THF afforded complex mixtures of products, while at room 
temperature the starting material was converted only marginally. Eventually, 
treatment of 61 with a high excess of LiBH4 in combination with BH3-THF
 at 
room temperature for 3 days80 afforded glucoside 62 in 68% yield. Catalytic 
hydrogenation finally provided casuarine-6-O- α -glucoside (50) in 77% yield as 
a white foam (Scheme 3.16). 
1H- and 13 C-NMR data for synthetic 50 are in good agreement with 
those of natural casuarine 6-O-α-glucoside.34 
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Scheme 3.16. Casuarine-6-O-α-D-glucopyranoside synthesis 
Reaction conditions: a) Ac2O, Py, rt, 15 h, 100%; b) Hg(CF3CO2)2, TFA, AcOH, AcOOH, CHCl3, 
82%; c) BnOC(=NH)CCl3, CF3SO3H, Et2O, rt, 3 h; d) Ambersep 900 OH, MeOH, rt, 15 h, 75% (2 
steps); e) TMSOTf, Et2O, -20 °C, 40 min, 72%; f) LiBH4, BH3
.THF, THF, 23 °C, 3 d, 68%; g) H2, 
Pd/C, MeOH, HCl, 77%. 
The hydrogenation of the full protected lactam 61 which provided 
glucosyl derivative 63 in 77% yield (Scheme 3.17). 
Scheme 3.17. Synthesis of the lactam derivate 72 
Reaction condition: a) H2, Pd/C, MeOH/EtOAc, rt, 24 h, 77%. 
The synthesis of the lactam derivatives 57, 60 and 63 was undertaken in 
order to investigate the importance of the basic nitrogen atom for inhibition. 
With all these compounds in hand, we investigated the inhibition properties 
towards a wide range of commercial glycosidases (See Chapter 5). 
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3.4 Conclusion 
In summary, we developed a novel and efficient synthetic strategy 
which allowed us to prepare natural iminosugars, such as casuarine, (-)-
uniflorine A and hyacinthacine A2, as well as non natural casuarine-like 
pyrrolizidines, such as 7-deoxycasuarine and 7-homocasuarine, together with 
natural and unnatural 6-O-α-glucoside derivatives. 
Our methodology is based on a highly regio- and totally stereoselective 
1,3 dipolar cycloaddition of suitable substituted alkenes to a carbohydrate-
derived nitrone. After N-O bond cleavage of the obtained cycloadducts, the 
lactam intermediates were used in the synthesis of all the target compounds, 
including the glucosyl derivatives that were obtained by selective α-
glucosylation.  
All the target molecules were tested towards a wide range of 
glycosidases (see Chapter 5) like commercially available glycosidases, 
trehalases and human maltase-glucoamylase. 
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3.5 Experimental Section 
General experimental aspect are mentioned in Chapter 2.3.1. 
3.5.1 Synthesis of hyacinthacine A2, 7-deoxycasuarine and its 
lactam 
(2R,3aR,4R,5R,6R)-4,5-bis(benzyloxy)-6-[(benzyloxy)methyl]-N,N-
dimethylhexahydropyrrolo [1,2-b]isoxazole-2-carboxiamide (20). A solution of 
nitrone 1 (800 mg, 1.96 mmol) and dimethylacrylamide (19, 242 μL, 2.35 
mmol) in CH2Cl2 (3 mL) was stirred for 3 days at rt, then the solvent was 
removed under reduced pressure. Purification by flash column 
chromatography on silica gel (eluent petroleum ether/EtOAc 1:2) afforded 
pure 20 (Rf=0.35) as a white solid (858 mg, 85%), mp 72-74 °C. [α]D
20 = - 52.5 (c 
0.86, CHCl3). 
1H-NMR (CDCl3, 400 MHz) δ 7.40-7.27 (m, 15 H, Ar), 4.85 (dd, 
J=7.4, 6.6 Hz, 1H, H-2), 4.64-4.50 (m, 6 H, Bn), 4.05 (dd, J=6.0, 3.5 Hz, 1 H, H-5), 
4.01 (t, J=3.3 Hz, 1 H, H-4), 3.90 (ddd, J=9.0, 6.0, 3.1 Hz, 1 H, H-3a), 3.76 (dd, 
J=9.9, 5.0 Hz, 1 H, Ha-8), 3.65 (dd, J=9.9, 6.3 Hz, 1 H, Hb-8), 3.40 (m, 1 H, H-6), 
3.06 (s, 3 H, NMe), 3.01 (ddd, J=12.5, 9.0, 6.4 Hz, 1 H, Ha-3), 2.95 (s, 3 H, NMe), 
2.26 (ddd, J=12.6, 7.6, 6.1, 1H, Hb-3). 13C-NMR (CDCl3, 100 MHz) δ 168.0 (s, 
C=O), 138.2, 137.8, 137.5 (s, Ar), 128.4-127.5 (d, 15 C, Ar), 86.6 (d, C-5), 84.0 
(d, C-4), 74.7 (d, C-2), 73.3, 72.3, 71.6 (t, Bn), 70.1 (t, C-8), 70.0 (d, C-6), 68.5 (d, 
C-3a), 37.0 (q, NMe), 36.1 (t, C-3), 35.8 (q, NMe). IR (CDCl3): 3066, 2930, 2867, 
1649, 1497, 1454, 1216, 1100 cm-1. MS (EI): m/z 516 (M+, 0.2), 444 (5), 197 
(13), 107 (62), 90 (100), 77 (63), 56 (33). Anal. Calcd for C31H36N2O5 (516.63): C, 
72.07; H, 7.02; N, 5.42. Found: C, 72.17; H, 7.20; N, 5.70. 
(1R,2R,3R,6R,7aR)-1,2-bis(benzyloxy)-3-[(benzyloxy)methyl]-6-
hydroxyhexahydro-5H-pyrrolizin-5-one (21). A mixture of 20 (816 mg, 1.58 
mmol) and Zn dust (407 mg) in CH3COOH/H2O 9:1 (12.5 mL) was heated to 50 
°C for 4 h and then filtered through cotton. The solution was cooled to 0 °C 
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and, under vigorously stirring, saturated aqueous solution of NaHCO3 (100 mL) 
was added until basic pH was reached. The aqueous phase was extracted with 
EtOAc (3 x 20 mL) and the combined organic phases were dried over Na2SO4. 
After filtration and evaporation under reduced pressure, was obtained 21 as 
an yellow oil, enough pure to be used for the next step (598 mg, 80%). An 
analytically pure sample was obtained through purification by flash column 
chromatography on silica gel (eluent petroleum ether/EtOAc 1:2, Rf=0.4). 
[α]D
20= + 3.05 (c 0.9, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ 7.38-7.26 (m, 15 H, 
Ar), 4.60-4.45 (m, 7 H, Bn, H-6), 4.34 (t, J=4.3 Hz, 1 H, H-2), 4.11 (q, J=4.5 Hz, 1 
H, H-3), 3.87 (bs, 1 H, OH), 3.79 (dd, J=6.9, 5.0 Hz 1 H, H-1), 3.73 (dt, J=8.6, 6.5 
Hz, 1 H, H-7a), 3.63 (dd, J=9.8, 5.5 Hz, 1 H, Ha-8), 3.52 (dd, J=9.8, 4.1 Hz, 1 H, 
Hb-8), 2.70 (ddd, J=12.3, 7.8, 6.1 Hz, 1 H, Ha-7), 1.80 (ddd, J=12.3, 10.4, 8.6 Hz, 
1 H, Hb-7). 13C-NMR (50 MHz, CDCl3) δ 174.5 (s, C=O), 137.8, 137.7, 137.4 (s, 
Ar), 128.5-127.6 (d, 15 C, Ar), 89.1 (d, C-1), 85.7 (d, C-2), 73.3, 72.6, 72.4 (t, Bn), 
72.0 (d, C-6), 68.8 (t, C-8), 59.9 (d, C-7a), 58.6 (d, C-3), 37.2 (t, C-7). IR (CDCl3): 
3671, 3373, 3012, 2867, 1697, 1454, 1100 cm-1. MS (EI): m/z 381 (M+- Bn, 12), 
336 (20), 275 (32), 180 (98), 153 (100), 88 (100). Anal. Calcd for C29H31NO5 
(473.56): C, 73.55; H, 6.60; N, 2.96. Found: C, 73.33; H, 6.80; N, 2.87. 
(1R,2R,3R,6R,7aR)-1,2,6-Trihydroxy-3-(hydroxymethyl)hexahydro-5H-
pyrrolizin-5-one (15). To a stirred solution of 21 (150 mg, 0.32 mmol) in 15 mL 
of EtOH, 300 mg of Pd (10% on C) was added under nitrogen atmosphere. The 
suspension was stirred at rt for 3 days under hydrogen atmosphere, then 
filtered through Celite® and washed with MeOH. Evaporation under reduced 
pressure afforded a viscous oil that was purified by flash column 
chromatography on silica gel (eluent MeOH/EtOAc 1:3, Rf=0.14) affording pure 
15 as a transparent oil (57 mg, 88 % yield). [α]D
20 = - 1.2 (c 0.25, MeOH). 1H-
NMR (400 MHz, CD3OD) δ 4.54 (dd, J= 10.5, 7.8 Hz, 1H, H-6), 4.16 (t, J= 6.3 Hz, 
1H, H-2), 3.84 (dd, J= 3.0, 8.0 Hz, 1H, Ha-8), 3.67-3.53 (m, 4H, Hb-8, H-1, H-3, 
H-7a), 2.78 (ddd, J= 12.2, 7.8, 5.9 Hz, 1H, Ha-7), 1.74 (ddd, J= 12.0, 10.7, 8.3 Hz, 
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1H, Hb-7). 13C-NMR (50 MHz, CD3OD) δ 175.29 (s, C-5), 81.76 (d, C-1), 78.30 (d, 
C-2), 71.66 (d, C-6), 61.99 (d, C-3), 60.17 (t, C-8), 59.82 (d, C-7a), 36.83 (t, C-7). 
MS: m/z 204 (5, M++H), 203 (3, M+), 185 (27, M+-O), 172 (52), 144 (74), 126 
(51), 100 (87), 86 (100), 72 (59), 57 (38). Anal. Calcd for C8H13NO5 (203.19): C, 
47.29; H, 6.45; N, 6.89. Found: C, 47.54; H, 6.36; N, 6.95. 
(1R,2R,3R,6R,7aR)-1,2-bis(benzyloxy)-3-[(benzyloxy)methyl] hexahydro-
1H-pyrrolizin-6-ol (22). To a cooled (0°C) solution of 21 (255 mg, 0.54 mmol) in 
dry THF (6 mL), a 1 M solution of LiAlH4 in THF (1.6 mL, 1.61 mmol) was added 
under nitrogen atmosphere. The mixture was then refluxed for 1.5 hours. 
Then, after cooling at 0°C, 560 μL of an aqueous saturated solution of Na2SO4 
were added dropwise. The suspension was then filtered through Celite® and 
washed with EtOAc. Evaporation under reduced pressure afforded 22 as a 
yellow oil enough pure for the next step (185 mg, 75 % yield). An analytically 
pure sample was obtained through purification by flash column 
chromatography on silica gel (eluent petroleum ether/EtOAc 1:4, Rf=0.3). [α]D
20 
= + 9.1 (c 0.83, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ 7.36-7.24 (m, 15 H, Ar), 
4.67-4.46 (m, 6 H, Bn), 4.35-4.31 (m, 1 H, H-6), 4.11 (t, J=4.6 Hz, 1 H, H-1), 4.07 
(t, J=4.7 Hz, 1 H, H-2), 3.60-3.44 (m, 4 H, H-7a, H-3, Ha-8, Hb-8), 3.21 (dd, 
J=12.3, 4.5 Hz 1 H, Ha-5), 2.98 (dm, J=12.3 Hz, 1 H, Hb-5), 2.21 (ddd, J=13.8, 
9.0, 5.7 Hz, 1H, Ha-7), 1.84 (dm, J=13.8 Hz, 1H, Hb-7). 13C-NMR (50 MHz, CDCl3) 
δ 138.1, 137.8, 137.4 (s, Ar), 128.1-127.2 (d, 15 C, Ar), 88.9 (d, C-1), 85.2 (d, C-
2), 73.6 (d, C-6), 72.9, 72.1, 71.8, 71.6 (t, Bn, C-8), 69.9 (d, C-3), 67.4 (d, C-7a), 
63.3 (t, C-5), 40.0 (t, C-7). IR (CDCl3): 3392, 3010, 2927, 2858, 1748, 1710, 1454, 
1262 cm-1. MS (EI): m/z 366 (6), 336 (100), 216 (61), 160 (100), 90 (100). Anal. 
Calcd for C29H33NO4 (459.58): C, 75.79; H, 7.24; N, 3.05. Found: C, 75.99; H, 
7.16; N, 3.02.  
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(1R,2R,3R,6R,7aR)-3-(hydroxymethyl)hexahydro-1H-pyrrolizine-1,2,6-
triol (7-deoxycasuarine, 14).81 To a stirred solution of 22 (120 mg, 0.26 mmol) 
in EtOH (10.5 mL), 4-5 drops of concentrated HCl and 250 mg of Pd (10% on C) 
were added under nitrogen atmosphere. The suspension was stirred at rt for 3 
days under hydrogen atmosphere, then filtered through Celite® and washed 
with MeOH. Evaporation under reduced pressure afforded a viscous yellow oil 
(66 mg) that was transferred to a column of DOWEX 50WX8 and then washed 
with MeOH (10 mL), H2O (10 mL) to remove non amine containing products, 
and then with 6% NH4OH (15 mL) to elute 7-deoxycasuarine 14 as a white solid 
(43 mg, 88% yield), mp 205-208°C. [α]D
20 = + 19.8 (c 0.4, H2O). 
1H-NMR (400 
MHz, D2O) δ 4.44-4.38 (m, 1H, H-6), 4.05 (t, J=8.2 Hz, 1 H, H-1), 3.74-3.69 (m, 2 
H), 3.56 (dd, J=11.9, 6.5 Hz, 1 H), 3.24 (ddd, J=12.6, 8.2, 4.2 Hz, 1 H), 3.09-3.02 
(m, 2 H), 2.86 (m, 2 H, Ha-5, Hb-5), 2.12 (ddd, J=13.6, 8.5, 3.4 Hz, 1 H, Ha-7), 
1.89 (dtd, J=13.6, 3.8, 1.4 Hz, 1 H, Hb-7). 13C-NMR (50 MHz, D2O) δ 82.6 (d, C-
1), 79.0 (d, C-2), 75.1 (d, C-6), 72.5 (d, C-7a), 67.9 (d, C-3), 64.6 (t, C-8), 63.3 (t, 
C-5), 39.3 (t, C-7). MS (EI): m/z 190 (M++H, 3), 189 (M+, 1), 176 (66), 158 (M+-
CH2OH, 65), 132 (64), 112 (23), 85 (62), 58 (100). Anal. Calcd for C8H15NO4 
(189.21): C, 50.78; H, 7.99; N, 7.40. Found: C, 50.37; H, 7.63; N, 7.74.  
(1R,2R,3R,6R,7aR)-1,2-Bis-benzyloxy-3-benzyloxymethyl-6-
metansulfonyloxy-hexahydro-1H-pyrrolizine (23). To a stirred solution of 21 
(95 mg, 0.20 mmol) in dry CH2Cl2 (0.45 mL), NEt3 (75 μL, 0.54 mmol) was added 
under nitrogen atmosphere, and, at 0 °C, MsCl (20 μL, 0.26 mmol) was added 
dropwise. The solution was left stirring at 0 °C for 30 minutes and for 2 h at rt. 
The mixture was filtered through Celite® and washed with EtOAc. Evaporation 
under reduce pressure afforded 23, as a white oil, (quantitative yield), enough 
pure to be used for the next step (110 mg, quantitative yield). [α]D
27= + 12.3 (c 
1.06, CH2Cl2). 
1H-NMR (400 MHz, CDCl3) δ 7.38-7.26 (m, 15 H, Ar), 5.33 (dd, J = 
9.9, 8.2 Hz, 1 H, H-6), 4.61-4.43 (m, 6 H, Bn), 4.32 (t, J = 4.6 Hz, 1 H, H-2), 4.09 
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(q, J = 4.3 Hz, 1 H, H-3), 3.77 (dd, J = 6.8, 4.9 Hz, 1 H, H-1), 3.72 (dd, J = 8.1, 6.5 
Hz, 1 H, H-7a), 3.60 (dd, J = 9.9, 5.2 Hz, 1 H, Ha-8), 3.49 (dd, J = 9.9, 4.1 Hz, 1 H, 
Hb-8), 3.27 (s, 3 H, Ms), 2.76 (ddd, J = 12.8, 8.2, 6.2 Hz, 1 H, Ha-7), 2.00 (ddd, J 
= 12.8, 10.0, 8.2 Hz, 1 H, Hb-7). 13C-NMR (50 MHz, CDCl3) δ 167.5 (s, C-5), 
137.3-137.1 (s, 3 C, Ar), 128.3-127.4 (d, 15 C, Ar), 88.5 (d, C-1), 85.2 (d, C-2), 
78.2 (d, C-6), 73.0, 72.4, 72.2 (t, Bn), 68.1 (t, C-8), 59.2 (d, C-7a), 58.6 (d, C-3), 
39.7 (q, Ms), 34.6 (t, C-7). IR (CH2Cl2): 3065, 3033, 2868, 1717, 1454, 1364, 
1267, 1179, 1104, 1028 cm-1. Anal. Calcd for C30H33NO7S (551.20): C, 67.02; H, 
6.56; N, 2.61. Found: C, 66.90; H, 6.70; N, 2.74. 
(1R,2R,3R,7aR)-1,2-bis-benzyloxy-3-benzyloxymethyl-hexahydro-1H-
pyrrolizine (24).40 To a stirred solution of 23 (110 mg, 0.2 mmol) in dry THF (2.5 
mL) a 1M solution of LiAlH4 in THF (0.8 mL, 0.8 mmol) was added dropwise at 0 
°C under nitrogen atmosphere. The mixture was heated at reflux temperature 
for 3 hours. An aqueous saturated solution of Na2SO4 (280 μL) was added 
dropwise and the mixture was left stirring at rt for other 10 min. After filtration 
through Celite®, 109 mg of a crude residue were obtained, that were purified 
by flash column chromatography on silica gel (petroleum ether/ethyl acetate 
1:2, Rf = 0.28) affording pure 24 (71 mg, 80 % yield) as an oil. [α]D
24 = - 5.1 (c 
0.6, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ 7.37-7.25 (m, 15 H, Ar), 4.73-4.46 (m, 6 
H, Bn), 4.08 (dd, J = 7.4, 5.9 Hz, 1H, H-2), 3.81 (t, J = 5.9 Hz, 1H, H-1), 3.60 (dd, J 
= 9.6, 4.7 Hz, 1 H, Ha-8), 3.54 (dd, J = 9.6, 5.7 Hz, 1 H, H-7a), 3.51-3.46 (m, 1 H, 
Hb-8), 3.07 (dt, J = 10.5, 6.1 Hz, 1 H, Ha-5), 2.98-2.94 (m, 1 H, H-3), 2.78 (dt, J = 
10.5, 6.6 Hz, 1 H, Hb-5), 2.03-1.95 (m, 1 H, Ha-7), 1.91-1.82 (m, 1 H, Ha-6), 
1.81-1.74 (m, 1 H, Hb-6), 1.72-1.62 (m, 1 H, Hb-7). 13C-NMR (50 MHz, CDCl3) δ 
138.2, 138.1, 137.9 (s, Ar), 128.0- 127.1 (d, 15 C, Ar), 88.6 (d, C-1), 85.5 (d, C-2), 
73.0, 72.3, 71.8, 71.6 (t, C-8, Bn), 68.0 (d, C-3), 67.2 (d, C-7a), 54.8 (t, C-5), 31.4 
(t, C-6), 25.5 (t, C-7). 
(1R,2R,3R,7aR)-1,2-Dihydroxy-3-hydroxymethyl-hexahydro-1H-
pyrrolizine(hyacinthacine A2, 13).
40, 36 To a stirred solution of 24 (25 mg, 0.056 
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mmol) in MeOH (2.5 mL) 3 drops of concentrated HCl and 45 mg of Pd (10% on 
C) were added. The mixture was left stirring at rt for 3 days under hydrogen 
atmosphere. The mixture was then filtered through Celite® and washed with 
MeOH. The solvent was evaporated under reduced pressure affording a 
viscous white oil, that was transferred to a column of DOWEX 50WX8 and then 
washed with MeOH (10 mL), H2O (10 mL) to remove non amine containing 
products and then with 6% NH4OH (15 mL) to elute hyacinthacine A2 13 as a 
white solid (7 mg, 72% yield). [α]D
24 = +  12.4 (c 0.2, H2O); 
1H-NMR (200 MHz, 
D2O) δ 3.72-3.61 (m, 3 H), 3.53 (dd, J=11.7, 6.2 Hz, 1 H), 3.10-3.00 (m, 1 H), 
2.86-2.75 (m, 1 H), 2.70-2.56 (m, 2 H), 1.90-1.58 (m, 4 H); 13C-NMR (50 MHz, 
D2O) δ 82.6 (d, C-1), 79.6 (d, C-2), 71.7 (d, C-3), 68.6 (d, C-7a), 65.3 (t, C-8), 57.4 
(t, C-5), 32.2 (t, C-7), 27.0 (t, C-6). Anal. Calcd for C8H15NO3 (173.21): C, 55.47; 
H, 8.73; N, 8.09. Found: C, 55.49; H, 8.61; N, 8.10. 
3.5.2 Synthesis of 7-homocasuarine 
Dimethyl(2R,3S,3aR,4R,5R,6R)-4,5-bis(benzyloxy)-6[(-benzyloxy) 
methyl]hexahydropyrrolo[1,2-b]isoxazole-2,3-dicarboxilate (26). A solution of 
nitrone 1 (1.47 g, 3.52 mmol) and dimethyl maleate (25, 440 μL, 3.52 mmol) in 
CH2Cl2 (23 mL) was stirred at rt for 4 days, then the solvent was removed 
under reduced pressure. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether/EtOAc 2:1) afforded pure 26 
(Rf=0.35) as a white solid (1.54 g, 78% yield), mp 59-62 °C. [α]D
20 = - 86.0 (c 
0.95, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ 7.40-7.25 (m, 15H, Ar), 4.94 (d, J=8.2 
Hz, 1H, H-2), 4.66-4.49 (m, 6H, Bn), 4.28 (d, J=7.6 Hz, 1H, H-3a), 4.12 (m, 1H, H-
4), 4.09-4.08 (m, 1 H, H-5), 3.80 (s, 3 H, Me), 3.75 (s, 3H, Me), 3.79-3.74 (m, 2H, 
H-3, Ha-8), 3.60 (dd, J=9.7, 7.7 Hz, 1H, Hb-8), 3.48-3.45 (m, 1H, H-6); 13C-NMR 
(CDCl3, 50 MHz) δ 169.4 (s, C=O), 168.9 (s, C=O), 138.1, 137.5, 137.4 (s, Ar), 
128.4-127.5 (d, 15 C, Ar), 85.0, 84.3 (d, C-4, C-5) 77.8 (d, C-2), 73.4, 72.1 (t, Bn), 
71.9 (d, C-6), 71.6 (t, Bn), 71.4 (d, C-3a), 70.0 (t, C-8), 54.1 (d, C-3), 52.6 (q, 2 C, 
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Me). IR (CDCl3): 3160, 3080, 3030, 3000, 2960, 2920, 2880, 1730, 1625, 1570, 
1460, 1380, 1250, 1088 cm-1. MS (EI): m/z 561 (M+, 0.2), 531 (0.6), 502 (M+, 
0.3), 113 (8), 91 (100), 65 (3), 77 (3). Anal. Calcd for C32H35NO8 (561.6): C, 68.43; 
H, 6.28; N, 2.49. Found: C, 68.00; H, 6.42; N, 2.34. 
Methyl(1S,2R,6R,7R,7aR)-6,7-bis(benzyloxy)-5-[(benzyloxy)methyl]-2-
hydroxy-3-oxohexahydro-1H-pyrrolizine-1-carboxylate (27). A mixture of 26 
(870 mg, 1.55 mmol) and Zn dust (400 mg, 6.2 mmol) in CH3COOH/H2O 9:1 
(12.5 mL) was heated to 50 °C for 3 h and then filtered through cotton. The 
solution was cooled to 0°C and, under vigorously stirring, saturated aqueous 
solution of NaHCO3 (100 mL) was added until basic pH was reached. The 
aqueous phase was extracted with EtOAc (3 x 60 mL) and the combined 
organic phases were dried over Na2SO4. After filtration and evaporation under 
reduced pressure, was obtained pure 27 as a white solid (743 mg, 90% yield), 
mp 111-113 °C. [α]D
20 = - 28.7 (c 0.635, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ 
7.37-7.23 (m, 15 H, Ar), 4.76 (dd, J=9.8, 2.9 Hz, 1 H, H-2), 4.57-4.44 (m, 6 H, 
Bn), 4.31-4.28 (m, 1 H, H-5), 4.23-4.22 (m, 1 H, H-6), 3.98-3.95 (m, 1 H, H-7a), 
3.92-3.90 (m, 1 H, H-7), 3.79 (s, 3H, Me), 3.58-3.50 (m, 2 H, H-8), 3.44 (d, J=3.1 
Hz, 1 H, OH), 3.03 (t, J=9.3 Hz, 1 H, H-1). 13C-NMR (50 MHz, CDCl3) δ 173.2, 
171.1 (s, C=O), 137.7-137.2 (s, 3 C, Ar), 128.4-127.5 (d, 15 C, Ar), 87.3 (d, C-7), 
84.6 (d, C-6), 74.2 (d, C-2), 73.1, 72.1, 71.8 (t, Bn), 68.1 (t, C-8), 62.7 (d, C-7a), 
59.3 (d, C-5), 54.8 (d, C-1), 52.5 (q, Me). IR (CHCl3): 3690, 3600-3500 (broad), 
3027, 2920, 1708, 1601, 1155, 1070 cm-1. MS (EI): m/z 513 (M+-H2O, 0.6), 212 
(4), 91 (100), 69 (14). Anal. Calcd for C31H33NO7 (531.6): C, 70.04; H, 2.63; N, 
6.26. Found: C, 70.02; H, 2.56; N, 6.28. 
(1R,2R,3R,6R,7R,7aR)-1,2-bis(benzyloxy)-3[(benzyloxy)methyl]-7-
(hydroxymethyl)hexahydro-1H-pyrrolizin-6-ol (28). To a cooled (0 °C) solution 
of 27 (115 mg, 0.22 mmol) in dry THF (3 mL) a 1 M solution of LiAlH4 in THF (1.1 
mL, 1.1 mmol) was added under nitrogen atmosphere. The mixture was then 
refluxed for 2 hours. Then, after cooling at 0°C, 700 μL of an aqueous saturated 
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solution of Na2SO4 were added dropwise. The suspension was then filtered 
through Celite® and washed with EtOAc. Evaporation under reduced pressure 
afforded the solid 28 enough pure to be used for the next step (104 mg, 
quantitative yield). An analytically pure sample was obtained by filtration over 
a short pad of silica gel (eluent EtOAc then EtOAc /MeOH 5:1), mp 85-87 °C. 
[α]D
20 = + 3.58 (c 1.18, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ 7.40-7.25 (m, 15 H, 
Ar), 4.64-4.56 (m, 6 H, Bn), 4.22 (q, J=5.6 Hz, H-6), 4.13-4.09 (m, 2 H, H-1, H-2), 
3.68 (d, J=6.8 Hz, 2H, Ha-8, Hb-8), 3.53 (d, J=6.4 Hz, 2 H, Ha-9, Hb-9) 3.43-3.37 
(m, 2 H, H-3, Ha-5) 3.27 (dd, J=7.0, 3.9 Hz, 1 H, H-7a), 2.95 (dd, J=10.8, 5.6 Hz, 1 
H, Hb-5), 2.24 (quint., J=6.6 Hz, 1 H, H-7). 13C-NMR (50 MHz, CDCl3) δ 138.2-
137.7 (s, 3 C, Ar), 128.5-127.5 (d, 15 C, Ar), 88.0 (d, 1 C), 86.1 (d, 1 C), 76.6 (d, 1 
C), 73.3 (t, 1 C), 72.4 (t, 1 C), 72.0 (t, 1 C), 71.5 (t, 1 C), 70.4 (d, 1 C), 70.4 (d, 1 
C), 64.2 (t, 1 C), 62.4 (t, 1 C), 54.3 (d, 1 C). IR (CDCl3): 3412, 3031, 3010, 2866, 
1496, 1454, 1363, 1216, 1212, 1211, 1097 cm-1. MS (EI): m/z 398 (M+-C7H7, 11), 
368 (85), 248 (11), 186 (27), 160 (30), 142 (25), 116 (22), 91 (100), 64 (21). 
Anal. Calcd for C30H31NO5 (489.3): C, 73.59; H, 7.21; N, 2.86. Found: C, 73.58; H, 
7.09; N, 3.18.  
(1R,2R,3R,6R,7R,7aR)-3,7-bis(hydroxymethyl)hexahydro-1H-pyrrolizine-
1,2,6-triol (7-homocasuarine, 16). To a stirred solution of 28 (106 mg, 0.22 
mmol), in EtOH (14 mL), 4-5 drops of concentrated HCl and 230 mg of Pd (10% 
on C) were added. The suspension was stirred at rt under hydrogen 
atmosphere for 4 days, then filtered through Celite® and washed with EtOH. 
Evaporation under reduced pressure afforded a viscous oil that was 
transferred to a column of DOWEX 50WX8 and then washed with MeOH (10 
mL), H2O (10 mL) to remove non amine containing products and then with 6% 
NH4OH (15 mL) to elute 7-homocasuarine (16). Evaporation of the solvent 
afforded 7-homocasuarine as a yellow viscous oil (38.5 mg, 89%). [α]D
20 = + 
30.8 (c 0.7, MeOH). 1H-NMR (400 MHz, D2O) δ 4.39 (q, J=10.0 Hz, 1 H, H-6), 
4.04 (t, J=7.8 Hz, 1 H, H-1), 3.71 (t, J=8.5 Hz, 1 H, H-2), 3.67 (dd, J=11.7, 3.5 Hz, 
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1 H, Ha-8), 3.55-3.44 (m, 3 H, Hb-8, Ha-9, Hb-9), 3.19 (dd, J=10.0, 5.2 Hz, 1 H, 
Ha-5), 3.02 -2.95 (m, 2 H, H-3, H-7a), 2.80 (dd, J=10.0, 5.2 Hz, 1 H, Hb-5), 2.21 
(q, J=5.9 Hz, 1H, H-7). 13C-NMR (50 MHz, D2O) δ 80.2 (d, C-1), 77.5 (d, C-2), 74.5 
(d, C-6), 70.6, 68.5 (d, C-3, C-7), 62.7 (t, C-8), 61.3 (t, C-9), 60.4 (t, C-5), 52.9 (d, 
C-7a). MS (EI): m/z 188 (100), 170 (10), 159 (13), 142 (14), 128 (83), 116 (26), 
68 (38), 55 (24). Anal. Calcd for C9H17NO5 (219.23): C, 49.31; H, 7.82; N, 6.39. 
Found: C, 49.06; H, 7.43; N, 6.54. 
3.5.3 Syntheses of Casuarine and 7-epiaustraline 
Ethyl 3-[dimethyl(phenyl)silyl]-2-propynoate (33). A solution of 
(dimethylphenylsilyl)-acetylene (32, 4.0 g, 25.0 mmol) in dry THF was cooled to 
–78 °C and n-butyllithium (1.6 M in hexanes, 23.5 mL, 37.4 mmol) was added 
dropwise. Ethyl chloroformate (7.0 g, 64.9 mmol) was added after 15 minutes 
and the reaction mixture was stirred at –78 °C for 3 h; then, the mixture was 
allowed to heat to –10 °C, H2O (80 mL) was added dropwise and the product 
was extracted with petroleum ether (3 x 80 mL). The collected organic phase 
was dried over anhydrous Na2SO4, filtered and concentrated to give the crude 
product, that was further purified by flash chromatography on silica gel 
(petroleum ether-ethyl acetate 30:1) to give the pure alkyne 33 (Rf=0.61, 5.11 
g, 22.0 mmol, 88%) as a colourless liquid. 1H NMR (400 MHz, CDCl3) δ 7.62-7.60 
(m, 2 H, Ar), 7.42-7.38 (m, 3 H, Ar), 4.24 (q, J = 7.0 Hz, 2 H, CH2CH3), 1.32 (t, J = 
7.0 Hz, 3 H, CH2CH3), 0.50 (s, 6 H, SiMe2). 
13C NMR (50 MHz, CDCl3) δ 152.6 (s, 
C=O), 134.2 (s, Ar), 133.4 (d, 2 C, Ar), 129.7 (d, Ar), 127.8 (d, 2 C, Ar), 95.7 (s, 
C≡C), 91.3 (s, C≡C), 61.8 (t, CH2CH3), 13.8 (q, CH2CH3), -1.9 (q, 2 C, SiMe2). IR 
(CDCl3): 3383, 3072, 2964, 2257, 2180, 1690, 1429, 1225, 1115, 1026 cm
-1; MS 
(EI): m/z 217 (M+- CH3, 5), 189 (84), 159 (95), 145 (100), 137 (49). Anal. Calcd. 
for C13H16O2Si (232.35): C, 67.20; H, 6.94. Found: C, 67.17; H, 6.83. 
Ethyl (2Z)-3-[dimethyl(phenyl)silyl]-2-propenoate (31) A solution of the 
pure alkyne 33 5.11 g, 22.0 mmol) in toluene (55 mL) was stirred at rt under H2 
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atmosphere in the presence of Lindlar catalyst (510 mg) and monitored every 
30 minutes via 1H NMR control. After 4 h, filtration through Celite® and 
evaporation of the solvent under reduced pressure afforded 31 (4.84 g, 20.7 
mmol, 94%) as a pale yellow liquid, pure enough to be used for the next step. 
An analytically pure sample was obtained by purification on silica gel 
(petroleum ether-diethyl ether 20:1, Rf=0.35). 
1H NMR (400 MHz, CDCl3) δ 
7.59-7.55 (m, 2 H, Ar), 7.37-7.26 (m, 3 H, Ar), 6.67 (A part of an AB system, J = 
14.4 Hz, 1H, H-2 or H-3), 6.60 (B part of an AB system, J = 14.4 Hz, 1H, H-2 or H-
3), 4.12 (q, J = 7.2 Hz, 2 H, CH2CH3), 1.21 (t, J = 7.2 Hz, 3 H, CH2CH3), 0.49 (s, 6 H, 
SiMe2). 
13C NMR (50 MHz, CDCl3) δ 166.3 (s, C=O), 149.2 (d, 2 C, Ar), 139.2 (s, 
Ar), 136.6 (d, C=C), 133.5 (d, Ar), 128.8 (d, C=C), 127.7 (d, 2 C, Ar), 60.5 (t, 
CH2CH3), 14.3 (q, CH2CH3), -1.7 (q, 2 C, SiMe2). IR (CDCl3): 3069, 2983, 2247, 
1726, 1588, 1427, 1370 cm-1; MS (EI): m/z 235 (M++ 1, 0.5), 234 (M+, 0.7), 219 
(M+- CH3, 71), 191 (100), 175 (14), 157 (M
+-Ph, 68), 129 (85). Anal. Calcd. for 
C13H18O2Si (234.37): C, 66.62; H, 7.74. Found: C, 66.91; H, 8.17. 
Ethyl(2S,3S,3aS,4R,5R,6R)-4,5-bis(benzyloxy)-6-(benzyloxy)methyl-3-
[dimethyl(phenyl)silyl]-hexahydropyrrolo[1,2-b]isoxazole-2-carboxylate (34): A 
solution of nitrone 1 (1.23 g, 2.95 mmol) and 31 (1.17 g, 6.16 mmol) in CH2Cl2 
(3 mL) was stirred at rt for 36 h, then the solvent was removed under reduced 
pressure. Purification of the residue by chromatography on silica gel 
(petroleum ether-ethyl acetate 7:1) afforded pure 34 (1.52 g, 2.33 mmol, 79%) 
as a colourless oil. Rf  = 0.22 (petroleum ether-ethyl acetate 7:1). [α]D
22 = - 76.6 
(c 0.56, CHCl3). 
1H-NMR (400 MHz, CDCl3, 25°C) δ 7.47-7.44 (m, 2 H, Ar), 7.38-
7.24 (m, 15 H, Ar), 7.21-7.17 (m, 3 H, Ar), 4.85 (d, J = 8.8 Hz, 1 H, H-2), 4.58 (A 
part of an AB system, J = 12.2 Hz, 1 H, Bn), 4.55 (B part of an AB system, J = 
12.2 Hz, 1 H, Bn), 4.39 (A part of an AB system, J = 11.9 Hz, 1 H, Bn), 4.33 (B 
part of an AB system, J = 11.9 Hz, 1 H, Bn), 4.24 (A part of an AB system, J = 
12.0 Hz, 1 H, Bn), 4.16 (B part of an AB system, J = 12.0 Hz, 1 H, Bn), 4.05-3.90 
(m, 4 H, H-5, H-3a, CH2CH3), 3.78 (dd, J = 9.8, 4.7 Hz, 1 H, Ha-8), 3.65 (m, 1 H, H-
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4), 3.57 (dd, J = 9.8, 8.2 Hz, 1 H, Hb-8), 3.40 (dt, J = 8.6, 4.7 Hz, 1 H, H-6), 2.40 
(dd, J = 11.1, 8.8 Hz, 1 H, H-3), 1.17 (t, J = 7.2 Hz, 3 H, CH2CH3), 0.39 (s, 3 H, 
SiMe), 0.38 (s, 3 H, SiMe). 13C-NMR (50 MHz, CDCl3, 25°C) δ 170.8 (s; C=O), 
138.4-137.1 (s, 4 C; Ar), 134.1-127.5 (d, 20 C; Ar), 85.3 (d; C-5), 83.9 (d; C-4), 
80.7 (d; C-2), 73.4 (t; Bn), 72.7 (d; C-6), 71.8 (d; C-3a), 71.6, 71.1 (t, 2 C; Bn), 
70.8 (t; C-8), 61.1 (t; CH2CH3), 36.9 (d; C-3), 14.0 (q; CH2CH3), -2.7, -4.2 (q, 2 C; 
SiMe2). IR (CDCl3): 3688, 3029, 3012, 2930, 1739, 1496, 1454, 1253 cm
-1; MS 
(70 eV): m/z 560 (2), 400 (53), 296 (65), 188 (40), 181 (60), 105 (48), 91 (100). 
Anal. Calcd for C39H45NO6Si (651.3): C, 71.86; H, 6.96; N, 2.15. Found: C, 71.58; 
H, 7.13; N, 2.08. 
(1R,2R,3R,6S,7S,7aS)-1,2-Bis(benzyloxy)-3-[(benzyloxy)methyl-7-
[dimethyl(phenyl)silyl]-6-hydroxyhexahydro-5H-pyrrolizin-5-one (35). A 
mixture of 34 (484 mg, 0.74 mmol) and Zn dust (244 mg) in CH3COOH/H2O 9:1 
(8 mL) was heated to 60-65 °C for 5 h and then filtered through cotton. The 
solution was cooled to 0 °C and, under vigorous stirring, a saturated aqueous 
solution of NaHCO3 (60 mL) was added until alkaline pH was reached. The 
aqueous phase was extracted with AcOEt (3 x 60 mL) and the combined 
organic phases were dried over Na2SO4. After filtration and evaporation under 
reduced pressure, a viscous oil was obtained. Purification on silica gel 
(petroleum ether/ethyl acetate 3:2) afforded pure 35 (420 mg, 0.69 mmol, 
93%) as a colourless viscous oil. Rf = 0.4 (petroleum ether/ethyl acetate 3:2). 
[α]D
22 - 47.0 (c 1.87, CHCl3). 
1H-NMR (400 MHz, CDCl3, 25°C) δ 7.55-7.53 (m, 2 
H, Ar), 7.38-7.23 (m, 16 H, Ar), 7.14-7.12 (m, 2 H, Ar), 4.55 (d, J = 11.7 Hz, 1 H, 
Bn), 4.46 (s, 2 H, Bn), 4.38-4.34 (m, 2 H, Bn, H-3), 4.30 (d, J = 11.1 Hz, 1 H, H-6), 
4.22 (d, J = 11.3 Hz, 1 H, Bn), 4.12-4.09 (m, 2 H, H-2, Bn), 3.62 (dd, J = 9.8, 4.1 
Hz, 1 H, H-7a), 3.58-3.56 (m, 1 H, H-1), 3.47 (dd, J = 9.6, 5.8 Hz, 1 H, Ha-8), 3.43 
(dd, J = 9.6, 8.0 Hz, 1 H, Hb-8), 2.75 (br s, 1 H, OH), 1.63 (dd, J = 11.1, 9.8 Hz, 1 
H, H-7), 0.44 (s, 3 H, SiMe), 0.39 (s, 3 H, SiMe). 13C-NMR (50 MHz, CDCl3, 25°C) 
δ 176.6 (s, C-5), 138.0-136.3 (s, 4 C, Ar), 134.3-127.7 (d, 20 C, Ar), 89.0 (d, C-1), 
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84.4 (d, C-2), 73.9 (d, C-6), 73.0, 72.0, 71.5 (t, 3 C, Bn), 68.5 (t, C-8), 63.2 (d, C-
7a), 59.1 (d, C-3), 38.9 (d, C-7), -3.6, -4.8 (q, 2 C, SiMe2). IR (CDCl3): 3400, 3000, 
2850, 1700 cm-1; MS (70 eV): m/z 516 (4), 289 (26), 181 (13), 135 (89), 91 
(100). Anal. Calcd for C37H41NO5Si (607.81): C 73.11; H 6.80; N 2.30. Found: C 
72.78; H 6.81; N 2.15. 
(1R,2R,3R,6S,7S,7aR)-1,2-Bis(benzyloxy)-3-[(benzyloxy)methyl]-6,7-
dihydroxyhexahydro-1H-pyrrolizine (36). Mercuric trifluoroacetate (64 mg, 
0.15 mmol) was added to a stirred solution of 35 (47 mg, 0.079 mmol) in CHCl3 
(0.47 mL), acetic acid (0.12 mL) and trifluoroacetic acid (0.23 mL). The solution 
was stirred at rt for 1 h; then, peracetic acid (1.35 mL) was added dropwise to 
the mixture with ice cooling. After 1 h stirring at room temperature the 
solution was cooled to -10 °C and a saturated aqueous solution of Na2S2O3 (10 
mL) was added dropwise. The mixture was extracted with AcOEt (3 x 30 mL) 
and the combined organic layers were washed with a saturated aqueous 
solution of Na2CO3 (30 mL), dried over anhydrous Na2SO4, filtered and 
evaporated under reduced pressure. Purification of the residue by flash 
column chromatography on silica gel (petroleum ether/ethyl acetate 2:3) 
afforded pure 36 (29 mg, 0.06 mmol, 76%) as a colourless oil. Rf = 0.2 
(petroleum ether/ethyl acetate 2:3). [α]D
20 - 41.5 (c 0.68, CHCl3). 
1H-NMR (400 
MHz, CDCl3, 25°C) δ 7.36-7.20 (m, 15 H, Ar), 4.71 (d, J = 11.7 Hz, 1 H, Bn), 4.56-
4.42 (m, 6 H, Bn, H-6), 4.26 (t, J = 3.6 Hz, 1 H, H-2), 4.15-4.12 (m, 2 H, H-7, H-3), 
3.91 (t, J = 4.7 Hz, 1H, H-1), 3.66 (t, J = 6.3 Hz, 1 H, H-7a), 3.58 (dd, J = 9.7, 5.8 
Hz, 1 H, Ha-8), 3.50 (dd, J = 9.7, 4.3 Hz, 1 H, Hb-8). 13C-NMR (50 MHz, CDCl3, 
25°C): δ = 172.6 (s, C-5), 137.9-137.7 (s, 3 C, Ar), 128.5-127.8 (d, 15 C, Ar), 86.9 
(d, C-1), 85.1 (d, C-2), 80.5 (d, C-7), 78.3 (d, C-6), 73.3 (t, Bn), 72.1 (t, 2 C, Bn), 
68.3 (t, C-8), 66.8 (d, C-7a), 59.0 (d, C-3). IR (CDCl3): 3372, 3011, 2866, 1703, 
1454, 1214, 1102 cm-1. MS (70 eV): m/z 428 (11), 398 (4), 368 (M+-CH2OBn, 3), 
292 (20), 262 (12), 171 (90), 169 (57), 90 (100). Anal. Calcd for C29H31NO6 
(489.56): C 71.15; H 6.38; N, 2.86. Found: C 70.90; H 6.31; N 2.80. 
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(1R,2R,3R,6S,7S,7aR)-1,2-Bis(benzyloxy)-3-[(benzyloxy)methyl]-6,7-
dihydroxyhexahydro-1H-pyrrolizine (37). To a cooled (0 °C) solution of 36 (173 
mg, 0.35 mmol) in dry THF (4.2 mL) a 1 M solution of LiAlH4 in THF (1.3 mL, 1.3 
mmol) was added under nitrogen atmosphere. The mixture was then refluxed 
for 2 h. After cooling to 0 °C, a sat. Na2SO4 solution (600 μL) was added 
dropwise. The suspension was then filtered through Celite® and washed with 
AcOEt. Evaporation under reduced pressure afforded a viscous oil, that was 
quickly filtered over a short pad of silica gel (eluent: ethyl acetate) obtaining 
pure 37 as a viscous oil (130 mg, 0.27 mmol, 78%). Rf = 0.6 (eluent: ethyl 
acetate). [α]D
20 - 2.9 (c 0.53, CDCl3). 
1H-NMR (400 MHz, CDCl3, 25°C) δ 7.32-
7.23 (m, 15 H, Ar), 4.66-4.61 (m, 2 H, Bn), 4.56-4.49 (m, 4 H, Bn), 4.13-4.10 (m, 
2 H, H-1, H-6), 4.04 (t, J = 5.6 Hz, 1 H, H-2), 3.96 (t, J = 5.1 Hz, 1 H, H-7), 3.51 
(dd, J = 9.6, 5.3 Hz, 1 H, Ha-8), 3.46 (dd, J = 9.6, 6.3 Hz, 1 H, Hb-8), 3.40 (dd, J = 
11.0, 5.6 Hz, 1H, Ha-5), 3.36 (t, J = 5.3 Hz, 1H, H-7a), 3.24 (dt, J = 5.6, 5.5 Hz, 
1H, H-3), 2.81 (dd, J = 11.0, 5.3 Hz, 1H, Hb-5). 13C-NMR (50 MHz, CDCl3, 25°C) δ 
138.2-137.9 (s, 3 C, Ar), 128.4-127.5 (d, 15 C, Ar), 86.8 (d, C-1), 85.2 (d, C-2), 
81.1 (d, C-7), 78.7 (d, C-6), 73.6 (d, C-7a), 73.3, 72.5, 72.0 (t, Bn), 71. 6 (t, C-8), 
69.8 (d, C-3), 59.9 (t, C-5). IR (CDCl3): 3393, 2870, 2246, 1711, 1596, 1495, 
1453, 1362, 1101 cm-1, MS (70 eV): m/z 354 (M+-CH2OBn, 38), 234 (3), 172 
(18), 160 (12), 91 (100). Anal. Calcd for C29H33NO5 (475.58): C 73.24; H 6.99, N 
2.95. Found: C 72.98; H 7.23; N 2.83. 
(1R,2R,3R,6S,7S,7aR)-3-(Hydroxymethyl)hexahydro-1H-pyrrolizine-
1,2,6,7-tetrol (casuarine, 11). To a stirred solution of 37 (89 mg, 0.19 mmol) in 
MeOH (12.5 mL), 4-5 drops of conc. HCl and 100 mg of Pd (10% on C) were 
added. The suspension was stirred under hydrogen atmosphere for 4 d, then 
filtered through Celite® and washed with MeOH. Evaporation under reduced 
pressure afforded a vitreous solid that was transferred to a column of DOWEX 
50WX8 and then washed with MeOH (15 mL), H2O (10 mL) to remove non 
amine containing products and then with 7% NH4OH (25 mL) to elute casuarine 
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(11). Evaporation of the solvent afforded Casuarine as a white solid (39 mg, 
0.19 mmol, 100%), m.p. 180-182 °C. [α]D
20 + 14.4 (c 0.52, H2O). 
1H-NMR (400 
MHz, D2O, 25°C) δ 4.19-4.13 (m, 2 H, H-6, H-7), 4.15 (t, J = 8.2 Hz, 1 H, H-1), 
3.80-3-75 (m, 2 H, H-2, Ha-8) 3.60 (dd, J = 11.7, 6.6 Hz, 1 H, Hb-8), 3.27 (dd, J = 
11.8, 3.7 Hz, 1H, Ha-5), 3.10 (dd, J = 8.5, 2.5 Hz, 1H, H-7a), 3.07-3.04 (m, 1 H, H-
3), 2.94 (dd, J = 11.8, 3.0 Hz, 1 H, Hb-5). 13C-NMR (50 MHz, D2O, 25°C) δ 78.9 (d, 
C-7), 77.8 (d, C-1), 77.6 (d, C-6), 76.6 (d, C-2), 72.7 (d, C-7a), 70.3 (d, C-3), 62.1 
(t, C-8), 58.3 (t, C-5). IR (KBr): 3329, 2917, 1650, 1416 cm-1. MS (70 eV): m/z 
205 (M+, 0.9), 188 (M+-H2O, 0.2), 174 (M
+
-CH2OH, 100), 128 (15), 102 (17), 70 
(40). Anal. Calcd for C8H15NO5 (205.21): C 46.82; H 7.37; N 6.83. Found: C 
46.51; H 7.54; N 6.73. 
(1R,2R,3R,6S,7S,7aS)-6-Acetyloxy-1,2-bis(benzyloxy)-3-[(benzyloxy) 
methyl]-7-[dimethyl(phenyl)silyl] -hexahydro-5H-pyrrolizin-5-one (38). A 
mixture of 34 (484 mg, 0.74 mmol) and Zn dust (244 mg) in CH3COOH/H2O 9:1 
(8 mL) was heated to 60-65 °C for 5 h and then filtered through cotton. The 
solution was cooled to 0 °C and, under vigorous stirring, a saturated aqueous 
solution of NaHCO3 (60 mL) was added until alkaline pH was reached. The 
aqueous phase was extracted with AcOEt (3 x 60 mL) and the combined 
organic phases were dried over Na2SO4. After filtration and evaporation under 
reduced pressure, a viscous oil was obtained. The crude (418 mg, 0.69 mmol) 
was dissolved in pyridine (1 mL) and acetic anhydride (0.5 mL) was added. The 
mixture was stirred at rt overnight. The mixture was concentrated under 
vacuum to afford an orange oil. Purification on silica gel (petroleum 
ether/ethyl acetate 3:1) afforded pure acetate derivative 38 (Rf=0.5, 448 mg, 
0.69 mmol, 93% yield over 2 steps) as a colourless oil. [α]D
26 = - 15.4 (c 1.05, 
CHCl3), 
1H NMR (400 MHz, CDCl3) δ 7.50-7.48 (m, 2 H, Ar), 7.39-7.24 (m, 16 H, 
Ar), 7.18-7.15 (m, 2 H, Ar), 5.64 (d, J = 11.3 Hz, 1 H, H-6), 4.59 (d, J = 11.7 Hz, 1 
H, Bn), 4.48 (s, 2 H, Bn), 4.37 (d, J = 11.7 Hz, 1 H, Bn), 4.37-4.34 (m, 1 H, H-3), 
4.33 (d, J = 11.7 Hz, 1 H, Bn), 4.21 (d, J = 11.7 Hz, 1 H, Bn), 4.19 (m, 1 H, H-1), 
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3.68-3.65 (m, 2 H, H-2, H-7a), 3.50 (dd, J = 9.4, 5.5 Hz, 1 H, Ha-8), 3.45 (dd, J = 
9.4, 7.8 Hz, 1 H, Hb-8), 1.92 (s, 3 H, CH3), 1.81 (dd, J = 11.3, 9.0 Hz, 1 H, H-7), 
0.37 (s, 3 H, SiMe), 0.35 (s, 3 H, SiMe). 13C NMR (50 MHz, CDCl3) δ 171.3, 169.6 
(s, 2 C, CH3-C=O, C-5), 137.8-135.3 (s, 4 C, Ar), 134.0-127.5 (d, 20 C, Ar), 89.2 (d, 
C-2), 84.6 (d, C-1), 73.2 (d, C-6), 73.0-71.5 (t, 3 C, Bn), 68.6 (t, C-8), 62.7 (d, C-
7a), 59.1 (d, C-3), 35.5 (d, C-7), 20.5 (q, CH3), -4.6, -4.9 (q, SiMe2). IR (CDCl3): 
3089, 3068, 2956, 2866, 1745, 1709, 1428, 1234, 1114 cm-1. MS (EI): m/z 649 
(1), 590 (3), 528 (1), 392 (2), 286 (4), 243 (5), 135 (30), 91 (100). Anal. Calcd for 
C39H43NO6Si (649.85): C, 72.08; H, 6.67; N, 2.16. Found: C, 72.08; H, 6.17; N, 
2.06. 
(1R,2R,3R,6R,7S,7aR)-6-Acetyloxy-1,2-bis(benzyloxy)-3-[(benzyloxy) 
methyl]-7-hydroxy-hexahydro-5H-pyrrolizin-5-one (39). Mercuric trifluoro-
acetate (1.31 g, 3.08 mmol) was added to a stirred solution of 38 (1.00 g, 1.54 
mmol) in CHCl3 (9.1 mL), acetic acid (2.3 mL) and trifluoroacetic acid (4.6 mL). 
The solution was stirred at rt for 1 h, then, peracetic acid (26.4 mL) was added 
dropwise to the mixture with ice cooling. After 1 h stirring at rt the solution 
was cooled to 0 °C and a sat. Na2S2O3 solution (120 mL) was added dropwise. 
The mixture was extracted with AcOEt (3 x 100 mL) and the combined organic 
layers were washed with a sat. Na2CO3 solution (4 x 60 mL), dried over 
anhydrous Na2SO4, filtered and evaporated under reduced pressure. 
Purification of the residue by flash column chromatography on silica gel 
(petroleum ether/ethyl acetate 3:2) afforded pure 39 (Rf=0.38, 671 mg, 1.26 
mmol, 82%) as a colourless oil. [α]D
26 = - 65.0 (c 0.83, CHCl3), 
1H-NMR (400 
MHz, CDCl3) δ 7.38-7.23 (m, 15 H, Ar), 5.29 (d, J = 7.6 Hz, 1 H, H-6), 4.71 (d, J = 
11.9 Hz, 1 H, Bn), 4.58-4.45 (m, 5 H, Bn), 4.30 (dd, J = 4.1, 3.9 Hz, 1 H, H-2), 
4.20-4.18 (m, 1 H, H-3), 4.17 (dd, J = 7.6, 6.4 Hz, 1 H, H-7), 3.90 (dd, J = 6.1, 4.4 
Hz, 1 H, H-1), 3.80 (br s, 1 H, OH), 3.73 (t, J = 6.2 Hz, 1 H, H-7a), 3.62 (dd, J = 
9.8, 5.9 Hz, 1 H, Ha-8), 3.53 (dd, J = 9.8, 4.5 Hz, 1 H, Hb-8), 2.21 (s, 3 H, CH3). 
13C-NMR (50 MHz, CDCl3) δ 172.3, 166.9 (s, 2 C, C=O), 137.7-137.4 (s, 3 C, Ar), 
1,3-dipolar cycloaddiotions 
75 
 
128.4-127.6 (d, 15 C, Ar), 86.9 (d, C-1), 85.1 (d, C-2), 80.8 (d, C-6), 78.7 (d, C-7), 
73.2-71.9 (t, 3 C, Bn), 68.2 (t, C-8), 67.2 (d, C-7a), 59.1 (d, C-3), 20.7 (q, CH3). IR 
(CDCl3): 3508, 3088, 3067, 3032, 2868, 1720, 1454, 1362, 1246, 1100 cm
-1. MS 
(EI): m/z 531 (6), 516 (1), 279 (1), 219 (2), 167 (7), 149 (18), 91 (100), 83 (57). 
Anal. Calcd for C31H33NO7 (531.60): C, 70.04; H, 6.26; N, 2.63. Found: C, 70.01; 
H, 6.19; N, 2.72. 
(1R,2R,3R,6R,7S,7aR)-1,2,7-Tris(benzyloxy)-3-[(benzyloxy)methyl]-6-
hydroxyhexahydro-5H-pyrrolizin-5-one (40). To a mixture of 39 (209 mg, 0.40 
mmol), 3 Å molecular sieves (300 mg) and benzyl trichloroacetimidate (202 
mg, 0.80 mmol) in Et2O (4 mL), triflic acid (0.04 mL, 0.48 mmoL) was added 
under nitrogen atmosphere. The mixture was stirred for 3 h at rt, filtered and 
washed with a sat. Na2CO3 solution. The organic layer was dried and 
evaporated under reduced pressure to afford a yellow oil, that was dissolved 
in MeOH (30 mL). Ambersep 900 OH (350 mg) was added and the mixture was 
stirred at rt for 15 h, filtered and evaporated under reduced pressure. 
Purification of the residue by chromatography on silica gel (petroleum 
ether/ethyl acetate 5:2) afforded pure 40 (Rf=0.27, 173 mg, 0.30 mmol, 75% 
yield over two steps) as a colourless oil. [α]D
25 = - 32.0 (c 0.63, CHCl3), 
1H-NMR 
(400 MHz, CDCl3) δ 7.37-7.21 (m, 20 H, Ar), 4.81 (d, J = 11.8 Hz, 1 H, Bn), 4.67 
(d, J = 11.8 Hz, 1 H, Bn), 4.59 (d, J = 7.8 Hz, 1 H, H-6), 4.57 (d, J = 11.8 Hz, 1 H, 
Bn), 4.54-4.42 (m, 5 H, Bn), 4.24 (dd, J = 3.7, 3.4 Hz, 1 H, H-2), 4.22 (m, 1 H, H-
3), 4.00 (dd, J = 7.8, 6.9 Hz, 1 H, H-7), 3.84 (dd, J = 5.5, 3.7 Hz, 1 H, H-1), 3.75 
(dd, J = 6.9, 5.5 Hz, 1 H, H-7a), 3.58 (dd, J = 9.9, 6.1 Hz, 1 H, Ha-8), 3.52 (dd, J = 
9.9, 4.8 Hz, 1 H, Hb-8), 3.38 (br s, 1 H, OH). 13C-NMR (50 MHz, CDCl3) δ 172.5 (s, 
C-5), 137.8 (s, 2 C, Ar), 137.4-137.3 (s, 2 C, Ar), 128.9-127.6 (d, 20 C, Ar), 86.7 
(d, C-1), 86.3 (d, C-7), 84.9 (d, C-2), 77.5 (d, C-6), 73.2-71.8 (t, 4 C, Bn), 68.4 (t, 
C-8), 65.9 (d, C-7a), 59.1 (d, C-3). IR (CHCl3): 3654, 3066, 3031, 3011, 2868, 
1709, 1454, 1364, 1102 cm-1. MS (EI): m/z 579 (0.3), 488 (0.4), 382 (1), 261 
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(13), 181 (5), 91 (100). Anal. Calcd for C36H37NO6
 (579.68): C, 74.59; H, 6.43; N, 
2.42. Found: C, 74.56; H, 6.37; N, 2.76. 
(1R,2R,3R,6R,7S,7aR)-1,2,7-Tris(benzyloxy)-3-[(benzyloxy)methyl]-6-
(methylsulfonyl)hexahydro-5H-pyrrolizin-5-one (41). To a solution of 40 (77 
mg, 0.13 mmol) in dry DCM (2 mL), triethylamine (0.05 ml, 0.35 mmol) and 
mesyl chloride (0.01 mL, 0.17 mmoL) was added under nitrogen atmosphere. 
The mixture was stirred for 4 h at rt, then 3 ml of water were added. Afetr 
extraction with DCM, the organic layer was dried and evaporated under 
reduced pressure to afford a yellow oil, that purificated by chromatography on 
silica gel (petroleum ether/ethyl acetate 3:1) afforded pure 41 (Rf=0.23, 72 mg, 
0.11 mmol, 84% yield) as a yellow oil. [α]D
25 = - 14.3 (c 0.52, CHCl3), 
1H-NMR 
(400 MHz, CDCl3) δ 7.26-7.12 (m, 20 H, Ar), 5.43 (d, J = 7.3 Hz, 1 H, H-6), 4.71 
(d, J = 11.7 Hz, 1 H, Bn), 4.55 (d, J = 11.7 Hz, 1 H, Bn), 4.48-4.32 (m, 6 H, Bn), 
4.14-4.03 (m, 3 H, H-2, H-7, H-3), 3.73 (dd, J = 5.4, 3.9 Hz, 1 H, H-1), 3.69-3.66 
(m, 1 H, H-7a), 3.48 (dd, J = 9.8, 5.9 Hz, 1 H, Ha-8), 3.40 (dd, J = 9.8, 4.7 Hz, 1 H, 
Hb-8), 3.26 (s, 3 H, Ms). 13C-NMR (50 MHz, CDCl3) δ 166.3 (s, C-5), 137.3, 136.9, 
136.8, 136.2 (s, Ar), 128.2-127.4 (d, 20 C, Ar), 86.2 (d, C-1), 84.3 (d, C-2), 83.9 
(d, C-6), 82.4 (d, C-7), 72.9, 71.9, (t, Bn), 71.7 (t, 2 C, Bn), 67.8 (t, C-8), 65.7 (d, 
C-7a), 59.4 (d, C-3), 40.1 (q, Ms). IR (CHCl3): 3024, 1270, 1365, 1220, 1176 cm
-1. 
MS (ESI): m/z 680 (M + Na+, 100). Anal. Calcd for C37H39NO8S
 (657.77): C, 67.56; 
H, 5.98; N, 2.13. Found: C, 66.70; H, 6.49; N, 2.15. 
3.5.4 Synthesis of (-)-Uniflorine A  
(1R,2R,3R,6S,7S,7aS)-1,2,7-Tri(benzyloxy)-3-[(benzyloxy)methyl]-5-oxo-
hexahydro-5H-pyrrolizin-6-yl benzoate (48). Triphenylphosphine (68 mg, 0.26 
mmol) and benzoic acid (31.7 mg, 0.26 mmol) were added to a solution of 40 
(125 mg, 0.216 mmol) in dry THF (4 mL), then DIAD (51 μL, 0.26 mmol) was 
added at 0 °C. The mixture was stirred at rt for 18 h, then the solvent was 
removed at reduced pressure and the crude product purified by FCC (eluent 
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petroleum ether:EtOAc 5:1, then 1:1), affording pure 48 (111 mg, 0.162 mmol, 
75%). [α]D
28 -55.6 (CH2Cl2, c 0.25), 
1H NMR (CDCl3) δ 8.00-7.98 (m, 2H), 7.52-
7.48 (m, 1H), 7.37-7.33 (m, 2H), 7.28-7.13 (m, 20H, Ar), 5.63 (d, J = 5.4 Hz, H-6), 
4.60 (d, J = 11.2 Hz, 1H, Bn), 4.53-4.29 (m, 7H, Bn), 4.23-4.15 (m, 2H, H-2, H-3), 
4.01 (dd, J = 6.8, 5.4 Hz, 1H, H-7a), 3.90 (dd, J = 6.8, 5.4 Hz, 1H, H-7), 3.70 (dd, J 
= 5.4, 3.4 Hz, 1H, H-1), 3.63-3.52 (m, 2H, Ha-8, Hb-8), 13C NMR (CDCl3) δ 168.4 
(s), 165.1 (s, C-5), 137.6-136.5 (s, 5C), 133.0 (d, 1C), 139.7-128.9 (d, 2C), 128.1-
127.2 (d, 22C, Ar), 85.4 (d, 2C, C-1, C-2), 77.8 (d, C-7), 72.9-71.5 (t, Bn), 72.3 (d, 
C-6), 68.4 (d, C-7a), 67.9 (t, C-8), 59.2 (d, C-3). IR (CDCl3): 1726 cm
-1. MS (ESI): 
m/z 706 (M + Na+, 100). Anal. Calcd for C43H41NO7 (683.29) C, 75.53; H, 6.04; N, 
2.05; Found: C, 75.16; H, 6.37; N, 1.95. 
(1R,2R,3R,6S,7S,7aS)-1,2,7-Tri(benzyloxy)-3-[(benzyloxy)methyl]-
hexahydro-1H-pyrrolizin-6-ol (49). LiAlH4 (25 mg, 0.66 mmol) was added to a 
solution of 48 (111 mg, 0.162 mmol) in dry THF (3 mL). The mixture was stirred 
at reflux under nitrogen atmosphere for 5 h, then 0.30 mL of a sat. solution of 
Na2SO4 was added dropwise at room temperature. The resulting mixture was 
filtered through Celite®, washed with EtOAc, then the solvent was evaporated. 
Purification of the crude product by FCC (eluent petroleum ether:EtOAc 1:1) 
gave pure 49 as a pale yellow oil (42 mg, 0.074 mmol, 45%). [α]D
22 - 6.0 (c 
0.25, CH2Cl2). 
1H NMR (400 MHz, CDCl3) δ 7.35-7.18 (m, 20H, Ar), 4.62-4.44 (m, 
8H, Bn), 4.29-4.26 (m, 1H, H-6), 4.03 (pseudo t, J = 4.9 Hz, 1H, H-2), 3.89 (t, J = 
4.2 Hz, 1H, H-1), 3.83 (dd, J = 6.9, 4.6 Hz, 1H, H-7), 3.62 (m, 1H, H-7a), 3.57-
3.49 (m, 2H, H-8), 3.33-3.30 (m, 1H, Ha-5), 3.03-2.99 (m, 2H, H-3, Hb-5). 13C 
NMR (50 MHz, CDCl3) δ 137.6-137.1 (s, 4C, Ar), 128.3-127.4 (d, 20C, Ar), 85.4 
(d, 2C, C-1 + C-2), 82.5 (d, C-7), 73.0-71.3 (5C, 4Bn + C-8), 70.5 and 70.3 (d, 2C, 
C-6 + C-7a), 69.8 (d, C-3), 60.2 (t, C-5). IR (CDCl3): 3689, 3605, 2956, 2926, 
2854, 1732, 161, 1457, 1378 cm-1. MS (ESI) m/z 566 (M + H+, 100). Anal. Calcd 
for C36H39NO5 (565.70) C, 76.43; H, 6.95; N, 2.48; Found: C, 76,40; H, 7,37; N, 
2,75. 
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(1R,2R,3R,6S,7S,7aS)-3-(Hydroxymethyl)hexahydro-1H-pyrrolizin-1,2,6,7-
tetraol ((-)-uniflorine A, 18). HCl 37% (0.1 ml) and 10% Pd on C (33 mg) were 
added to a solution of 49 (35 mg, 0.062 mmol) in MeOH (4 mL). The 
suspension was stirred under H2 atmosphere for 4 days, then filtered through 
Celite® and washed with MeOH. Evaporation of the solvent under reduced 
pressure afforded crude 18 that was transferred to a column of Dowex 50WX8 
and washed with MeOH (10 mL) and H2O (10 mL) to remove non basic 
impurities, then with 6% NH4OH (15 mL) to elute (-) - uniflorine A (18) as a 
yellowish solid (9 mg, 0.044 mmol, 71%), mp 177-180 °C. [α]D
21 - 6.9 (c 0.415, 
H2O). 
1H NMR (400 MHz, D2O) δ 4.23 (q, J = 5.2 Hz, 1H, H-6), 4.08 (pseudo t, J = 
4.7 Hz, 1H, H-7), 3.83 (t, J =7.4 Hz, 1H, H-1), 3.71 (dd, J = 8.8, 7.6 Hz, 1H, H-2), 
3.65 (dd, J = 11.9, 3.7 Hz, 1H, Ha-8), 3.50 (dd, J = 11.9, 6.4 Hz, 1H, Hb-8), 3.08 
(dd, J = 7.2, 5.0 Hz, 1H, H-7a), 2.97 (dd, J = 12.1, 5.4 Hz, 1H, Ha-5), 2.89 (dd, J = 
12.1, 5.0 Hz, 1H, Hb-5), 2.70 (ddd, J = 9.1, 6.4, 3.7 Hz, 1H, H-3). 13C NMR (100 
MHz, D2O) δ 78.7 (d, C-1), 77.5 (d, C-2), 75.7 (d, C-7), 72.0 (d, C-6), 71.8 (d, C-
7a), 70.9 (d, C-3), 62.3 (t, C-8), 58.1 (t, C-5). MS (ESI): m/z 206 (M+H+, 100), 158 
(10), 132 (13), 118 (22), 95 (30), 79 (73), 55 (17). Anal. Calcd for C8H15NO5 
(205.21) C, 46.82; H, 7.37; N, 6.83; Found: C, 46.85; H, 7.68; N, 7.11. 
3.5.5 Syntheses of 7-deoxycasuarine and 7-homocasuarine 
glucoside and their derivatives 
(2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl)-(1→6)-O-tris(benzyloxy)-7-
deoxy-5-oxo casuarine (54). A solution of glucopyranosyl tricholoroacetimidate 
5382 (190 mg, 0.29 mmol) and pyrrolizidine 21 (79 mg, 0.17 mmol) in dry Et2O 
(3 mL) was stirred for 10 minutes at rt under nitrogen atmosphere in the 
presence of 3 Å molecoular sieves (150 mg). After cooling to – 20°C and 
addition of TMSOTf (20 µL, 0.09 mmol), stirring was continued for 40 minutes; 
                                                            
82Rathore, T.; Hashimoto, K.; Igarashi, H.; Nukaya, D.; Fullerton, S. Tetrahedron 1985, 
41, 5427. 
1,3-dipolar cycloaddiotions 
79 
 
during this period the temperature was raised to rt. The mixture was washed 
with a saturated aqueous solution of Na2CO3 (2 mL), the combined organic 
layers were dried over Na2SO4, filtered and evaporated to dryness. The residue 
was purified by flash column chromatography on silica gel (pentane/EtOAc 5:1, 
increasing polarity) to afford pure 54 as a colourless oil (140 mg, 88 % yield). 
[α]D
22 = + 44.0 (c 1.23, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ 7.48-7.46 (m, 2 H, 
Ar), 7.38-7.25 (m, 31 H, Ar), 7.17-7.14 (m, 2 H, Ar), 5.68 (d, J = 3.5 Hz, 1 H, H-1), 
5.05 (d, J = 11.3 Hz, 1 H, Bn), 5.02 (d, J = 12.1 Hz, 1 H, Bn), 4.86 (d, J = 10.5 Hz, 1 
H, Bn), 4.79 (d, J = 10.9 Hz, 1 H, Bn), 4.75 (d, J = 11.7 Hz, 1 H, Bn), 4.65 (dd, J = 
10.1, 8.6 Hz, 1 H, H-6’), 4.60-4.46 (m, 9 H, Bn), 4.37 (dd, J = 5.5, 5.1 Hz, 1 H, H-
2’), 4.05 (m, 1 H, H-3’), 4.01 (t, J = 9.4 Hz, 1 H, H-4), 3.83 (dd, J = 7.4, 5.5 Hz, 1 
H, H-1’), 3.76-3.58 (m, 7 H, H-2, H-3, H-5, Ha-6, Hb-6, H-7a’, Ha-8’), 3.54 (dd, J = 
9.8, 3.5 Hz, 1 H, Hb-8’), 2.60 (m, 1 H, Ha-7’), 2.01 (m, 1 H, Hb-7’). 13C-NMR (50 
MHz, CDCl3) δ 171.3 (s, C-5’), 138.8-137.4 (s, 7 C, Ar), 128.5-127.4 (d, 35 C, Ar), 
95.6 (d, C-1), 89.0 (d, C-1’), 86.1 (d, C-2’), 81.5 (d, C-4), 78.8, 77.4 (d, 2 C), 75.7, 
75.2 (t, Bn), 73.6 (d, C-6’), 73.5, 73.3, 72.5, 72.3, 71.6 (t, Bn), 70.8 (d, 1 C), 69.0 
(t, C-8’), 68.6 (t, C-6), 59.2 (d, 1 C), 58.3 (d, C-3’), 34.9 (t, C-7’). IR (CDCl3): 3090, 
3067, 3033, 2868, 1702, 1454, 1363, 1099, 1071 cm-1. MS (EI): m/z 1018 (100, 
[M+Na]+), 996 (35, M+). Anal. Calcd for C63H65NO10 (996.19): C, 75.96; H, 6.58; 
N, 1.41. Found: C, 75.75; H, 6.82; N, 1.44. 
(2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl)-(1→6)-O-tris(benzyloxy)-7-
deoxy casuarine (55). To a cooled (0°C) solution of 54 (73 mg, 0.053 mmol) in 
dry THF (0.75 mL) a 1 M solution of LiAlH4 in THF (0.250 mL) was added under 
nitrogen atmosphere. The mixture was stirred at rt for 1 h, then, after cooling 
at 0 °C, a saturated aqueous solution of Na2SO4 (0.3 mL) was added dropwise. 
The suspension was then filtered through Celite®, washed with EtOAc and 
concentrated under reduced pressure to afford the crude product, that was 
purified by flash column chromatography on silica gel (EtOAc /petroleum ether 
7:3, Rf=0.35) to give pure 55 as a colourless oil (30 mg, 58 %). [α]D
29 = + 36.7 (c 
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1.20, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ 7.35-7.17 (m, 35 H, Ar), 4.95 (d, J = 
10.9 Hz, 1 H, Bn), 4.87 (d, J = 10.7 Hz, 1 H, Bn), 4.84 (d, J = 3.5 Hz, 1 H, H-1), 
4.78 (d, J = 10.7 Hz, 1 H, Bn), 4.73 (d, J = 11.7 Hz, 1 H, Bn), 4.72 (d, J = 12.1 Hz, 1 
H, Bn), 4.65 (d, J = 12.1 Hz, 1 H, Bn), 4.63 (d, J = 12.5 Hz, 1 H, Bn), 4.59-4.48 (m, 
7 H, Bn), 4.33 (m, 1 H, H-6’), 4.13 (dd, J = 6.6 Hz, 1 H, H-1’), 4.07 (dd, J = 7.4, 7.0 
Hz, 1 H, H-2’), 3.95 (t, J = 9.4 Hz, 1 H, H-3), 3.79 (m, 1 H, H-5), 3.75 (dd, J = 10.5, 
3.5 Hz, 1 H, Ha-6), 3.67 (dd, J = 9.4 Hz, 1 H, H-4), 3.65 (dd, J = 10.5, 1.7 Hz, 1 H, 
Hb-6), 3.58-3.46 (m, 5 H, H-2, H-3’, H-7a’, Ha-8’, Hb-8’), 3.19 (dd, J = 11.3, 4.3 
Hz, 1 H, Ha-5’), 3.05 (m, 1 H, Hb-5’), 2.21 (m, 1 H, Ha-7’), 1.93 (m, 1 H, Hb-7’). 
13C-NMR (50 MHz, CDCl3) δ 138.7, 138.6, 138.5, 138.3, 138.2, 138.1, 137.9 (s, 
Ar.), 128.6-127.4 (d, 35 C, Ar), 96.3 (d, C-1), 88.1 (d, C-1’), 84.6 (d, C-2’), 81.8 
(d, C-3), 79.9 (d, 1 C), 78.8 (d, C-6’), 77.6 (d, C-4), 75.6-72.2 (t, 7 C, Bn), 72.1 (t, 
C-8’), 70.7 (d, C-5), 68.5 (t, C-6), 67.6 (d, 1 C), 66.0 (d, 1 C), 58.7 (t, C-5’), 37.8 (t, 
C-7’). IR (CDCl3): 3088, 3066, 3031, 2926, 2866, 1496, 1453, 1363, 1207, 1070 
cm-1. MS (EI): m/z 1004 (M+Na+, 32), 982 (M+, 100). Anal. Calcd for C63H67NO9 
(982.21): C, 77.04; H, 6.88; N, 1.43. Found: C, 77.38; H, 6.74; N, 1.73. 
6-α-D-Glucopyranosyl-(1→6)-O-7-deoxycasuarine (51). To a stirred 
solution of 55 (46 mg, 0.05 mmol) in MeOH (5 mL), 20 mg of Pd (10% on C) and 
2 drops of HCl were added. The suspension was stirred at rt under hydrogen 
atmosphere for 12 h when filtered through Celite® and washed with MeOH. 
Evaporation under reduced pressure afforded a vitreous solid that was 
transferred to a column of DOWEX 50WX8 and then washed with MeOH (15 
mL), H2O (10 mL) to remove non amine containing products and then with 7% 
NH4OH (25 mL) to elute the product 51. Evaporation of the solvent afforded 
the product as a colourless highly hygroscopic solid (13 mg, 77% yield). [α]D
29 = 
+ 97.8 (c 0.88, H2O). 
1H-NMR (400 MHz, D2O) δ 4.89 (d, J = 3.9 Hz, 1 H, H-1), 
4.38 (m, 1 H, H-6’), 4.03 (t, J = 8.2 Hz, 1 H, H-1’), 3.77-3.55 (m, 7 H, H-2’, Ha,b-
8’), 3.46 (dd, J = 9.9, 3.9 Hz, 1 H, H-2), 3.36-3.28 (m, 2 H, H7a’), 3.22 (ddd, J = 
9.6, 6.0, 3.5 Hz, 1 H, H-3’), 3.19-3.16 (m, 1 H, Ha-5’), 3.01 (dd, J = 13.1, 3.7 Hz, 1 
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H, Hb-5’), 2.20-2.13 (m, 1 H, Ha-7’), 2.09-2.06 (m, 1 H, Hb-7’). 13C-NMR (50 
MHz, D2O) δ 99.6 (d, C-1), 81.8 (d, C-1’), 81.0 (d, C-6’), 77.9 (d, C-2’), 74.8, 74.4, 
73.2, 71.8, 71.4, 68.3 (d, C-2, C-3, C-4, C-5, C-3’, C-7a’), 63.5, 62.6 (t, C-6, C-8’), 
60.2 (t, C-5’), 37.7 (t, C-7’). 1H-NMR (400 MHz, CD3OD) δ 4.92 (d, J = 3.7 Hz, 1 H, 
H-1), 4.51 (m, 1 H, H-6’), 4.13 (t, J = 8.0 Hz, 1 H, H-1’), 3.89-3.63 (m, 7 H, H-2’, 
Ha,b-6, Ha,b-8’), 3.47 (dd, J = 9.8, 3.8 Hz, 2 H), 3.45-3.43 (m, 1 H, H7a’), 3.39-
3.31 (m, 3 H, H-3’, Ha-5’), 3.12 (dd, J = 12.7, 3.6 Hz, 1 H, Hb-5’), 2.30-2.19 (m, 2 
H, Ha,b-7’). 13C-NMR (50 MHz, CD3OD) δ 96.9 (d, C-1), 79.3 (d, C-1’), 77.5 (d, C-
6’), 75.4 (d, C-2’), 72.3, 72.0, 70.9, 69.6, 69.2 (d, C-2, C-3, C-4, C-5, C-3’), 66.4 
(d, C-7a’) 60.4, 60.3 (t, C-6, C-8’), 57.1 (t, C-5’), 35.1 (t, C-7’). MS (EI): m/z 350 
(M⋅+-1, 0.4), 320 (100), 172 (9), 158 (42), 68 (21). Anal. Calcd for C14H25NO9 
(351.35): C, 47.86; H, 7.17; N, 3.99. Found: C, 47.26; H, 7.90; N, 3.80. 
(2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl)-(1→6)-O-tris(benzyloxy)-7-
methoxycarbonyl-5-oxo-casuarine (56). A solution of glucopyranosyl 
tricholoroacetimidate 5382 (890 mg, 1.30 mmol) and pyrrolizidine 27 (429 mg, 
0.81 mmol) in Et2O/DCM 3:1 was stirred for 10 minutes at rt under nitrogen 
atmosphere in the presence of 3 Å molecular sieves (200 mg). After cooling to 
–20°C and addition of TMSOTf (73 µL, 0.40 mmol), stirring was continued for 1 
hour; during this period the temperature was raised to rt. The mixture was 
washed with 8 mL of a saturated aqueous solution of Na2CO3 and the 
combined organic layer was dried over Na2SO4, filtered and concentrated to 
dryness. The residue was purified by flash column chromatography on silica gel 
(hexane/EtOAc 7:1) to afford pure 56 (Rf=0.26 petroleum ether/EtOAc 3:1) as a 
colourless oil (598 mg, 75%). [α]D
21 = + 32.7 (c 0.2, CHCl3). 
1H-NMR (400 MHz, 
CDCl3) δ 7.45-7.11 (m, 35 H, Ar), 5.80 (d, J = 3.5 Hz, 1 H, H-1), 5.01 (d, J = 10.6 
Hz, 2 H, Bn), 5.00 (d, J = 9.6 Hz, 1 H, H-6’), 4.82 (d, J = 10.5 Hz, 1 H, Bn), 4.75 (d, 
J = 10.8 Hz, 1 H, Bn), 4.71 (d, J = 12 Hz, 1 H, Bn), 4.64 (d, J = 12 Hz, 1 H, Bn), 
4.57-4.46 (m, 8 H, Bn), 4.27 (t, J = 4 Hz, 1 H, H-2), 4.17-4.14 (m, 1 H, H-3’), 3.96 
(dd, J = 6.4, 4.4 Hz, 1 H, H-1’), 3.94 (dd, J = 10.4 Hz, 1 H, H-3), 3.86 (dd, J = 6.4, 1 
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H, H-7a’), 3.77 (dd, J = 10 Hz, 1 H, H-5), 3.71-3.62 (m, 7 H, OCH3, H-6a, H-6b, H-
4, H-2), 3.57 (dd, J = 9.6 Hz, 1 H, H-8a’), 3.51 (dd, J = 9.6, 4.4 Hz, 1 H, H-8b’), 
3.26 (dd, J = 10, 2 Hz, 1 H, H-7’). 13C-NMR (50 MHz, CDCl3) δ 170.7, 170.0 (s, 
C=O). 138.6-137.1 (s, 7 C, Ar.), 128.3-127.2 (d, 35 C, Ar), 95.2 (d, C-1), 87.8 (d, 
C-1’), 85.2 (d, C-2’), 81.1 (d, C-3), 78.5 (d, C-2), 76.7 (d, C-6’), 75.5 (t, Bn), 75.2 
(d, C-5), 74.9-71.8 (t, 6 C, Bn), 70.5 (d, C-4), 68.3 (t, C-8’), 67.8 (t, C-6), 61.8 (d, 
C-7a’), 58.5 (d, C-3’), 52.3 (q, Me), 51.84 (d, C-7’). IR (CDCl3): 2925, 2867, 1737 
(C=O), 1711 (C=O), 1454, 1071 cm-1. HRMS (ESI) for C65H67NO12Na [M+Na]
+ 
calculated: 1076.4556; found: 1076.4553. Anal. Calcd for C65H67NO12 (1054.23): 
C, 74.05; H, 6.41; N, 1.33. Found: C, 73.63; H, 6.43; N, 0.99. 
6-α-D-Glucopyranosyl-(1→6)-O-7-methoxycarbonyl-5-oxo-casuarine 
(57). To a stirred solution of 56 (125 mg, 0.118 mmol) in MeOH/AcOEt 3:1 (12 
mL), 150 mg of Pd (10% on C) were added. The suspension was stirred at rt 
under hydrogen atmosphere for 4 days, then filtered through Celite® and 
washed with MeOH. Evaporation under reduced pressure afford pure 57 as a 
waxy solid (48 mg, 96%). [α]D
21 = + 75.3 (c 0.15, MeOH). 1H-NMR (400 MHz, 
D2O) δ 5.18 (d, J = 3.6 Hz, 1 H, H-1), 4.97 (d, J = 9.6 Hz, 1 H, H-6’), 4.08 (dd, J = 
6.8, 6.4 Hz, 1 H, H-2’), 3.88 (dd, J = 7.6, 7.2 Hz ,1 H, H-1’), 3.80-3.55 (m, 11H, H-
5, OCH3, H-4, H-3, Ha-6, Hb-6, Ha-8’, H-7a’, H-3’), 3.41 (dd, J = 10, 4 Hz, 1 H, H-
2), 3.37 (dd, J = 9.6 Hz, 1 H, Hb-8’), 3.28 (dd, J = 9.2 Hz, 1 H, H-7’). 13C-NMR (50 
MHz, D2O) δ 171.9, 171.5 (s, C=O), 98.8 (d, C-1), 79.2 (d, C-6’), 78.3, 77.3, 72.2, 
72.1, 70.9, 68.6, 61.4, 60.9 (d, 1 C), 59.5, 52.2 (t, 1 C), 52.8 (q, OMe), 52.2 (d, 1 
C). IR (KBr): 3420 (OH), 1710 (C=O), 1684 (C=O), 1205, 1143, 1024 cm-1. HRMS 
(ESI) for C16H25NO12Na [M+Na]
+ calculated: 446.1269; found: 446.1266. Anal. 
Calcd for C16H25NO12 (423.37): C, 45.39; H, 5.95; N, 3.31. Found: C, 44,73; H, 
6,27; N, 3,37. 
(2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl)-(1→6)-O-tris(benzyloxy)-7-
[(hydroxy)methyl]-casuarine (58). To a cooled (0°C) solution of 56 (100 mg, 
0.09 mmol) in dry THF (1.5 mL) a 2 M solution of LiBH4 in THF (0.9 mL) and a 
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1M solution of BH3 in THF (1.8 mL) were added dropwise. The reaction mixture 
was stirred at rt for 5 days and then, after cooling to -20°C, H2O was added 
dropwise. The mixture was filtered through Celite® and washed with CHCl3, 
then concentrated under reduced pressure afford a viscous oil. Purification by 
flash column chromatography on silica gel (EtOAc/hexane 1:3) afforded pure 
58 (Rf=0.28) as a colourless oil (89 mg, 98%). [α]D
20 = + 25.3 (c 0.6, CHCl3). 
1H-
NMR (400 MHz, CDCl3) δ 7.35-7.14 (m, 35 H, Ar), 4.88-4.82 (m, 2H, Bn), 4.79 (d, 
J = 3.6 Hz, 1 H, H-1), 4.74-4.45 (m, 10 H, Bn), 4.37-4.28 (m, 3H, H-1’, Bn), 4.17-
4.02 (m, 3 H), 3.89-3.84 (m, 2 H), 3.77-3.73 (m, 1 H), 3.66-3.42 (m, 9 H), 3.34 
(dd, J = 13.5, 5.3 Hz,  1 H), 2.36 (m, 1 H, H-7’). 13C-NMR (50 MHz, CDCl3) δ 
138.2-137.8 (s, 7 C, Ar), 128.6-127.5 (d, 35 C, Ar), 95.5 (d, C-1), 86.9, 83.2, 81.8, 
79.7, 79.6, 78.9, 77.8 (d, 1C), 75.7, 75.3, 73.7, 73.3, 72.9, 72.7, 72.2 (t, 1C), 
71.2, 70.3 (d, 1 C), 69.0, 68.1, 66.9, 61.7 (t, 1 C), 53.9 (d, C-7’). IR (CDCl3): 3480 
(OH), 3032, 2925, 2870, 2386, 1454, 1078 cm-1. HRMS (ESI) for C64H69NO10 [M
+] 
calculated: 1012.4994; found: 1012.4993. Anal. Calcd for C64H69NO10 (1012.23): 
C, 75.94; H,6.87; N,1.38; Found: C, 75.46; H, 7.05; N, 1.45. 
6-α-D-Glucopyranosyl-(1→6)-O-7-hydroxymethil-casuarine (52). To a 
stirred solution of 58 (89 mg, 0.09 mmol) in MeOH (8 mL), 20 mg of Pd (10% on 
C) and 2 drops of HCl were added. The suspension was stirred at rt under 
hydrogen atmosphere for 2 days when filtered through Celite® and washed 
with MeOH. Evaporation under reduced pressure afforded a vitreous solid that 
was transferred to a column of DOWEX 50WX8 and then washed with MeOH 
(15 mL), H2O (10 mL) to remove non amine containing products and then with 
7% NH4OH (25 mL) to elute the product 52. Evaporation of the solvent 
afforded the product as a colourless highly hygroscopic solid ( 27 mg, 79%). 
[α]D
26 = + 102.5 (c 0.105, MeOH). 1H-NMR (400 MHz, D2O) δ 4.89 (d, J = 3.7 Hz, 
1 H, H-1), 4.26-4.25 (m, 1 H, H-6’), 4.08 (t, J = 7.7 Hz, 1 H, H-1’), 3.77-3.42 (m, 
10 H), 3.32 (dd, J = 9.8, 9.0 Hz, 1 H, H-3’), 3.24-3.15 (br m ,3 H, Ha-5’), 3.04 (br 
m, 1 H, H-7a’), 2.50-2.48 (m, 1 H, H-7’). 13C-NMR (50 MHz, D2O) δ 96.9 (d,C-1), 
Chapter 3 
84 
 
79.8 (d, C-1’), 79.1 (d, C-2’), 76.0 (d, C-6’), 72.3, 71.9, 70.6, 69.2, 68.6 (d, 6 C, C-
2, C-3, C-4, C-5, C-3’, C-7a’), 61.2, 60.9, 60.0 (t, C-6, C-8’, C-9’), 51.3 (t, C-5’). IR 
(KBr):3399, 1419, 1023 cm-1. MS (EI): m/z 351 (26); 350 (85); 207 (22), 188 (37); 
110 (19), 91 (22), 73 (44), 60 (100), 55 (64). Anal. Calcd for C15H27NO10 (381.38): 
C, 47.24; H, 7.14; N, 3.67; Found: C, 46.50; H, 7.65; N, 3.29. 
(2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl)-(1→6)-O-tris(benzyloxy)-7-
[(hydroxy)methyl]-5-oxo-casuarine (59). To a cooled (0°C) solution of 56 (221 
mg, 0.21 mmol) in dry THF (1.5 mL) a 2 M solution of LiBH4 in THF (0.42 mL) 
was added dropwise. The reaction mixture was stirred at rt overnight and 
then, after cooling to 0°C, H2O was added dropwise. The mixture was then 
filtered through Celite®, washed with CHCl3 and concentrated under reduced 
pressure. The residue was purified by flash column chromatography on silica 
gel (EtOAc/hexane 1:4) to afford pure 59 (Rf=0.33 EtOAc/petroleum ether 1:3) 
as a colourless oil (134 mg, 62%). [α]D
23 = + 44.4 (c 0.4, CHCl3). 
1H-NMR (400 
MHz, CDCl3) δ 7.47-7.08 (m, 35 H, Ar), 5.68 (d, J = 3.6 Hz, 1 H, H-1), 5.06 (dd, J = 
2 Hz, 2 H, Bn), 4.81-4.75 (m, 3 H, Bn), 4.72 (d, J = 7.6 Hz, 1 H, H-6’), 4.60-4.40 
(m, 9 H, Bn), 4.26 (dd, J = 3.6, 4 Hz, 1 H, H-2'), 4.21 (m, 1 H, H-3’), 3.94 (t, J = 9.2 
Hz, 1 H, H-3) 3.87-3.66 (m, 6 H, H-5, Ha-6, H-7a’, Ha,b-8’, H-1’,), 3.60 (dd, J = 
9.2, 3.6 Hz, 1 H, H-2), 3.45 (d, J = 5.2 Hz, 2 H, Ha,b-9’), 3.37 (dd, J = 7.6, 1 H, Hb-
6), 3.26 (dd, J = 10.8, 9.2 Hz, 1 H, H-4), 3.13 (t, 1 H, OH), 2.44 (m, 1 H, H-7’). 13C-
NMR (50 MHz, CDCl3) δ 171.4 (s, C=O), 138.4-136.7 (s, 7 C, Ar), 128.7-127.3 (d, 
35 C, Ar), 94.9 (d, C-1), 87.7 (d, C-1’), 86.1 (d, C-2’), 81.4 (d, C-3), 78.2 (d, C-2), 
77.4 (d, C-4), 75.6 (d, C-6’), 75.6, 74.9, 73.3, 73.0, 71.9, 71.7, 71.2 (t, Bn), 70.5 
(d, C-5), 68.8 (t, C-6), 68.7 (t, C-9’), 60.5 (d, C-7a’), 58.4 (t, C-8’), 58.4 (d, C-3’), 
50.4 (d, C-7’). IR (CDCl3): 3463 (OH), 3032, 2925, 2870, 1703 (C=O), 1454, 1078 
cm-1. HRMS (ESI) for C64H67NO11Na [M+Na]
+ calculated: 1048.4606; found: 
1048.4602. Anal. Calcd for C64H67NO11 (1026.22) C, 74.90; H, 6.58; N, 1.36; 
Found: C, 74,65 ; H, 6,69; N, 1,53. 
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6-α-D-Glucopyranosyl-(1→6)-O-7-hydroxymethil-5-oxo-casuarine (60). 
To a stirred solution of 59 (134 mg, 0.13 mmol) in MeOH (13 mL), 230 mg of Pd 
(10% on C) were added. The suspension was stirred at rt under hydrogen 
atmosphere for 24 h when filtered through Celite® and washed with MeOH. 
Evaporation under reduced pressure afford pure 60 as a waxy solid (37 mg, 
72%). [α]D
26 = + 59.3 (c 0.75, MeOH). 1H-NMR (400 MHz, D2O) δ 5.18 (d, J = 4 
Hz, 1 H, H-1), 4.57 (d, J = 9.6 Hz, 1 H, H-6’), 4.09 (dd, J = 6.8, 6.4 Hz, 1 H, H-2’), 
3.82-3.58 (m, 10 H, H-1’, H-3’, Ha,b-8’, Ha-9’, H-3, H-4, H-5, Ha,b-6), 3.50-3.45 
(m, 2 H, H-7a’, H-2), 3.34 (dd, J = 9.6, 9.2 Hz, 1 H, Hb-9’), 2.50-2.44 (m, 1 H, H-
7’). 13C-NMR (50 MHz, D2O) δ 173.9 (s, C=O), 98.6 (d, C-1), 79.9 (d, C-6’), 77.9, 
77.3, 72.7, 72.5, 71.2, 69.3, 62.1, 61.2 (d, 1 C), 60.3, 59.8, 59.7 (t, 1 C), 50.0 (d, 
1 C). IR (KBr): 3378 (OH), 1689 (C) cm-1. HRMS (ESI) for C65H67NO12Na [M+Na]
+ 
calculated: 418.1320; found: 418.1312. Anal. Calcd for C15H25NO11 (395.36): C, 
45.57; H, 6.37; N, 3.54; Found: C, 44.80; H, 6.28; N, 3.04. 
3.5.6 Casuarine-6-O-α-D-glucopyranoside and its unnatural 
lactam 
(2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl)-(1→6)-O-tetra(benzyloxy)-
5-oxo-casuarine (61). A solution of glucopyranosyl tricholoroacetimidate (53, 
230 mg, 0.33 mmol) and pyrrolizidine 40 (115 mg, 0.20 mmol) in dry diethyl 
ether (4 mL) was stirred for 10 min at room temperature under nitrogen 
atmosphere in the presence of 3 Å molecoular sieves (150 mg). After cooling to 
–20 °C and addition of trimethylsilyl trifluoromethanesulfonate (18 µL, 0.10 
mmol), stirring was continued for 40 min; during this period the temperature 
was raised to rt. The mixture was washed with a sat. Na2CO3 solution (2 mL), 
dried over Na2SO4, filtered and concentrated to dryness. The residue was 
purified by flash column chromatography on silica gel (petroleum ether/ethyl 
acetate 5:1) to afford pure 61 (159 mg, 0.144 mmol, 72%) as a colourless oil. Rf 
= 0.32 (petroleum ether/ethyl acetate 5:1). [α]D
24 = + 51.5 (c 0.87, CHCl3). 
1H-
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NMR (400 MHz, CDCl3, 25°C) δ 7.47-7.12 (m, 40 H, Ar), 5.69 (d, J = 3.5 Hz, 1 H, 
H-1), 5.01 (d, J = 10.8 Hz, 1 H, Bn), 5.00 (d, J = 11.9 Hz, 1 H, Bn), 4.84 (d, J = 10.9 
Hz, 1 H, Bn), 4.77 (d, J = 10.8 Hz, 1 H, Bn), 4.75 (d, J = 10.5 Hz, 1 H, Bn), 4.73 (d, 
J = 8.2 Hz, 1 H, H-6’), 4.64-4.32 (m, 11 H, Bn), 4.31 (dd, J = 4.1, 3.7 Hz, 1 H, H-
2’), 4.21-4.17 (m, 2 H, H-3’, H-7’), 3.99 (dd, J = 9.4, 9.2 Hz, 1 H, H-4), 3.99-3.94 
(m, 2 H, H-5, H-1’), 3.74 (dd, J = 6.6, 6.4 Hz, 1 H, H-7a’), 3.68 (dd, J = 9.6, 9.2 Hz, 
1 H, H-3), 3.64 (dd, J = 9.6, 3.5 Hz, 1 H, H-2), 3.61-3.53 (m, 3 H, Ha-6, Ha-8’, Hb-
8’), 3.45 (dd, J = 10.7, 1.7 Hz, 1 H, Hb-6). 13C-NMR (50 MHz, CDCl3, 25°C) δ 
169.4 (s, C-5’), 138.9-137.2 (s, 8 C, Ar), 128.5-127.5 (d, 40 C, Ar), 95.2 (d, C-1), 
87.2 (d, C-1’), 86.1 (d, C-2’), 84.4 (d, C-7’), 81.6 (d, C-4), 78.6 (d, C-2), 77.9 (d, C-
6’), 77.3 (d, C-3), 75.7, 74.9 (t, 2 C, Bn), 73.3 (t, 2 C, Bn), 72.3 (t, Bn), 72.0 (t, 2 
C, Bn), 71.7 (t, Bn), 70.4 (d, C-5), 69.2 (t, C-8’), 68.1 (t, C-6), 65.8 (d, C-7a’), 58.9 
(d, C-3’). IR (CHCl3): 3066, 3032, 3010, 2867, 1711, 1454, 1098 cm
-1. HRMS (ESI) 
calcd for C70H71NO11Na [M+Na]
+: 1124.4919; found: 1124.4918. Anal. Calcd for 
C70H71NO11 (1102.31): C, 76.27; H, 6.49; N, 1.27: Found: C, 76.53; H, 6.76; N, 
1.38. 
(2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl)-(1→6)-O-tetra(benzyloxy)-
casuarine (62). To a stirred solution of 61 (134 mg, 0.13 mmol) in MeOH (13 
mL), 230 mg of Pd (10% on C) were added. The suspension was stirred at rt 
under hydrogen atmosphere for 24 h when filtered through Celite® and 
washed with MeOH. Evaporation under reduced pressure afford pure 62 as a 
waxy solid (37 mg, 72%). [α]D
26 = + 59.3 (c 0.75, MeOH). 1H-NMR (400 MHz, 
D2O) δ 5.18 (d, J = 4 Hz, 1 H, H-1), 4.57 (d, J = 9.6 Hz, 1 H, H-6’), 4.09 (dd, J = 
6.8, 6.4 Hz, 1 H, H-2’), 3.82-3.58 (m, 10 H, H-1’, H-3’, Ha,b-8’, Ha-9’, H-3, H-4, H-
5, Ha,b-6), 3.50-3.45 (m, 2 H, H-7a’, H-2), 3.34 (dd, J = 9.6, 9.2 Hz, 1 H, Hb-9’), 
2.50-2.44 (m, 1 H, H-7’). 13C-NMR (50 MHz, D2O) δ 173.9 (s, C=O), 98.6 (d, C-1), 
79.9 (d, C-6’), 77.9, 77.3, 72.7, 72.5, 71.2, 69.3, 62.1, 61.2 (d, 1 C), 60.3, 59.8, 
59.7 (t, 1 C), 50.0 (d, 1 C). IR (KBr): 3378 (OH), 1689 (C) cm-1. HRMS (ESI) for 
C65H67NO12Na [M+Na]
+ calculated: 418.1320; found: 418.1312. Anal. Calcd for 
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C15H25NO11 (395.36): C, 45.57; H, 6.37; N, 3.54; Found: C, 44.80; H, 6.28; N, 
3.04. 
6-α-D-Glucopyranosyl-O-casuarine (50). A solution of 62 (196 mg, 0.18 
mmol) in MeOH (25 mL) was stirred at room temperature under H2 
atmosphere for 24 h in the presence of 10% Pd/C (350 mg) and 4-5 drops of 
conc. HCl. Filtration through Celite® afforded a waxy solid that was transferred 
to a column of DOWEX 50WX8 and then washed with MeOH (15 mL), H2O (10 
mL) to remove non amine containing products and then with 7% NH4OH (25 
mL) to elute pure 50 (50 mg, 0.14 mmol, 77%) as a white foam. An analytically 
pure sample was obtained by filtration through DOWEX 50WX8-200. [α]D
23 = + 
91.9 (c 0.35, H2O). 
1H-NMR (400 MHz, D2O, 25°C) δ 4.89 (d, J = 3.7 Hz, 1 H, H-1), 
4.24 (t, J = 3.0 Hz, 1 H, H-7’), 4.09 (dt, J = 4.3, 3.0 Hz, 1 H, H-6’), 4.00 (t, J = 8.2 
Hz, 1 H, H-1’), 3.79-3.75 (m, 1 H, Ha-6), 3.68-3.56 (m, 5 H, H-3, H-5, Hb-6, H-2’, 
Ha-8’), 3.49 (dd, J = 11.8, 6.3 Hz, 1 H, Hb-8’), 3.47 (dd, J = 10.0, 3.7 Hz, 1 H, H-
2), 3.31 (t, J = 9.4 Hz, 1 H, H-4), 3.13 (dd, J = 12.9, 4.3 Hz, 1 H, Ha-5’), 3.01-2.96 
(m, 3 H, H-3’, Hb-5’, H7a’). 13C-NMR (50 MHz, D2O, 25°C) δ 96.7 (d, C-1), 83.0 
(d, C-6’), 77.4 (d, C-7’), 76.9 (d, C-1’), 76.1 (d, C-2’), 72.1 (d, C-7a’), 71.9 (d, C-3), 
71.5 (d, C-5), 70.3 (d, C-2), 68.9 (d, C-4), 68.6 (d, C-3’), 62.0 (t, C-8’), 59.8 (t, C-
6), 55.1 (t, C-5’). HRMS (ESI) calcd for C14H26NO10 [M+H]
+: 368.1551; found: 
368.1544. Anal. Calcd for C14H25NO10 (367.35): C, 45.77; H, 6.86; N, 3.81. 
Found: C, 45.39; H, 6.57; N, 3.46. 
6-α-D-Glucopyranosyl-O-5’-oxo-casuarine (63). To a stirred solution of 61 
(159 mg, 0.144 mmol) in MeOH/EtOAc 7:1 (12 mL), 180 mg of Pd (10% on C) 
were added. The suspension was stirred at rt under hydrogen atmosphere for 
24, then filtered through Celite® and then washed with MeOH. Evaporation 
under reduced pressure afforded pure 63 (42 mg, 0.110 mmol, 77 % yield) as 
an hygroscopic pale yellow oil. [α]D
24 = + 37.6 (c 0.28, MeOH). 1H-NMR (400 
MHz, D2O) δ 5.14 (d, J = 3.7 Hz, 1 H, H-1), 4.53 (d, J = 8.4 Hz, 1 H, H-6’), 4.27 
(dd, J = 8.4, 7.0 Hz, 1 H, H-7’), 4.08 (t, J = 6.1 Hz, 1 H, H-2’), 3.90 (t, J = 6.8 Hz, 1 
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H, H-1’), 3.78-3.58 (m, 7 H, H-3, H-3’,H-5, Ha,b-6, Ha,b-8’), 3.50-3.44 (m, 2 H, H-
2, H-7a’), 3.34 (t, J = 9.5 Hz, 1 H, H-4). 13C-NMR (50 MHz, D2O) δ 170.8 (s, C-5’), 
98.0 (d, C-1), 81.6 (d, C-6’), 78.2 (d, 1 C), 77.3 (d, C-7’), 76.9 (d, C-2’), 71.9 (d, 1 
C), 71.5 (d, 1 C), 70.5 (d, 1 C), 68.6 (d, C-4), 64.7 (d, 1 C), 60.7 (d, 1 C), 59.6 (t, 1 
C), 58.8 (t, 1 C). MS (ESI): m/z 404 (100, M++Na), 405 (16), 406 (4); Anal. Calcd 
for C14H23NO11 (381.33): C, 44.10; H, 6.08; N, 3.67 Found: C, 43.96; H, 6.19; N, 
3.42.
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4.1 Introduction 
In this chapter, organometallic additions to the key nitrone for obtaining 
two different classes of polyhydroxylated alkaloids will be discussed. 
As mentioned (Chapter 2.1), organometallic addition on a chiral 
pyrroline nitrone can be used to obtain pyrrolidine and pyrrolizidine alkaloids: 
N
BnO OBn
O
OBn
N
OHH
OH
OH
C
RO
N
H
HO OH
OH
R'
R''
R'''
M
Li
R'
Scheme 4.1. General organometallic addition synthetic strategy 
The different procedures utilized for obtaining both the classes of 
products are discussed herein. 
Part of the work described in section 4.2 was developed in the 
Laboratory of Asymmetric synthesis of Prof. Pedro Merino, Department of 
Organic Chemistry, University of Zaragoza (Aragona, Spain); and some of the 
work described in section 4.3 was developed in the research group of Prof. 
Hans-Ulrich Reiβig, Freie Universität Berlin, Institut für Chemie und Biochemie 
Organische Chemie (Berlin, Germany).  
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4.2 Synthesis of pyrrolidine alkaloids 
4.2.1 Introduction 
A great variety of alkaloids possessing the structure of polyhydroxylated 
pyrrolidines, otherwise known as iminocyclitols, has been isolated from natural 
sources, including plants and microorganisms,83 and many of them are 
powerful inhibitors of biologically important enzymes such as glycosidases and 
those closely related with the metabolism of N-linked glycoproteins.84 Due to 
that biological activity, iminocyclitols might constitute powerful tools against 
cancer,85 viral infections86 or diabetes.87 Naturally occurring DMDP (64), a fairly 
widespread secondary metabolite firstly isolated from Derris elliptica 
(Leguminosae)23 and since then found in microorganisms and plant species of 
quite unrelated families,88 and its unnatural synthetic analogues are known to 
                                                            
83
 a) De Melo, E. B.; Da S. Gomes, A.; Carvalho, I. Tetrahedron 2006, 62, 10277 b) 
Ref. 24. c) Ref. 29. d) Martin, O. R. Ann. Pharm. Francaises 2007, 65, 5. 
84
 a) Compain, P.; Martin, O. R. Iminosugars: From Synthesis to Therapeutic 
Applications. Wiley, Chichester, 2007. b) Asano, N. Glycobiology 2003, 13, 93R. c) 
Nishimura, Y. Curr. Top. Med. Chem. 2003, 3, 575. d) Stütz, A. E. Iminosugars as 
Glycosidase Inhibitors: Nojirimycin and Beyond; Wiley-VCH, Weinheim, 1999. e) 
Jacob, G. S. Curr. Op. Struct. Biol. 1995, 5, 605. 
85
 a) Bernacki, R. J.; Niedbala, M. J.; Korytnyk, W. Cancer Metastasis Rev. 1985, 4, 81. 
b) Goss, P. E.; Baptiste, J.; Fernandes, B.; Baker, M.; Dennis, J. W. Cancer Res. 1994, 
54, 1450. c) Gerber-Lemaire, S.; Juillerat-Jeanneret, L. Mini-Rev. Med. Chem. 2006, 6, 
1043. d) Noda, I.; Fujieda, S.; Seki, M.; Tanaka, N.; Sunaga, H.; Ohtsubo, T.; Tsuzuki, 
H.; Fan, G.-K.; Saito, H. Int. J. Cancer 1999, 80, 279. 
86
 a) Tanaka, Y.; Kato, J.; Kohara, M.; Galinski, M. S. Antiviral Res. 2006, 71, 1. b) 
Robina, I.; Moreno-Vargas, A. J.; Carmona, A. T.; Vogel, P. Curr. Drug Metab. 2004, 
5, 329. c) Nishimura, Y. Studies Nat. Prod. Chem. 1995, 16, 75. d) Asano, N.; Nishida, 
M.; Kato, A.; Kizu, H.; Matsui, K.; Shimada, Y.; Itoh, T.; Baba, M.; Watson, A. A.; 
Nash, R. J.; de Lilley, P. M.; Watkin, D. J.; Fleet, G. W. J. J. Med. Chem.1998, 41, 
2565. 
87
 a) Chang, C.-F.; Ho, C. -W.; Wu, C.-Y.; Chao, T.-A.; Wong, C.-H.; Lin, C.-H. Chem. 
Biol. 2004, 11, 1301. b) Painter, G. F.; Eldridge, P. J.; Falshaw, A. Bioorg. Med. Chem. 
2004, 12, 225. c) Beck, R. Pharma. Chem. 2003, 2, 14. d) Lee, S. M. Diabetes 1982, 
31, 249. 
88
 a) Juettner, F.; Wessel, H. P. J. Phycol. 2003, 39, 26. b) Satoshi, W.; Hideki, K.; 
Kouzo, N.; Hiroshi, A. Bioscience, Biotech. Biochem. 1995, 59, 936. c) Ref. 77. d) 
Molyneux, R. J. Phytochem. Anal. 1993, 4, 193. e) Fellows, L. E. Pesticide Sci. 1986, 
17, 602. 
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be selective inhibitors of glycosidases and showed to have potentialities to be 
used as antiviral and anticancer therapeutic drugs as well as 
immunomodulators.89  
 
Figure 4.1. DMDP (64) and N-acetyl-2-(aminomethyl) iminocyclitol (65) 
The biological activity of iminocyclitols is due to the structural similarity 
of the conjugates ammonium acids, formed by protonation under physiological 
conditions, with the flattened half-chair conformation found for the transition 
structures of substrates involved in the mechanism of glycosidases.90 In the 
particular case of N-acetyl-β-hexosaminidases, important enzymes whose 
inefficiency results in osteoarthritis, it has been suggested the participation of 
the neighboring C-2 acetamido group of the substrate.91 Following this 
hypothesis, Wong and co-wokers92 found that N-acetyl-2-(aminomethyl) 
iminocyclitol 65 and structural analogues are potent inhibitors of N-acetyl-β-
hexosaminidases, and hence are expected to have potential as 
chondrotherapeutic agents.93 Closely related derivatives of 65 bearing 
lipophilic aliphatic or aromatic amides attached to C-1 have been found to 
inhibit β-glucosidase in the nanomolar range.94 Simpler synthetic analogues of 
                                                            
89
 a) Moreno-Vargas, A. J.; Carmona, A. T.; Mora, F.; Vogel, P.; Robina, I. J. Chem. 
Soc. Chem. Commun. 2005, 4949. b) Fiaux, H.; Popowycz, F.; Favre, S.; Schutz, C.; 
Vogel, P.; Gerber-Lemaire, S.; Juillerat-Jeanneret, L. J. Med. Chem. 2005, 48, 4237. 
90
 Caines, M. E. C.; Hancock, S. M.; Tarling, C. A.; Wrodnigg, T. M.; Stick, R. V.; 
Stuetz, A. E.; Vasella, A.; Withers, S. G.; Strynadka, N. C. J. Angew. Chem. Int. Ed. 
2007, 46, 4474. 
91
 Vocadlo, D. J.; Davies, G. J.; Laine, R.; Withers, S. G. Nature 2001, 412, 835. 
92
 Liu, J.; Shikhman, A. R.; Lotz, M. K.; Wong, C.-H. Chem. Biol. 2001, 8, 701. 
93
 Liu, J.; Numa, M. M. D.; Liu, H.; Huang, S.-J.; Sears, P.; Shikhman, A. R.; Wong, 
C.-H. J. Org. Chem. 2004, 69, 6273. 
94
 a) Wrodnigg, T. M.; Withers, S. G.; Stütz, A. E. Bioorg. Med. Chem. Lett. 2001, 11, 
1063. b) Hermetter, A.; Scholze, H.; Stütz, A. E.; Withers, S. G.; Wrodnigg, T. M. 
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65 are also inhibitors of several glycosidases as reported by Vogel.95 Other 
syntheses of polyhydroxylated 2-(aminomethyl)pyrrolidines have been 
reported by Jäger96 and Correia.97 Several of these compounds have also been 
used as ligands forming chelates with a variety of metals including vanadium,98 
gold,99 zinc,100 palladium,101 nickel,102 ruthenium,103 platinum,104 rhodium,105 
titanium and zirconium,106 that served as catalysts in a variety of 
enantioselective reactions such as homocoupling of boronic acids107 and 
                                                                                                                                                     
Bioorg. Med. Chem. Lett. 2001, 11, 1339. c) Wrodnigg, T. M.; Diness, F.; Gruber, C.; 
Häusler, H.; Lundt, I.; Rupitz, K.; Steiner, A. J.; Stütz, A. E.; Tarling, C. A.; Withers, S. 
G.; Wölfler, W. Bioorg. Med. Chem. Lett. 2004, 12, 3485. 
95
 a) Popowycz, F.; Gerber-Lemaire, S.; Schutz, C.; Vogel, P. Helv. Chim. Acta 2004, 
87, 800. b) Popowycz, F.; Gerber-Lemaire, S.; Rodriguez-Garcia, E.; Schutz, C.; Vogel, 
P. Helv. Chim. Acta 2003, 86, 1914. c) Gerber-Lemaire, S.; Popowycz, F.; Rodriguez-
Garcia, E.; Asenjo, A. T. C.; Robina, I.; Vogel, P. ChemBioChem 2002, 466. d) 
Popowycz, F.; Gerber-Lemaire, S.; Demange, R.; Rodriguez-Garcia, E.; Asenjo, A. T. 
C.; Robina, I.; Vogel, P. Bioorg. Med. Chem. Lett. 2001, 11, 2489. 
96
 a) Bierer, L. Ph.D. dissertation. 1999 (Supervisor: Jäger, V., University of Stuttgart, 
Germany). b) Jäger, V.; Bierer, L.; Dong, H.-Q.; Palmer, A. M.; Shaw, D.; Frey, W. J. 
Heterocycl. Chem. 2000, 37, 455. 
97
 Pohlit, A. M.; Correia, C. R. D. Heterocycles 1997, 45, 2321. 
98
 Kwiatkowski, E.; Romanowski, G.; Nowicki, W.; Kwiatkowski, M. Polyhedron 
2006, 25, 2809. 
99
 Comas-Vives, A.; Gonzalez-Arellano, C.; Corma, A.; Iglesias, M.; Sanchez, F.; 
Ujaque, G. J. Am. Chem. Soc. 2006, 128, 4756. 
100
 Koehn, U.; Schulz, M.; Goerls, H.; Anders, E. Tetrahedron: Asymmetry 2005, 16, 
2125. 
101
 Gonzalez-Arellano, C.; Corma, A.; Iglesias, M.; Sanchez, F. Adv. Synth. Cat. 2004, 
346, 1316. 
102
 Gonzalez-Arellano, C.; Gutierrez-Puebla, E.; Iglesias, M.; Sanchez, F. Eur. J. Inorg. 
Chem. 2004, 1955. 
103
 Jones, M. D.; Paz, A. A. F.; Davies, J. E.; Raja, R.; Klinowski, J.; Johnson, B. F. G. 
Inorg. Chim. Acta 2004, 357, 1247. 
104
 a) Goto, M.; Yamamoto, Y.; Sumimoto, M.; Tsuruda, N.; Kurosaki, H. Chem. 
Pharm. Bull. 2003, 51, 1157. b) Kim, D.-K.; Kim, Y.-W.; Kim, H.-T.; Kim, K.-H. 
Bioorg. Med. Chem. Lett. 1996, 6, 643. c) Diakos, C. I.; Fenton, R. R.; Hanmbley, T. 
W. J. Inorg. Biochem. 2006, 100, 1965. 
105
 Jones, M. D.; Raja, R.; Thomas, J. M.; Johnson, B. F. G.; Lewis, D. W.; Rouzaud, J.; 
Harris, K. D. M. Angew. Chem. Int. Ed. 2003, 42, 4326. 
106
 Carpentier, J.-F.; Martin, A.; Swenson, D. C.; Jordan, R. F. Organometallics 2003, 
22, 4999. 
107
 Gonzalez-Arellano, C.; Corma, A.; Iglesias, M.; Sanchez, F. J. Chem. Soc. Chem. 
Commun. 2005, 1990. 
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hydrogenation.108 Platinum-complexes of 2-(aminomethyl) pyrrolidines have 
also been evaluated against several human cancer lines104b and their DNA-
binding properties have been studied.104c 
4.2.2 The synthetic strategy 
We decided to take advantage of the availability of nitrone 1, which can 
be easily prepared from carbohydrates (See chapter 2.2.2), thus providing the 
configuration of three stereogenic centers of the pyrrolidine ring as derived 
from the chiral pool precursor. To obtain the target compounds we addressed 
the synthetic plan illustrated in Scheme 4.2, where nitrone A serves as 
electrophile in nucleophilic addition reactions. 
The additions were expected to be highly stereoselective, according to 
previous experience,109 by virtue of the presence of vicinal stereogenic centers 
that would discriminate between the two faces of the nitrone.  
In order to introduce suitable groups we have chosen as nucleophiles 
hydroxymethyl anion synthetic equivalents,110 cyanide (as an aminomethyl 
synthon equivalent)111 and Grignard reagents.112 To gain access to other 
                                                            
108
 a) Jones, M. D.; Raja, R.; Meurig; T. J.; Johnson, B. F. G. Topics in Catalysis  2003, 
25, 71. b) Raja, R.; Thomas, J. M.; Jones, M. D.; Johnson, B. F. G.; Vaughan, D. E. W. 
J. Am. Chem. Soc. 2003, 125, 14982. 
109
 ) Goti, A.; Cicchi, S.; Mannucci, V.; Cardona, F.; Guarna, F.; Merino, P.; Tejero, T. 
Org. Lett. 2003, 5, 4235. 
110
 For a previous study with acyclic nitrones, see: Merino, P.; Franco, S.; Merchan, F. 
L.; Revuelta, J.; Tejero, T. Tetrahedron Lett. 2002, 43, 459. 
111
 For previous studies on the reactivity of cyanide nucleophiles with nitrones see: a) 
Merino, P.; Tejero, T.; Revuelta, J.; Romero, P.; Cicchi, S.; Mannucci, V.; Brandi, A.; 
Goti, A. Tetrahedron: Asymmetry 2003, 14, 367. b) Merino, P.; Lanaspa, A.; Merchan, 
F. L.; Tejero, T. J. Org. Chem. 1996, 61, 9028. (c) Merchan, F. L.; Merino, P.; Tejero, 
T. Tetrahedron Lett. 1995, 36, 6949. 
112
 For recent examples of nucleophilic additions of Grignard reagents to nitrones, see: 
a) Merino, P.; Padar, P.; Delso, I.; Thirumalaikumar, M.; Tejero, T.; Kovacs, L. 
Tetrahedron Lett. 2006, 47, 5013. b) Murga, J.; Portoles, R.; Falomir, E.; Carda, M.; 
Marco, A. Tetrahedron: Asymmetry 2005, 16, 1807. c) Bonanni, M.; Marradi, M.; 
Cicchi, S.; Faggi, C.; Goti, A. Org. Lett. 2005, 7, 319. d) Bonanni, M.; Marradi, M.; 
Cicchi, S.; Goti, A. Synlett 2008, 2, 197. e) Kazuta, Y.; Abem; H.; Matsuda, A.; Shuto, 
S. J. Org. Chem. 2004, 69, 9143. f) Toyao, A.; Tamura, O.; Takagi, H.; Ishibashi, H. 
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isomers, an oxidation-reduction protocol was envisaged on the 
hydroxylamines B immediately obtained after the nucleophilic addition step. 
The route involved oxidation of compounds B to nitrones C, followed by 
stereoselective reduction to epimeric hydroxylamines D (Scheme 4.2). 
 
Scheme 4.2. Synthetic strategy 
Finally, further elaboration of intermediates B and D would allow the 
obtention of the target polyhydroxylated pyrrolidines. It should be pointed out 
that the oxidation of B to furnish C may account with regioselectivity since two 
possible isomers can be formed, being possible to predict to some extent the 
major one. This feature, combined with a suitable study on the reduction 
scheme, gives a great malleability to our approach, which will allow one to play 
around with a wide panel of substrates leading to an ample diversity of 
configurational combinations. 
 
                                                                                                                                                     
Synlett 2003, 35. g) Cardona, F.; Moreno, G.; Guarna, F.; Vogel, P.; Schuetz, C.; 
Merino, P.; Goti, A. J. Org. Chem. 2005, 70, 6552. For a review, see: h) Ref. 46 c. 
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4.2.3 Synthesis of DMDP and structural analogues  
The synthetic strategy required the addition of an organometallic 
reagent to nitrone 1. The synthetic equivalent chosen for the hydroxymethyl 
anion was the benzyl-protected (hydroxymethyl)-lithium derivatives 66, 
generated in situ from the corresponding tributyltin derivative as described.113 
The choice of 66 as organometal derivative for the synthesis of DMDP (64) is 
due to the possibility of removing all the benzyl groups in one step at a later 
stage of the synthesis. 
The nucleophilic addition of this reagent to nitrone 1 allowed formation 
of only one diastereoisomer, namely hydroxylamine 67 with 71% yield. As 
expected, the Grignard reagent reacted with the cyclic nitrone at the less 
hindered face opposite to the OBn substituent at C-3 (Scheme 4.3). 
 
 
Scheme 4.3. Organometallic addition on nitrone 1 
Reaction condition: a) THF, -80°C, 71%. 
Contrary to what found for acyclic α-alkoxy nitrones, stereocontrol of 
the nucleophilic additions to cyclic derivatives could not be achieved using 
Lewis acids.114, 111c In order to gain access to C-2 epimers of hydroxylamine 67 it 
was then necessary to apply an oxidation (to nitrone) – reduction (to 
                                                            
113
 Still, W. C. J. Am. Chem. Soc. 1978, 100, 1481. 
114a) Merino, P. Compt. Rend. Chimie 2005, 8, 775. b) Merino, P. In Targets in 
Heterocyclic Systems. Chemistry and Properties (Eds.: O. A. Attanasi, D. Spinelli), 
Italian Society of Chemistry, Rome, 2003, Vol. 7, pp. 140. c) Ref. 46e. d) Goti, A.; 
Cicchi, S.; Cordero, F. M.; Fedi, V.; Brandi, A. Molecules 1999, 4, 1. e) Brandi, A.; 
Cardona, F.; Cicchi, S.; Cordero, F. M.; Goti, A. Curr. Trends in Org. Synth. 1999, 213. 
f) Ref.47. 
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hydroxylamine) sequence, which had been successfully used in Prof. Merino 
laboratories for the synthesis of substituted prolines.115,116  
Because of its C2 symmetry, no regioselectivity issue applied to the 
oxidation of hydroxylamine 67 with manganese (IV) oxide117 and nitrone 68 
was afforded quantitatively (Scheme 4.4). The oxidation was found to be clean, 
no purification of the obtained nitrone being necessary after usual work-up. 
 
Scheme 4.4. Oxydation/reduction strategy 
Reaction conditions: a) MnO2, DCM, r.t., 100%. b) L-Selecride, THF, -80°C, 18 h, 100%. 
The reduction of nitrone 68 with L-Selectride was found to be 
completely selective towards the expected isomer. The absolute configuration 
of the newly created stereogenic center in hydroxylamines 67 and 69 was 
unambiguously ascertained by 1D NOE and 2D NOESY and COSY NMR 
experiments, which unequivocally showed the expected interactions between 
the protons of the pyrrolidine ring. For compound 67 both the 1H and 13C 
                                                            
115
 a) Marradi, M.; Cicchi, S.; Delso, J. I.; Rosi, L.; Tejero, T.; Merino, P.; Goti, A. 
Tetrahedron Lett. 2005, 46, 1287. b) Merino, P.; Delso, I.; Tejero, T.; Cardona, F.; Goti,  
Synlett 2007, 2651. 
116
 Merino, P.; Revuelta, J.; Tejero, T.; Cicchi, S.; Goti, A. Eur. J. Org. Chem. 2004, 
776. 
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 Cicchi, S.; Marradi, M.; Goti, A.; Brandi, A. Tetrahedron Lett. 2001, 42, 6503-6505. 
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spectra showed signals only consistent with the presence of a symmetry plane 
in the molecule. 
The target polyhydroxylated pyrrolidines were finally obtained by 
concomitant reduction and deprotection of the precursor hydroxylamines 
(Scheme 4.5). 
 
Scheme 4.5. Hydrogenation/deprotection of protected hydroxylamines 
Reaction conditions: a) H2, 10% Pd(OH)2-C, 20 atm, HCl-MeOH, r.t., 6 h, 100%. 
Compounds 67 and 69 were subjected to hydrogenolysis under 20 atm 
of hydrogen in HCl (conc): methanol and in the presence of 10% Pearlman’s 
catalyst to give the corresponding hydrochlorides in nearly quantitative yield. 
Thus, the hydrochloride of DMDP.HCl118 (64) and its C-2 epimer 70119 were 
obtained from nitrone 1 in 71% overall yield (Scheme 4.5). 
                                                            
118
 For representative and leading references on previous syntheses of DMDP and 
analogues, see: a) Behr, J. B.; Guillerm, G. Tetrahedron Lett. 2007, 48, 2369. b) Zhou, 
X.; Liu, W.-J.; Ye, J.-L.; Huang, P.-Q. Tetrahedron 2007, 63, 6346. c) Vyavahare, V. 
P.; Chattopadhyay, S.; Puranik, V. G.; Dhavale, D. D. Synlett 2007, 559. d) Trost, B. 
M.; Horne, D. B.; Woltering, M. J. Chem. Eur. J. 2006, 12, 6607. e) Garcia-Moreno, M. 
I.; Aguilar, M.; Mellet, C. O.; Fernandez, J. M. G. Org. Lett. 2006, 8, 297. f) Izquierdo, 
I.; Plaza, M. T.; Rodriguez, M.; Franco, F.; Martos, A. Tetrahedron 2005, 61, 11697. g) 
Badorrey, R.; Cativiela, C.; Diaz-de-Villegas, M. D.; Diez, R.; Galvez, J. A. Synlett 
2005, 1734. h) Donohoe, T. J.; Headley, C. E.; Cousins, R. P. C.; Cowley, A. Org. Lett. 
2003, 5, 999. i) Garcia, A. L. L.; Correia, C.;R. D. Tetrahedron Lett. 2003, 44, 1553. j) 
Izquierdo, I.; Plaza, M. T.; Franco, F. Tetrahedron: Asymmetry 2002, 13, 1503. 
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 Izquierdo-Cubero, I.; Plaza Lopez-Espinosa, M. T.; Robles-Diaz, R.; Franco-
Montalban, F. Carbohydr. Res. 2001, 330, 401. 
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The complete deprotection and reduction of 67 allowed, as in the other 
cases, an easy manipulation of the final compound as the corresponding 
hydrochloride 64·HCl, which showed to be stable at 25 °C for months without 
appreciable decomposition. Nevertheless, in order to compare the 
spectroscopic and physical properties of DMDP with those reported in the 
literature, the obtained pyrrolidine was also characterized as the free base 
after deposition onto a DOWEX 50W8-200 exchange resin and elution with 3N 
NH4OH in MeOH. Since some controversy about the presence of hydrochloride 
salts and free bases has been reported with other isomers,120 it should be 
pointed out that a trivial analysis of the 1H NMR showed more deshielded 
signals for the hydrochlorides than for the free base. In addition, the typical 
signal corresponding to ammonium species is revealed at 7-8 ppm in the 
spectrum of 64·HCl (as a consequence of the high symmetry around the 
nitrogen atom), thus unequivocally confirming the presence of the 
hydrochloride salt. Also, the elemental analyses fully agree with both 
hydrochloride and free salt. The analytical and spectroscopic data of 64 were 
in agreement, the NMR data being an exact match, with those previously 
reported.121 
 
Nitrone 1 is also itself a direct precursor of polyhydroxylated 
pyrrolidines of interest such DAB-1 (71), a potent inhibitor of α-glucosidases, 
α-D-arabinosidase, β-glucosidase and α-mannosidase, isolated from 
Angylocalyx sp. (Leguminosae).122,123 This compound was obtained in high yield 
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 Kumar, V.; Ramesh, N. G. Tetrahedron 2006, 62, 1877. 
121
 For a copy of NMR of (+)-DMDP see: Fechter, M. H.; Gradnig, G.; Berger, A.; 
Mirtl, C.; Schmid, W.; Stutz, A. E. Carbohydr. Res. 1998, 309, 367. 
122
 a) Jones, D. W. C.; Nash, R. J.; Bell, E. A.; William, J. M. Tetrahedron Lett. 1985, 
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(86%) by direct hydrogenation of nitrone 1 with Pd-C in HCl-MeOH (Scheme 
4.6). 
 
Scheme 4.6. Syntheses of DAB-1 and nectrisine 
Reaction conditions: a) H2, Pd-C, HCl-MeOH, r.t., 15 h then Dowex WX8-200, 98%. b) (MeO)3P, 
Ph3P, TEA, reflux, 62%. c) BCl3, DCM, 67%. 
Nectrisine 73 (also known as FR-900483), isolated from the fungus 
Nectria lucida F-4490 (Ascomycetes)124 is an inhibitor of glucosidases and 
mannosidases possessing also immunostimulating properties. Deoxygenation 
of nitrone 1 to imine 72 was obtained using a modification of a reported 
procedure,125 which employs trimethyl phosphine in refluxing TEA. The 
addition of 10 mol% of triphenylphosphine to trimethylphosphite in 
triethylamine allowed 72126 to be afforded in good yield. Debenzylation of 72 
with BCl3,
126 in order to preserve the imine functionality, gave nectrisine 73, 
which was found to be unstable in D2O solution,
127 affording hydrated 
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 Shibata, T.; Nakayama, O.; Tsurumi, Y.; Okuhara, M.; Terano, H.; Kohsaka, M. J. 
Antibiot. 1988, 41, 296. 
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 Milliet, P.; Lusinchi, X. Tetrahedron 1979, 35, 43. 
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 Bosco, M.; Bisseret, P.; Bouix-Peter, C.; Eustache, J. Tetrahedron Lett. 2001, 42, 
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derivatives. On the other hand, 13C NMR data of the crude compound were in 
agreement with those reported in the literature. 128 
The synthesis of 6-deoxy-DMDP 74, an inhibitor of β-mannosidase, β-
galactosidase, and α-fucosidase, isolated from Angylocalyx sp. 
(Leguminosae)129 was afforded through quantitative and complete 
stereoselective addition of methylmagnesium bromide to nitrone 1 (Scheme 
4.7).  
 
Scheme 4.7. Synthesis of 6-deoxy-DMDP 
Reaction conditions: a) MeMgBr, THF, 0°C, 100%. b) H2, Pd-C, HCl-MeOH, r.t., 16 h then Dowex 
WX8-200, 87%. 
As expected, the Grignard reagent reacted with the cyclic nitrone at the 
less hindered face opposite to the C-3 OBn substituent, to afford 
hydroxylamine 75 quantitatively. Hydrogenation of 75 with 10% Pd-C in HCl-
MeOH followed by elution through DOWEX WX8-200 with 6% ammonium 
hydroxide furnished the free amine 74 in 87% overall yield over two steps. 
4.2.4 Synthesis of 2-(aminomethyl)pyrrolidines 
Nitrone 1 was converted into the corresponding α-cyano hydroxylamine 
76 by reaction with trimethylsilyl cyanide in methanol (Scheme 4.8). 
Trimethylsilyl cyanide was slowly converted in situ into HCN,130 which reacted 
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 Kim, Y. J.; Takatsuki, A.; Kogoshi, N.; Kitahara, T. Tetrahedron 1999, 55, 8353. 
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smoothly with nitrone, no additive being necessary,131 to provide the free 
hydroxylamine 76 enough pure to be used for the next step. 
 
Scheme 4.8. Synthesis of the 2-cyano-N-hydroxypyrrolidine 76 
Reaction condition: a) MeOH, r.t., 100%. 
The selectivity of the reaction was complete and only the isomer 
showing a trans disposition to the C3 substituent could be detected by 1H 
NMR.  
Since all attempts to invert the stereocontrol in the hydrocyanation of 
nitrones had been unsuccessful,111a we focused our attention on the above 
described oxidation-reduction protocol to obtain epimeric hydroxylamine at C-
2. This was accomplished by oxidation of 76 to nitrone 77 with manganese (IV) 
oxide117 as described above, followed by stereoselective reduction with 
sodium borohydride (Scheme 4.9). 
 
Scheme 4.9. Synthesis of cyano derivative 78 
Reaction conditions: a) MnO2, DCM, 100%. b) NaBH4, MeOH, 100%. 
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Chapter 4 
104 
 
The oxidation and reduction were found to be completely regio- and 
stereoselective, respectively. Presumably, the regioselectivity of the reaction 
was controlled by conjugation of the incipient nitrone functionality with the 
cyanide moiety, so that the oxidation is directed solely towards the cyanide 
side. The relative stereochemistry of  pyrrolidine substituents in 76 and 78, and 
thus the absolute configuration of the new stereogenic centers was confirmed 
by 2D NMR (NOESY and COSY) experiments. 
The palladium-catalyzed hydrogenation-deprotection methodology used 
for the synthesis of 67 and 69 in Scheme 4.5 was then applied to the synthesis 
of 2-(aminomethyl)pyrrolidines. When compounds 76 and 78 were subjected 
to hydrogenolysis under 150 bar of hydrogen in 1N HCl in MeOH, the 
corresponding dihydrochlorides 79 and 80 were obtained in quantitative yield 
(Scheme 4.10). 
 
Scheme 4.10. Synthesis of 2-(aminomethyl)pyrrolidines 
Reaction conditions: a) H2, 5% Pd(OH)2-C, 150 atm, HCl-MeOH, r.t., 6 h, 100%. 
4.2.5 Synthesis of N-alkylated and dimeric derivatives of DAB-1 
In order to increase the inhibition of trehalases, docking studies have 
shown that DAB-1 dimers fit good with the enzyme catalytic site. The synthesis 
is easy and can be accomplished by the addition of dibromo-alkanes to DAB-1 
(71). 
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Unfortunately, the reaction took place only with dibromopropane in 
refluxing MeOH/dioxane affording the dimer 81 (Scheme 4.11): 
 
Scheme 4.11. Synthesis of DAB-1 dimer 81 
Reaction conditions: a) Br(CH2)3Br, NaHCO3, dioxane-MeOH, reflux., 24 h, 58%. 
The reactions with di-bromoethane, di-iodoethane and di-
chloroacetone, in the same conditions or changing the solvent (CH3CN) or the 
base (K2CO3), gave complex mixtures. An attempt using microwaves as heating 
source gave no reaction also. 
Similarly we attempt the alkylation at the nitrogen atom with 
bromoalkanes and we obtained the butyl derivate 82 (Scheme 4.12): 
 
Scheme 4.12. Synthesis of alkylated derivate 82 
Reaction conditions: a) n-BuBr, NaHCO3, dioxane-MeOH, reflux., 20 h, 64%. 
From the reaction with bromododecane in the same conditions or using 
microwave, only starting material was recovered. 
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4.3 Pyrrolizidine alkaloids 
4.3.1 Introduction  
Synthesis and use of allene derivatives have been rapidly expanded in 
preparative organic chemistry.132 In recent years, both acceptor-substituted 
allenes and electon-rich allenes, in particular methoxyallene, have emerged as 
versatile key building blocks for the synthesis of several natural products and 
related compounds. 
A most important aspect for applications of alkoxyallenes is the 
relatively high acidity of the hydrogen atom at C-1. Alkoxyallenes can smoothly 
be deprotonated at this position by butyllithium.133 The resulting lithium 
compound can react with different electrophiles leading to C-1 substituted 
derivatives. In particular the addition on lithiated alkoxyallenes (B) to nitrones 
(A) allowed formation of the allenyl hydroxylamine (C). In some cases it was 
possible to isolate it, with subsequent cyclization to 1,2-oxazines (D) or amine 
oxide (E) (Scheme 4.13).134 
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Scheme 4.13. Synthetic strategy 
We applied this strategy aimed to  the synthesis of pyrrolizidine 
alkaloids such as australine (42) and 6,7-di-epicasuarine (43). 
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Figure 4.2. Australine and 6,7-di-epicasuarine 
The synthetic strategy involves an organometallic addition reaction of 
lithiated benzyloxyallene 83 to nitrone 1 with formation of adduct 84. 
Spontaneous cyclization of 84 can, in principle, furnish N-oxide derivative 85 or 
1,2-oxazolidine derivative 86 (Scheme 4.14) which can be differently 
manipulated to obtain the target molecules. 
 
Scheme 4.14. Synthetic strategy for the synthesis of australine and 6,7-di-epicasuarine 
We first developed the synthetic strategy using methoxy allene, which is 
more easily available than benzyloxy allene. This also allowed to study the 
inhibitory properties of methoxy derivatives of the target molecules, 7-
methoxyaustraline 87 and 7-methoxy-6,7 di-epicasuarine 88 (Figure 4.3). 
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Figure 4.3. 7-Methoxyaustraline 96 and 7methoxy-6,7-di-epicasuarine 
4.3.2 Syntheses of methoxy derivatives 
Attempted syntheses of 87 and 88 started from the reaction of nitrone 1 
with lithiated methoxy allene 89, which provided adduct 90 that could not be 
isolated. The crude was stirred at rt in DCM affording only 1,2-oxazine 
derivative 91 (Scheme 4.15); no formation of the N-oxide derivative was 
observed.  
Scheme 4.15. Synthesis of adduct 93 
Reaction conditions: a) BuLi, -78°C, THF, 15 min; b) -78°C, THF, 2 h; c) DCM, rt, 48 h; 78% over 
three steps; d) BH3
.THF, THF, 2 h, rt, then NaOH, H2O2, 18 h, rt, 84% over two steps. 
Contrary to our expectation, hydroboration of 91 did not afford the 
desired stereoisomer 92; compound 93 was formed instead, as demonstrated 
by its NMR spectra (Scheme 4.15). 
We expected that BH3 would hydroborate from the apparently more 
accessible upper side of the molecule affording 92. The opposite result may be 
rationalized hypothesing that the nitrogen atom coordinates BH3 in the most 
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stable trans-fuse conformer, favouring its attack from the lower side of the 
molecule and affording adduct 93 (Figure 4.4). 
 
Figure 4.4. Coordination of the nitrogen atom to BH3 
With compound 93 in hand we completed the total synthesis of 
methoxy derivatives of casuarine 94 and 7-epiaustraline 95 (Figure 4.5), 
indeed, it was interesting to study their inhibition properties in order to 
understand the role of modification at C-7 of a very active molecule such as 
casuarine 11 (See chapter 5). 
 
Figure 4.5. 7-Methoxycasuarine 94 and 7-epi-7-methoxyaustraline 95 
We proceeded with the opening of the N-O bond mediated by SmI2, 
affording in 94% yield compound 96, which was mesylated with mesylchloride 
in DCM and in the presence of triethylamine to obtain intermediate 97 after 
spontaneously cyclization(Scheme 4.16). 
Scheme 4.16. Synthesis of mesylate derivative 97 
Reaction conditions: a) SmI2, THF, rt, 4 h, 94%; b) MsCl, DCM, TEA, rt, 1.5 h; 85%. 
Mesylate derivative 97 can be differently manipulated to obtain both 
the desired products 94 and 95 (Scheme 4.17). 
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Scheme 4.17. Syntheses of 94 and 95 
Reaction conditions: a) DIBAL-H, THF, rt, 2 h, 50%; b) LiAlH4, THF, rt, 2 h, 85%; c) H2, Pd/C, 
MeOH, HCl cat., rt, 18 h, 62%. 
Treatment of 97 with DIBAL-H afforded the deoxygenated 98 which can 
be hydrogenated in order to obtain 95. In contrast, reduction of 97 with LiAlH4 
gave demesylation to deprotected derivative 99 which afforded, after 
hydrogenation, 7-methoxycasuarine 94 (Scheme 4.17). 
4.3.3 Syntheses of casuarine and 7-epiaustraline 
Reaction of nitrone 1 with lithiated benzyloxy allene 100 afforded 
adduct 84 which could not be isolated and cyclised spontaneously to give, also 
in this case, oxazine 86 without any formation of N-oxide 85 (scheme 4.18). 
 
Scheme 4.18. Synthesis of compound 86 
Reaction conditions: a) BuLi, -78°C, THF, 2 h; b) DCM, rt, 48 h; 81% over two steps. 
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Also in this case treatment with BH3 afforded 101 and not the desired 
product 102. In order to obtain 102, the reaction was performed with the 
more hindered 9-BBN but only starting material was recovered (Scheme 4.19) 
in this case. 
 
Scheme 4.19. Synthesis of compound 101 
Reaction conditions: a) BH3
.THF, THF, rt, 2 h, then NaOH, H2O2, rt, 18 h, 81% over two steps; b) 
9-BBN, THF, rt, 2 h, then NaOH, H2O2, rt, 18 h. 
Oxazine 101 was treated with SmI2 affording 103, in 81% yield, which 
was mesylated to obtain pyrrolizidine 104 after spontaneously cyclization 
(scheme 4.20). 
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Scheme 4.20. Synthesis of compound 104 
Reaction conditions: a) SmI2, THF, rt, 4 h, 81%; b) MsCl, DCM, TEA, rt, 1.5 h; 94%. 
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Treatment of 104 with DIBAL-H afforded the deoxygenated 105 which 
was hydrogenated to obtain 7-epiaustraline 17. Treatment with LiAlH4 of 104 
afforded deprotected derivative 106 which gave, after hydrogenation, 
casuarine 11 (Scheme 4.21). 
 
Scheme 4.21. Syntheses of 7-epiaustraline (17) and casuarine (11) 
Reaction conditions: a) DIBAL-H, THF, rt, 2 h, 50%; b) H2, Pd/C, MeOH, HCl cat., rt, 18 h, 100%; 
c)LiAlH4, THF, rt, 2 h, 86%; d) H2, Pd/C, MeOH, HCl cat., rt, 18 h, 100%. 
In order to shorter the total synthesis of 7-epiaustraline (17), after 
hydroboration, compound 107 was treated with acetic acid or propionic acid, 
but no desired compound 108, which would have not required deoxygenation 
step, was obtained (Scheme 4.22). 
 
Scheme 4.22. Synthesis of compound 108 
In order to eliminate the deprotection step after mesylation in the 
casuarine (11) synthesis, we performed mesylation with only 1 eq. of mesyl 
chloride on compound 103, but we obtained a complex mixture of mono-
mesylate derivatives, starting material and compound 104. 
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In order to obtain 7-epiaminocasuarine (109), a reaction with NaN3 was 
performed on the same intermediate 104 affording compound 110, which can 
be hydrogenated in the presence of Pd/C to obtain 7-epiaminocasuarine (109) 
(scheme 4.23). 
 
Scheme 4.23. Synthesis of 7-epi-aminocasuarine 
Reaction conditions: a) NaN3, DMF, 100°C, 48 h, 62%; b) H2, Pd/C, MeOH, HCl, rt, 48 h, 80%. 
The total synthesis of australine (42) is still a target of our research 
group. For this reason we are investigating a new synthetic approach starting 
from oxazine 86 which, through N-O bond cleavage afforded compound 111 
(Scheme 4.24). 
 
Scheme 4.24. New route for the synthesis of australine 
Reaction conditions: a) Mo(CO)6, NaBH4, CH3CN/H2O, reflux, 3 h, 45%; b) MsCl, DCM, TEA, rt, 3 
h, 65%. 
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Compound 111 was treated with mesyl chloride affording 112 which can 
be hydrogenated in order to obtain australine. At the current stage, only 
preliminary, but promising results have been collected. Work is underway in 
our laboratory to target the synthesis of australine (42). 
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4.4 Conclusion 
In the first part of this chapter, the diastereoselective synthetic 
methodology studied allowed the preparation of several families of 
polyhydroxylated pyrrolidines and variants thereof with a great versatility. The 
complete diastereoselectivity found in nucleophilic additions to the key cyclic 
nitrone and the possibility of configurational inversion at the newly created 
stereocenter, through an oxidation-reduction protocol, makes this 
methodology complementary to other nucleophilic additions to acyclic 
nitrones tunable with Lewis acids. The protocol was used to synthesize 2-
(hydroxymethyl)- and 2-(aminomethyl)- polyhydroxylated pyrrolidines 
enantiospecifically, offering a new route to such systems competing with 
previously reported strategies. Finally, the work provided access to naturally 
occurring alkaloids DMDP, 6-deoxy-DMDP, DAB-1, and nectrisine as well as 
several structural analogues. The total synthesis of other natural 
polyhydroxylated pyrrolidines and analogues using the present methodology is 
under investigation in our laboratories. 
In the second part of this chapter, nucleophilic additions of allenes to 
the key nitrone were studied in order to obtain natural iminosugars and 
unnatural casuarine-like pyrrolizidines. The target molecules were studied 
toward amyloglucosidase from Aspergillus Niger (see Chapter 5) with 
interesting results. 
  
Chapter 4 
116 
 
4.5 Experimental Section 
General experimental aspect are mentioned in Chapter 2.3.1. 
4.5.1 Synthesis of DMDP and structural analogues 
(2R,3R,4R,5R)-3,4-bis(benzyloxy)-2,5-bis(benzyloxymethyl)-1-hydroxy 
pyrrolidine (67) To a cooled (-80 °C) solution of 66 (0.850 g, 2 mmol) in 
anhydrous THF (15 mL), butyllithium (3.2 mL of a 1.6 M solution in hexanes, 2 
mmol) was slowly added via syringe under an argon atmosphere. The resulting 
solution was stirred for 6 min at which time a cooled (-80 °C) solution of 1 
(0.334 g, 0.8 mmol) in THF (5 mL) was added during a period of 5 min via 
cannula. After 15 min at -80 °C  the reaction was quenched with sat aq NH4Cl 
(1 mL) and the reaction mixture was allowed to warm to room temperature. 
The reaction mixture was treated with additional sat aq NH4Cl (20 mL) and 
diethyl ether (30 mL). The organic layer was separated and the aqueous layer 
was extracted with diethyl ether (2 x 30 mL). The combined organic extracts 
were washed with brine, dried (MgSO4), filtered and evaporated under 
reduced pressure afforded pure 67 (0.306 g, 71%) as an oil; [α]D
25 = + 21 (c 
0.25, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ 7.34-7.20 (m, 20H, Ar), 6.04 (s, 1H, 
OH), 4.54 (2H, d, J = 12.1 Hz, Bn), 4.50 (2H, d, J = 12.1 Hz, Bn), 4.49 (2H, d, J = 
11.8 Hz, Bn), 4.43 (2H, d, J = 11.8 Hz, Bn), 4.00 (dd, J = 3.7, 1.5 Hz, 2H, H-3), 
3.78 (dd, J = 9.6, 4.8 Hz, 2H, H-6), 3.63 (dd, J = 9.6, 6.2 Hz, 2H, H-7), 3.51 (m, 
2H, H-2). 13C-NMR (100 MHz, CDCl3) δ 133.0 (s, 2C, Ar), 132.9 (s, 2C, Ar), 123.6-
122.6(d, 8C, Ar), 122.4 (d, 4C, Ar), 78.6 (d, 2C, C-3, C-4), 68.2 (t, 2c, Bn), 66.5 (t, 
2C, Bn), 64.4 (d, 2C, C-2, C-5), 62.6 (t, 2C, C-6, C-7). IR (KBr): 2441 (ν, OH), 3028 
(ν, =CH), 2912 (ν, -CH), 2000-1800 (overtones, Bn) cm-1. Anal Calcd. for 
C34H37NO5 (539.66): C, 75.67; H, 6.91; N, 2.60. Found: C, 75.52; H, 6.83; N, 2.87. 
(2R,3R,4R)-3,4-bis(benzyloxy)-2,5-bis(benzyloxymethyl)-3,4-dihydro-2H-
pyrrole-1-oxide (68). To a cooled (0°C) solution of 67 (1.078 g, 2 mmol) in 
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CH2Cl2 (30 mL), activated manganese (IV) oxide (2.09 g, 2.4 mmol) was added 
portionwise. After 15 min of stirring at 0 °C the reaction mixture was warmed 
to room temperature and stirring was continued until complete disappearance 
of the starting material (TLC, c.a. 2 h). Then, the reaction mixture was filtered 
through a pad of Celite® and anhydrous MgSO4 and the resulting filtrate was 
evaporated under reduced pressure afforded pure 68 (1.075 g, 100%) as an oil. 
[α]D
25 = - 38 (c 0.96, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ 7.13-7.28 (m, 20H, Ar), 
4.68 (s, 1H, H-3), 4.59 (d, J = 14.4 Hz, 1H, H-6), 4.53 (d, J = 11.7 Hz, 1H, Bn), 
4.48 (d, J = 12.0 Hz, 1H, Bn), 4.47 (s, 2H, Bn), 4.47 (d, J = 11.7 Hz, 1H, Bn), 4.41 
(d, J = 12.0 Hz, 1H, Bn), 4.39 (d, J = 11.9 Hz, 1H, Bn), 4.35 (d, J = 11.9 Hz, 1H, 
Bn), 4.25 (dt, J = 14.4, 1.3, Hz, 1H, H-6), 4.14 (dd, J = 2.9, 1.7, Hz, 1H, H-4), 3.94-
3.99 (m, 1H, H-5), 3.87 (dd, J = 10.1, 5.8, Hz, 1H, H-9), 3.72 (dd, J = 3.3, 10.1 Hz, 
1H, H-9). 13C-NMR (100 MHz, CDCl3) δ 143.9 (s, C-2), 137.7 (s, 4C, Ar), 137.5-
127.6 (d, 12C, Ar), 127.0 (d, 4C, Ar), 83.4 (d, C-3), 78.9 (d, C-4), 78.2 (d, C-5), 
73.6 (t, Bn), 73.5 (t, Bn), 72.1 (t, Bn), 71.6 (t, C-6), 66.8 (t, C-9), 62.4 (t, Bn). Anal 
Calcd. for C34H35NO5 (537.75): C, 79.95; H, 6.56; N, 2.61. Found: C, 79.88; H, 
6.73; N, 2.90. 
(2R,3R,4R,5S)-3,4-bis(benzyloxy)-2,5-bis(benzyloxymethyl)-1-hydroxy 
pyrrolidine (69). A cooled (-80 °C) solution of 68 (0.538 g, 1 mmol) in 
anhydrous THF (10 mL) was treated dropwise with L-Selectride (2 mL of a 1M 
solution in hexanes, 2 mmol) under an argon atmosphere. After stirring for 2 h 
at -80 °C the reaction misture was allowed to warm to 0 °C at which time sat 
aq NH4Cl (5 mL) was added. The resulting mixture was treated with diethyl 
ether (15 mL); the organic layer was separated and the aqueous layer was 
extracted with diethyl ether (2 x 15 mL). The combined organic extracts were 
washed with brine, dried (MgSO4) and evaporated under reduced pressure 
without exceeding 20 °C to give pure 69 (0.540 g, 100%) as an oil. This 
compound could not be characterized since it showed to be rather unstable 
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being oxidized immediately to the precursor nitrone 68. Because of this reason 
it was used immediately in the next step without any purification. 
(2R,3R,4R,5R)-2,5-bis(hydroxymethyl)-3,4-dihydroxypyrrolidine 
hydrochloride (DMDP, 64). A solution of hydroxylamine 67 (0.540 g, 1 mmol) in 
methanol (10 mL) was treated with Pd(OH)2-C (15 mg) and a 1M solution of 
HCl in methanol. The resulting mixture was stirred under 20 atm of hydrogen 
for 6 h. The catalyst was eliminated by filtration through a pad of Celite®, the 
filtrate was treated with 3M HCl in methanol and the resulting solution was 
stirred at room temperature for additional 10 min. The solvent was eliminated 
under reduced pressure to afforded pure 64 (0.2 g, 100 %) as a white solid; mp  
>150 °C (dec). [α]D
25 = + 48 (c 0.32, H2O). 
1H-NMR (400 MHz, D2O) δ 4.01-3.96 
(m, 2H, H-3), 3.84 (dd, J = 12.7, 3.7 Hz, 2H, H-4), 3.76 (dd, 2H, J = 12.7, 5.7 Hz, 
2H, H-4), 3.44–3.50 (m, 2H, H-2). 13C NMR (100 MHz, D2O) δ 74.2 (d, 2C, C-3), 
62.4 (d, 2C, C-2), 57.8 (t, 2C, C-4). Anal Calcd. for C6H14ClNO4 (199.63): C, 36.10; 
H, 7.07; N, 7.02. Found: C, 36.32; H, 7.21; N, 7.17. In order to compare with the 
literature data an analytical sample of the free amine was obtained by passing 
the hydrochloride through a Dowex 50WX8 ion-exchange resin. Elution with 
3M ammonia in methanol afforded after evaporation the free base of 64 as a 
white solid: mp 114-117 °C (Lit.[9d] mp 115-117 °C); [α]D
25 = + 53 (c 0.95, H2O) 
(Lit. [9d] [α]D = + 55.4 (c 1.3, H2O)). 
1H-NMR (400 MHz, D2O) δ 3.72-3.77 (m, 2H, 
H-3), 3.61 (dd, J = 11.9, 6.3 Hz, 2H, H-4), 3.53 (dd, 2H, J = 11.9, 4.3 Hz, 2H, H-4) 
2.92-2.99 (m, 2H, H-2). 13C NMR (100 MHz, D2O) δ 77.5 (d, 2C, C-3), 61.6 (t, 2C, 
C-4), 61.5 (d, 2C, C-2). Anal Calcd. for C6H13NO4 (163.17): C, 44.16; H, 8.03; N, 
8.58. Found: C, 43.87; H, 8.05; N, 8.53. 
(2S,3R,4R,5R)-2,5-bis(hydroxymethyl)-3,4-dihydroxypyrrolidine 
hydrochloride (70) A solution of hydroxylamine 69 (0.540 g, 1 mmol) in 
methanol (10 mL) was treated with Pd(OH)2-C (15 mg) and a 1M solution of 
HCl in methanol. The resulting mixture was stirred under 20 atm of hydrogen 
for 6 h. The catalyst was eliminated by filtration through a pad of Celite®, the 
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filtrate was treated with 3M HCl in methanol and the resulting solution was 
stirred at room temperature for additional 10 min. The solvent was eliminated 
under reduced pressure afforded pure 70 (0.2 g, 100 %) as a white solid; mp 
>150 °C (dec). [α]D
25 = - 5 (c 0.75, MeOH) (Lit.[59] [α]D
 = - 3.4 (c 1.0, MeOH)). 1H-
NMR (400 MHz, D2O) δ 4.16 (dd, J = 3.6, 2.2 Hz, 1H, H-4), 3.98 (dd, J = 3.6, 2.2 
Hz, 1H, H-3), 3.70–3.92 (m, 5H, H-5, Ha-6, Hb-6, Ha-7, Hb-7), 3.49 (ddd, J = 8.4, 
4.6, 3.6 Hz, 1H, H-2). 13C NMR (100 MHz, D2O) δ 75.8 (d, C-3), 74.3 (d, C-4), 66.6 
(d, C-2), 62.9 (d, C-5), 59.1, 56.7 (t, C-6, C-7). Anal Calcd. for C6H14ClNO4 
(199.59): C, 36.10; H, 7.07; N, 7.02. Found: C, 35.83; H, 7.15; N, 6.86. 
(2R,3R,4R)-2-(hydroxymethyl)-3,4-dihydroxypyrrolidine (DAB-1, 71). A 
solution of nitrone 1 (0.430 g, 1.03 mmol) in methanol (8 mL) was treated with 
Pd-C (420 mg) and concentrated HCl (4 drops). The resulting mixture was 
stirred under hydrogen atmosphere for 15 h. The catalyst was eliminated by 
filtration through a pad of Celite®, then the filtrate was concentrated under 
reduced pressure and passed through a short pad of Dowex WX8-200 eluting 
with water, MeOH and finally with a 6% NH4OH solution. Concentration of the 
fractions eluted with NH4OH afforded a brown oil (135 mg, 98% yield); [α]D
23 = 
+ 5.6 (c 0.285, H2O) (Lit.
[63] [α]D
 = + 6.3 (c 1, H2O)). 
1H-NMR (400 MHz, D2O) δ 
4.03 (dt, J = 5.7, 3.9 Hz, 1 H, H-4), 3.73 (dd, J = 5.7, 3.6 Hz, 1 H, H-3), 3.63 (dd, J 
= 11.5, 4.9 Hz, 1 H, Ha-6), 3.55 (dd, J = 11.5, 6.4 Hz, 1 H, Hb-6), 3.02 (dd, J = 
12.2, 5.7 Hz, 1 H, Ha-5), 2.90 (m, 1 H, H-2)2.74 (dd, J = 12.3, 3.9 Hz, 1 H, Hb-5). 
13C NMR (50 MHz, D2O) δ 78.0 (d, C-3), 76.4 (d, C-4), 64.4 (d, C-2), 61.0 (t, C-6), 
49.6 (t, C-5). Anal Calcd. for C5H11NO3 (133.12): C, 45.10; H, 8.33; N, 10.52. 
Found: C, 44.82; H, 8.11; N, 10.23. 
(2R,3R,4R)-3,4-bis(benzyloxy)-2-(benzyloxymethyl)-3,4-dihydro-2H-
pyrrole (72). To a solution of nitrone 1 (285 mg, 0.68 mmol) in 20 mL of a 10:1 
mixture of trimethyl phosphite and TEA, triphenylphosphine (75 mg, 0.30 
mmol) was added and the mixture was heated at reflux for 4 h. After 
evaporation under reduced pressure, purification by flash column 
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chromatography (eluent petroleum ether/EtOAc, 1.5:1) afforded pure 72 (170 
mg, 62%) as an oil; [α]D
22 = - 10.4 (c 0.76, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ 
7.64 (d, J = 2.34 Hz, 1 H, H-5), 7.23 – 7.40 (m, 15 H, Ar), 4.59 - 4.66 (m, 7 H, Bn, 
H-4), 4.18 - 4.21 (m, 1 H, H-2), 4.14 (t, J = 3.8 Hz, 1 H, H-3) 3.79 (dd, J = 9.8, 4.5 
Hz, 1 H, Ha-6), 3.58 (dd, J = 9.8, 6.3 Hz, 1 H, Hb-6). 13C NMR (50 MHz, D2O) δ 
165.9 (d, C-5), 138.1, 137.8, 137,4 (s, Ar), 128.5-127.6 (d, 15 C, Ar), 90.7 (d, C-
4), 84.5 (d, C-3), 76.9 (d, C-2), 73.4, 72.4, 72.1 (t, Bn), 71.1 (t, C-6). Anal Calcd. 
for C26H27NO3 (401.45): C, 77.78; H, 6.78; N, 3.49. Found: C, 77.58; H, 6.56; N, 
3.31. 
(2R,3R,4R)-2-(hydroxymethyl)-3,4-dihydro-2H-pyrrole-3,4-diol 
(Nectrisine, 73). To a solution of 72 (0.1 g, 0.25 mmol) in dry CH2Cl2 (0.5 mL) a 
1M solution of BCl3 in CH2Cl2 (1.75 mL) was added at -78 °C under nitrogen 
atmosphere. The mixture was stirred for 3 h, while the temperature raised to -
40 °C. Then, a saturated aqueous solution of NaHCO3 was added until neutral 
pH was reached. The solvent was evaporated under reduced pressure and the 
residue was taken up with 10 mL of AcOEt and stirred for 10 minutes. After 
decantation, this procedure was repeated 3 times. The combined organic 
phases were concentrated, affording a white solid, that was purified by flash 
column chromatography (eluent EtOAc/MeOH, 2:1) affording pure 73 (22 mg, 
67% yield) as an oil. 13C NMR (50 MHz, D2O) δ 170.6 (d), 83.4 (d), 78.3 (d), 76.8 
(d), 61.3 (t). Nectrisine (73) was found to be unstable in D2O solution, due to 
formation of hydrated derivatives.47 
(2R,3R,4R,5R)-3,4-bis(benzyloxy)-2-(benzyloxymethyl)-1-hydroxy-5-
methyl pyrrolidine (75). To a cooled (0 °C) solution of nitrone 1 (0.418 g, 1 
mmol) in anhydrous THF (10 mL), methyl magnesium bromide (3 mL of a 3M 
solution in THF, 3 mmol) was added dropwise under an argon atmosphere. The 
resulting solution was stirred at 0 °C for 3 h, at which time the reaction was 
quenched with sat aq NH4Cl (10 mL). The reaction mixture was diluted with 
diethyl ether (10 mL), the organic layer was separated and the aqueous layer 
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was extracted with diethyl ether (2 x 10 ml). The combined organic extracts 
were washed with brine (20 mL), dried over MgSO4, filtered and the solvent 
was eliminated under reduced pressure. The crude product was purified by 
column chromatography (Hexane/EtOAc, 4:1) to give pure 75 (0.434 g, 100%) 
as an oil. [α]D
24 = - 12.5 (c 0.135, CDCl3). 
1H-NMR (400 MHz, CDCl3) δ 7.25–7.37 
(m, 15H, Ar), 4.95 (bs, 1H, OH), 4.45–4.56 (m, 6H, Bn), 3.90 (dd, J = 4.1, 3.1 Hz, 
1H, H-2), 3.72–3.76 (m, 2H, H-3, H-4), 3.62 (dd, J = 9.6, 6.5 Hz, 1H, Ha-6), 3.51–
3.55 (m, 1H, Hb-6), 3.37–3.40 (m, 1H, H-5), 1.26 (d, J = 6.4 Hz, 3H, Me). 13C 
NMR (50 MHz, CDCl3) δ 135.3–135.6 (s, 3C, Ar), 125.4–126.8 (d, 15C, Ar), 85.0 
(d, C-3), 81.8 (d, C-2), 71.4, 71.1, 69.7 (t, Bn), 69.4 (t, C-6), 67.2 (d, C-4), 62.3 (d, 
C-5), 11.7 (q, Me). Anal Calcd. for C27H31NO4 (433.49): C, 74.80; H, 7.21; N, 3.23. 
Found: C, 74.78; H, 6.91; N, 3.44. 
(2R,3R,4R,5R)-2-(hydroxymethyl)-3,4-dihydroxy-5-methyl pyrrolidine (6-
deoxy-DMDP, 74). A solution of hydroxylamine 75 (0.141 g, 0.32 mmol) in 
methanol (20 mL) was treated with 10% Pd-C (170 mg) and 6 drops of conc HCl 
were added. The resulting mixture was stirred at room temperature under 
hydrogen for 16 h. The catalyst was eliminated by filtration through a pad of 
Celite®, the filtrate was passed through a Dowex 50WX8 ion-exchange resin. 
Elution with 3M ammonia in methanol afforded after evaporation pure 74 
(0.41 g, 87%) as a syrup. [α]D
20 = + 44.4 (c 0.71, MeOH) (Lit. [69a] [α]D
 = + 26.2 (c 
1.1, MeOH) for the natural compound, [α]D
 = + 42.9 (c 0.72, MeOH) for the 
synthetic compound. 1H-NMR(400 MHz, D2O) δ 3.69 (t, J = 7.0 Hz, 1 H, H-3), 
3.55 (dd, J = 11.4, 4.9 Hz, 1 H, Ha-6), 3.51-3.45 (m, 2 H, Hb-6, H-4), 2.92 (td, 6.6, 
4.9 Hz, 1 H, H-2), 2.83 (dq, J = 8.2, 6.4 Hz, 1 H, H-5), 1.06 (d, J = 6.4 Hz, 3 H, 
Me). 13C NMR (50 MHz, D2O) δ, 82.7 (d, C-4), 78.2 (d, C-3), 62.5 (t, C-6), 61.5 (d, 
C-2), 55.7 (d, C-5), 17.4 (q, Me). Anal Calcd. for C6H13NO3 (147.14): C, 48.97; H, 
8.90; N, 9.52. Found: C, 48.59; H, 9.02; N, 9.78. 
Chapter 4 
122 
 
4.5.2 Synthesis of 2-(aminomethyl)pyrrolidines 
2R,3R,4R,5R)-3,4-bis(benzyloxy)-5-(benzyloxymethyl)-1-hydroxy 
pyrrolidine-2-carbonitrile (76) To a solution of nitrone 1 (0.417 g, 1 mmol) in 
MeOH (10 mL) was added trimethylsilyl cyanide (0.100 g, 1 mmol) under an 
argon atmosphere. The resulting solution was stirred at room temperature for 
10 h, at which time the solvent was rotatory evaporated, without exceeding 35 
°C, afforded a crude product which was purified by column chromatography 
(Hexane/EtOAc, 4:1) to give pure 76 (0.444 g, 100 %) as an oil; [α]D
25 = + 9 (c 
1.08, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ 7.30 (m, 15H, Ar), 6.81 (s, 1H, OH), 
6.59 (d, J = 12.2 Hz, 1H, Bn), 6.54 (d, J = 11.7 Hz, 1H, Bn), 6.51-6.42 (m, 4H, Bn), 
4.25 (d, J = 1.9 Hz, 1H, H-2), 4.19 (t, J = 2.4 Hz, 1H, H-3), 3.97 (dd, J = 6.7, 2.3 
Hz, 1H, H-4), 3.76 (dd, J = 10.6, 3.5 Hz, 1H, Ha-6), 3.59 (dd, J = 10.6,  3.5 Hz, 1H, 
Hb-6), 3.32 (dt, J = 3.5, 7.0 Hz, 1H, H-5). 13C-NMR (100 MHz, CDCl3) δ 137.5, 
137.4, 136.6 (s, Ar), 128.8-127.9 (d, 15 C, Ar), 115.8 (s, CN), 83.7 (d, C-3), 81.3 
(d, C-4), 73.4, 72.3, 72.2 (t, Bn), 69.5 (d, C-5), 66.3 (t, C-6), 61.3 (d, C-2). Anal 
Calcd. for C27H28N2O4 (444.47): C, 72.95; H, 6.35; N, 6.30. Found: C, 73.05; H, 
6.28; N, 6.48. 
(2R,3R,4R)-3,4-bis(benzyloxy)-2-(benzyloxymethyl)-5-cyano-3,4-dihydro-
2H-pyrrole-1-oxide (77). To a cooled (0°C) solution of 76 (0.888 g, 2 mmol) in 
CH2Cl2 (30 mL), activated manganese (IV) oxide (2.09 g, 2.4 mmol) was added 
portionwise. After 15 min of stirring at 0 °C the reaction mixture was warmed 
to room temperature and stirring was continued until complete disappearance 
of the starting material (TLC, c.a. 2 h). Then, the reaction mixture was filtered 
through a pad of Celite® and anhydrous MgSO4 and the resulting filtrate was 
evaporated under reduced pressure afforded pure 77 (0.885 g, 100 %) as an 
oil; [α]D
25 = - 35 (c 2.50, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ 7.35-7.10 (m, 15H, 
Ar), 4.84 (dd, J = 2.0, 0.6 Hz, 1 H, H-4), 4.76 (d, J = 11.8 Hz, 1H, Bn), 4.65 (d, J = 
11.8 Hz, 1H, Bn), 4.59 (d, J = 12.0 Hz, 1H, Bn), 4.55 (d, J = 11.8 Hz, 1H, Bn), 4.51 
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(d, J = 12.0, 1H, Bn), 4.50 (d, J = 11.8 Hz, 1H, Bn), 4.40 (dd, J = 3.6, 2.0 Hz, 1H, H-
3), 4.11-4.07 (m, 1H, H-2), 4.01 (dd, J = 10.4, 4.9 Hz, 1H, Ha-6), 3.71 (dd, J = 3.2, 
10.4 Hz, 1H, Hb-6). 13C-NMR (100 MHz, CDCl3) δ 137.1, 136.5, 136.4 (s, Ar), 
128.7-127.8 (d, 15C, Ar), 118.0 (s, C-5), 111.1 (s, CN), 82.0 (d, C-4), 79.5 (d, C-
2), 79.3 (d C-3), 73.6, 72.2, 72.1 (t, Bn), 65.7 (t, C-6). Anal Calcd. for C27H26N2O4 
(442.45): C, 73.28; H, 5.92; N, 6.33. Found: C, 73.41; H, 5.78; N, 6.49. 
(2S,3R,4R,5R)-3,4-bis(benzyloxy)-5-(benzyloxymethyl)-1-
hydroxypyrrolidine-2-carbonitrile (78). To a cooled (0 °C) solution of nitrone 77 
(0.442 g, 1 mmol) in MeOH (6 mL), sodium borohydride (76 mg, 2 mmol) was 
added portionwise. The reaction mixture was stirred for an additional hour 
and sat aq NH4Cl (5 mL) was added. After stirring for 15 min the reaction 
mixture was diluted with diethyl ether (20 mL). The organic layer was 
separated and the aqueous layer was extracted with diethyl ether (2 x 20 mL). 
The combined organic extracts were washed with brine, dried over MgSO4 
filtered and the solvent was eliminated under reduced pressure afforded pure 
78 (0.444 g, 100 %) as an oil. [α]D
25 = + 11 (c 0.27, CHCl3). 
1H-NMR (400 MHz, 
CDCl3) δ 7.33-7.08 (m, 15H, Ar), 4.60 (d, J = 12.0 Hz, 1H, Bn), 4.48 (d, J = 12.0 
Hz, 1H, Bn), 4.47 (s, 2H, Bn), 4.34 (d, J = 11.8 Hz, 1H, Bn), 4.29 (d, J = 11.8 Hz, 
1H, Bn), 3.95 (s, 2H, H-2 and H-3), 3.76 (d, J = 5.2 Hz, 1H, H-4), 3.59 (dd, J = 
10.0, 5.4 Hz, 1H, Ha-6), 3.54 (dd, J = 10.0, 5.6 Hz, 1H, Hb-6), 3.03 (c, J = 5.4 Hz, 
1H, H-5). 13C-NMR (100MHz, CDCl3) δ 137.8, 137.2, 136.6 (s, Ar), 128.6-127.7 
(d, 15C, Ar), 116.3 (s, CN), 81.7 (d, C-3), 79.7 (d, C-4), 73.4, 72.6, (t, Bn), 71.9 (d, 
C-5), 71.8 (t, Bn), 68.7 (t, C-6), 62.1 (d, C-2). Anal Calcd. for C27H28N2O4 (444.47): 
C, 72.95; H, 6.35; N, 6.30. Found: C, 73.14; H, 6.21; N, 6.57. 
(2R,3R,4R,5R)-2-(aminomethyl)-5-(hydroxymethyl)-3,4-dihydroxy-
pyrrolidine dihydrochloride (79). A solution of hydroxylamine 76 (0.444 g, 1 
mmol) in methanol (10 mL) was treated with Pd(OH)2-C (15 mg) and a 1M 
solution of HCl in methanol. The resulting mixture was stirred under 20 atm of 
hydrogen for 6 h. The catalyst was eliminated by filtration through a pad of 
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Celite®, the filtrate was treated with 3M HCl in methanol and the resulting 
solution was stirred at room temperature for additional 10 min. The solvent 
was eliminated under reduced pressure to afford pure 79 (0.235 g, 100 %) as a 
white solid; mp >150 ºC (dec). [α]D
25 = + 43 (c 1.43, H2O); 
1H-NMR (400 MHz, 
D2O) δ 4.27 (dd, J = 3.5, 1.4 Hz, 1H, H-3), 4.05 (dd, J = 2.7, 1.7 Hz, 1H, H-4), 4.02 
(dt, J = 6.6, 3.6 Hz, 1H, H-2), 3.90 (dd, J = 12.1, 4.8 Hz, 1H, Ha-6), 3.76 (dd, J = 
12.1, 8.8 Hz, 1H, Hb-6), 3.62 (ddd, J = 8.8, 4.9, 2.4 Hz, 1H, H-5), 3.54 (dd, J = 
13.9, 6.8 Hz, 1H, Ha-7), 3.42 (dd, J = 13.9, 6.2 Hz, 1H, Hb-7). 13C-NMR (100MHz, 
D2O) δ 75.6 (d, C-4), 74.5 (d, C-3), 68.3 (d, C-5), 59.3 (t, C-6), 58.7 (d, C-2), 35.4 
(t, C-7). Anal Calcd. for C6H16Cl2N2O3 (235.07): C, 30.65; H, 6.86; N, 11.92. 
Found: C, 30.50; H, 6.93; N, 11.70. 
(2S,3R,4R,5R)-2-(aminomethyl)-5-(hydroxymethyl)-3,4-dihydroxy-
pyrrolidine dihydrochloride (80). A solution of hydroxylamine 78 (0.444 g, 1 
mmol) in methanol (10 mL) was treated with Pd(OH)2-C (15 mg) and a 1M 
solution of HCl in methanol. The resulting mixture was stirred under 20 atm of 
hydrogen for 6 h. The catalyst was eliminated by filtration through a pad of 
Celite®, the filtrate was treated with 3M HCl in methanol and the resulting 
solution was stirred at room temperature for additional 10 min. The solvent 
was eliminated under reduced pressure to afford pure 80 (0.235 g, 100 %) as a 
white solid; mp >150 ºC (dec). [α]D
25 = + 43 (c 1.43, H2O). 
1H-NMR (400 MHz, 
D2O) δ 4.27 (dd, J = 3.5, 1,4 Hz, 1H, H-3), 4.05 (dd, J = 2.7, 1.7 Hz, 1H, H-4), 4.02 
(dt, J = 6.6, 3.6 Hz, 1H, H-2), 3.90 (dd, J = 12.1, 4.8 Hz, 1H, Ha-6), 3.76 (dd, J = 
12.1, 8.8 Hz, 1H, Hb-6), 3.62 (ddd, J = 8.8, 4.9, 2.4 Hz, 1H, H-5), 3.54 (dd, J = 
13.9, 6.8 Hz, 1H, Ha-7), 3.54 (dd, J = 13.9, 6.2 Hz, 1H, Hb-7). 13C NMR (100 MHz, 
D2O) δ 75.6 (d, C-4), 74.5 (d, C-3), 68.3 (d, C-5), 59.3 (t, C-6), 58.7 (d, C-2), 35.4 
(t, C-7). Anal Calcd. for C6H16Cl2N2O3 (235.07): C, 30.65; H, 6.86; N, 11.92. 
Found: C, 30.89; H, 7.01; N, 11.83. 
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4.5.3 Synthesis of N-alkylated and dimeric derivatives of DAB-1 
(2R,3R,4R,2’R,3’R,4‘R)-1,1‘-propane-1,3-diylbis[2(hydroxymethyl)-
pyrrolidine-3,4-diol] (81) To a solution of DAB-1 71 (68 mg, 0.51 mmol) in 
MeOH/dioxane 3/2 (5 mL) was added NaHCO3 (128 mg, 1.53 mmol) and 1,3 di-
bromopropane (0.03 ml, 0.26 mmol). The mixture was refluxing for 24 h, at 
which time the mixture was filtered and the solvent was rotatory evaporated 
afforded a crude product which was purified by column chromatography 
(DCM/MeOH/NH3, 10:5:0.5) to give pure 81 (91 mg, 58 %) as an oil. [α]D
25 = - 
54 (c 0.40, MeOH). 1H-NMR (400 MHz, D2O) δ 4.01 (ddd, J = 5.5, 2.7, 2.3 Hz, 
2H,H-4), 3.81 (dd, J = 4.9, 2.9 Hz, 2H, H-3), 3. 61 (d, J = 5.5 Hz, 4H, H-6), 2.94 
(dd, J = 11.3, 1.6 Hz, 2H,Ha-5), 2.75 (dt, J = 12.0, 8.2 Hz, 2H,Ha-7), 2.69 (dd, J = 
11.3, 5.7 Hz, 2H, Hb-5), 2.48 (q, J = 5.2 Hz, 2H, H-2), 2.35 (dt, J = 12.0, 7.8 Hz, 
2H, Hb-7), 1.61 (quint., J = 7.8 Hz, 2H, H-8) 13C-NMR (50 MHz, D2O) δ 78.0 (d, 
2C, C-3), 74.5 (d, 2C, C-4), 71.2 (d, 2C, C-2), 60.2 (t, 2C, C-6), 57.4 (t, 2C, C-5), 
52.3 (t, 2C, C-7), 24.0 (t, C-8). MS (EI): m/z 288 (M+-H2O, 9), 174 (M
+-DAB-1, 7), 
156 (M+-DAB-1-H2O, 12), 146 (M
+
-DAB-1-CH2CH2, 87), 129 (M
+
-DAB-1-
CH2CH2-OH, 42), 116 (DAB-1-OH, 100). Anal Calcd. for C13H26N2O6 (306.36): C, 
50.97; H, 8.55; N, 9.14. Found: C, 51.58; H, 8.68; N, 8.67. 
(2R,3R,4R)-1-butyl-2-(hydroxymethyl)pyrrolidine-3,4-diol (82). To a 
solution of DAB-1 71 (70 mg, 0.53 mmol) in MeOH/dioxane 3/2 (5 mL) was 
added NaHCO3 (134 mg, 1.59 mmol) and bromobutane (0.07 ml, 0.64 mmol). 
The mixture was refluxing for 24 h, at which time the mixture was filtered and 
the solvent was rotatory evaporated afforded a crude product which was 
purified by column chromatography (DCM/MeOH/NH3, 10:3:0.3) to give pure 
82 (64 mg, 0.34 mmol, 64 %) as an oil; [α]D
25 = – 50 (c 0.67, H2O). 
1H-NMR (400 
MHz, D2O) δ 3.99 (dt, J = 5.8, 2.4 Hz, 1H,H-4), 3.81 (dd, J = 4.9, 2.7 Hz, 1H, H-3), 
3. 64-3.56 (m, 2H, Ha-6 , Hb-6), 2.90 (dd, J = 11.3, 2.0 Hz, 1H,Ha-5), 2.71 (dddd, 
J = 11.7, 10.9, 5.5 Hz, 1H,Ha-7), 2.64 (dd, J = 11.3, 5.9 Hz, 2H, Hb-5), 2.44 (dt, J 
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= 5.5, 5.2 Hz, 1H, H-2), 2.27 (dddd, J = 11.9, 10.5, 5.3 Hz, 1H, Hb-7), 1.43-1.27 
(m, 2H, Ha-8, Hb-8), 1.19 (sest., J = 7.4 Hz, 2H, Ha-9, Hb-9), 0.78 (t, J = 7.4, 3H, 
H-10). 13C-NMR (50 MHz, D2O) δ 79.2 (d, C-3), 75.5 (d, C-4), 72.0 (d, C-2), 61.4 
(t, C-6), 58.4 (t, C-5), 55.4 (t, C-7), 29.1 (t, C-8), 20.3 (t, C-9), 13.4 (q, C-10). MS 
(EI): m/z 189 (M+, 3), 158 (40). Anal Calcd. for C9H19NO3 (189.25): C, 57.12; H, 
10.12; N, 7.40. Found: C, 56.95; H, 9.96; N, 7.16. 
4.5.4 Syntheses of methoxy derivatives 
(4aS,5R,6R,7R)-5,6-bis(benzyloxy)-7-[(benzyloxy)methyl]-4-methoxy-
4a,5,6,7-tetrahydro-2H-pyrrolo[1,2-b][1,2]oxazine (91) To a stirred solution of 
methoxyallene (0.17 mL, 2.01 mmol) in dry THF (10 mL), a solution of BuLi 2.5 
M in THF (1.86 mmol, 0.74 mL) were added at -40°C under argon atmosphere. 
The mixture was stirring at -40°C for 10 minutes under argon atmosphere, 
then a solution of nitrone 1 (450 mg, 1.08 mmol) in dry THF (10 mL) were 
added at -78°C. The mixture was stirring at -78°C under argon atmosphere for 
2 hours. A TLC control (DCM/AcOEt 8:1) showed the disappearance of the 
starting material (Rf = 0.11) and the appearance of a new product (Rf = 0.59). 
H2O (17 mL) was added dropwise then the mixture was warm up to rt. The 
mixture was extracted with  AcOEt (3 x 20 mL) and the combined organic 
layers were dried over anhydrous Na2SO4, filtered and evaporated under 
reduced pressure. Purification of the residue by flash column chromatography 
on silica gel (Hexane/ethyl acetate 2:1) afforded pure 91 (Rf=0.32, 389 mg, 0.80 
mmol, 74 % yield) as a yellow oil. [α]D
20 = + 7.8 (c 0.4, CHCl3). 
1H-NMR (500 
MHz, CDCl3) δ 7.43-7.25 (m, 15 H, Ar), 4.74 (t, J = 2.9 Hz, 1 H, H-3), 4.69-4-49 
(m, 6 H, Bn), 4.39 (t, J = 2.3 Hz, 1 H, Ha-2), 4.33-4.29 (m,2 H, H-5, Hb-2), 4.09 (t, 
J = 4.3 Hz, 1 H, H-6), 3.75 (d, J = 6.4 Hz, 1 H, H-4a), 3.64-3.59 (m, 2 H, H-7, Ha-
8), 3.62 (s, 3 H, Me), 3.57-3.52 (m, 1 H, Hb-8). 13C-NMR (125 MHz, CDCl3) δ 
(ppm) 152.1 (s, C-4), 138.4-138.3 (s, 3 C, Ar), 128.4-127.7 (d, 12 C, Ar), 91.4 (d, 
C-3), 87.6 (d, C-5), 86.1 (d, C-6), 73.5, 72.2, 72.0 (t, Bn), 69.4 (t, C-8), 68.2 (d, C-
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7), 66.0 (d, C-4a), 63.6 (t, C-2), 54.5 (q, Me). IR (KBr): 3029, 2929, 2898, 2859, 
1675, 1452, 1360, 1221, 1072, 695 cm-1. HRMS (ESI) for C30H35NO5 [M+H]
+ 
calculated: 488.2392; found: 488.2427; Anal. Calcd for C30H33NO5 (487.59): C, 
73.90; H, 6.82; N, 2.87. Found: C, 73.65; H, 6.75; N, 2.88. 
(3S,4S,4aR,5R,6R,7R)-5,6-bis(benzyloxy)-7-[(benzyloxy)methyl]-4-
methoxyhexahydro-2H-pyrrolo[1,2-b][1,2]oxazin-3ol (93) To a stirred solution 
of 91 (177 mg, 0.36 mmol) in dry THF (8 mL), a solution of BH3
.THF 1M in THF 
(1.44 mmol, 1.44 mL) was added at -30°C under argon atmosphere. The 
solution was stirred at -30°C for 5 minutes and then at rt for 2 h. A TLC control 
(Hex/AcOEt 2:1) showed the disappearance of the starting material (Rf = 0.57) 
and the appearance of a new product (Rf = 0.86), then a solution of NaOH 2N 
(2.16 mL) and H2O2 (0.72 mL) were added dropwise at -10°C and the mixture 
was stirring overnight. Then a saturated aqueous solution of Na2S2O3 (2.5 mL) 
was added dropwise and the mixture was stirring for few minutes. The mixture 
was extracted with Et2O (3 x 15 mL) and the combined organic layers were 
dried over anhydrous Na2SO4, filtered and evaporated under reduced pressure. 
Purification of the residue by flash column chromatography on silica gel 
(hexane/ethyl acetate 1:1) afforded pure 93 (Rf=0.27, 145 mg, 0.29 mmol, 80 % 
yield) as a colourless oil. [α]D
20 = - 26.1 (c 0.93, CHCl3). 
1H-NMR (500 MHz, 
CDCl3): δ 7.36-7.25 (m, 15 H, Ar), 4.63-4.44 (m, 6 H, Bn), 4.33 (dd, J = 7.0, 2.7 
Hz, 1 H, H-5), 4.09 (t, J = 3.0 Hz, 1 H, H-6), 4.02 (d, J = 3.5 Hz, 1 H, Ha-2), 3.76-
3.66 (m, 4H, Hb-2, Ha-8, H-3, H-7), 3.51 (dd, J = 8.9, 7.4 Hz, 1 H, Hb-8), 3.46 (s, 
3 H, Me), 3.34 (t, J = 5.8 Hz, 1 H, H-4), 3.24 (dd, J = 7.0, 6.2 Hz, 1H, H-4a), 2.48 
(d, J = 3.5 Hz, 1H, OH). 13C-NMR (125 MHz, CDCl3): δ 138.2, 138.1, 137.9 (s, Ar), 
128.5-127.7 (d, 12 C, Ar), 85.7 (d, C-6), 84.9 (d, C-5), 79.1 (d, C-4), 73.5, 72.1, 
71.8 (t, Bn), 69.3 (t, C-2), 68.7 (t, C-8), 68.7 (d, 2 C, C-7, C-3), 68.6 (d, C-4a), 59.0 
(q, Me). IR (KBr): 3430, 3029, 2913, 2864, 1093, 734, 695 cm-1. HRMS (ESI) for 
C30H36NO6 [M+H]
+ calculated: 506.2498; found: 506.2537; Anal. Calcd for 
C30H35NO6 (505.60): C, 71.27; H, 6.98; N, 2.77. Found: C, 71.00; H, 7.23; N, 2.82. 
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(2’S,3’S)-3-{(2R,3R,4R,5R)-3,4-bis(benzyloxy)-5-[(benzyloxy)methyl] 
pyrrolidin-2-yl}-3’-methoxypropane-1,2-diol (96). To a stirred solution of 1,2-
diiodoethane (586 mg, 2.08 mmol) in dry THF (12 mL), Sm (341 mg, 2.27 mmol) 
was added at rt under argon atmosphere. The solution was stirred at rt for 2 h, 
then a solution of 93 (318 mg, 0.63 mmol) in dry THF (12 mL) was added and 
the mixture was stirring at rt for 2 h. A TLC control (Hex/AcOEt 1:1) showed the 
disappearance of the starting material (Rf = 0.31) and the appearance of a new 
product (Rf = 0.02), then a saturated aqueous solution NaHCO3 (6.0 mL) was 
added and the mixture was extracted with Et2O (3 x 20 mL) and the combined 
organic layers were dried over anhydrous Na2SO4, filtered and evaporated 
under reduced pressure. Purification of the residue by flash column 
chromatography on silica gel (dichloromethane/methanol 15:1) afforded pure 
96 (Rf=0.50, 298 mg, 0.59 mmol, 94 % yield) as an orange oil. [α]D
20 = + 2.94 (c 
0.34, CHCl3). 
1H-NMR (500 MHz, CDCl3) δ 7.35-7.23 (m, 15 H, Ar), 4.58-4.43 (m, 
6 H, Bn), 4.00-3.96 (m, 3 H, H-3, H-4, H-2’), 3.72 (d, J = 5.6 Hz, 2 H, Ha,b-1’), 
3.53 (d, J = 4.3 Hz, 2 H, Ha,b-6), 3.46 (dd, J = 9.6, 2.5 Hz, 1 H, H-3’), 3.40 (s, 3 H, 
Me), 3.36 (dd, J = 9.6, 3.8 Hz, 1 H, H-2), 3.28 (dt, J = 5.8, 4.3 Hz, 1H, H-5). 13C-
NMR (125 MHz, CDCl3) δ 138.1, 138.0, 137.8 (s, Ar), 128.5-127.8 (d, 12 C, Ar), 
87.2 (d, C-3), 85.8 (d, C-4), 78.6 (d, C-2), 73.2, 72.3, 71.4 (t, Bn), 71.6 (d, C-2’), 
68.3 (t, C-6), 64.0 (d, C-3’), 63.4 (t, C-1’), 62.1 (d, C-5), 58.2 (q, Me). IR (KBr): 
3318, 2926, 2829, 1090, 1072, 734, 696 cm-1. HRMS (ESI) for C30H38NO6 [M+H]
+ 
calculated: 508.2654; found: 508.2701; Anal. Calcd for C30H37NO6 (506.62): C, 
70.98; H, 7.35; N, 2.76. Found: C, 69.34; H, 2.55; N, 7.24. 
(1R,2R,3R,6S,7S,7aR)-1,2-bis(benzyloxy)-3-[(benzyloxy)methyl]-7-
methoxyhexahydro-1H-pyrrolizin-6-yl methanesulfonate (97) To a stirred 
solution of 96 (196 mg, 0.39 mmol) in dry DCM (29 mL), TEA (163 μL, 1.17 
mmol) and MsCl (67 μL, 0.86 mmol)  were added at rt under argon 
atmosphere. The solution was stirred at rt for 1.5 h. A TLC control 
(DCM/MeOH 9:1) showed the disappearance of the starting material (Rf = 
Organometallic additions 
129 
 
0.55) and the appearance of a new product (Rf = 0.78), then H2O (7.0 mL) was 
added and the mixture was extracted with DCM (3 x 20 mL) and the combined 
organic layers were dried over anhydrous MgSO4, filtered and evaporated 
under reduced pressure. Purification of the residue by flash column 
chromatography on silica gel (Hexane/ethyl acetate 1:1) afforded pure 97 
(Rf=0.43, 189 mg, 0.33 mmol, 85 % yield) a colourless oil. [α]D
20 = + 16.2 (c 0.37, 
CHCl3). 
1H-NMR (500 MHz, CDCl3) δ 7.37-7.24 (m, 15 H, Ar), 5.05 (dt, J = 5.2, 3.3 
Hz, 1 H, H-6), 4.65-4.52 (m, 6 H, Bn), 4.07 (t, J = 5.3 Hz, 1 H, H-1), 3.98 (dd, J = 
6.8, 5.3 Hz, 1 H, H-2), 3.94 (t, J = 3.8 Hz, 1 H, H-7), 3.55 (dd, J = 9.5, 4.6 Hz, 1 H, 
Ha-8), 3.46 (dd, J = 9.5, 6.4 Hz, 1 H, Hb-8), 3.44-3.39 (m, 2H, Ha-5, H-7a), 3.41 
(s, 3 H, Me), 3.30 (dd, J = 13.0, 3.4 Hz, 1 H, Hb-5), 3.23 (ddd, J = 11.3, 6.5, 4.7 
Hz, 1H, H-3), 2.93 (s, 3 H, Ms). 13C-NMR (125 MHz, CDCl3) δ 138.3, 138.2, 137.9 
(s, Ar), 128.6-127.7 (d, 12 C, Ar), 88.7 (d, C-7), 86.2 (d, C-1), 85.4 (d, C-2), 84.9 
(d, C-6), 73.5, 72.6 (t, Bn), 72.4 (d, C-7a), 72.3 (t, C-8), 72.0 (t, Bn), 68.1 (d, C-3), 
58.2 (q, Me), 57.0 (t, C-5), 38.7 (q, Ms). IR (KBr): 2930, 2904, 2862, 1359, 1341, 
1174, 1092, 950, 885, 734, 696 cm-1. HRMS (ESI) for C31H38NO7S [M+H]
+ 
calculated: 568.2324; found: 568.2369. Anal. Calcd for C31H37NO7S (567.69): C, 
65.59; H, 6.57; N, 2.47. Found: C, 65.62; H, 6.68; N, 2.56. 
(1R,2R,3R,7R,7aR)-2-(benzyloxy)-3-[(benzyloxy)methyl]hezahydro-1H-
pyrrolizine-1,7-diol (98). To a stirred solution of 97 (92 mg, 0.16 mmol) in dry 
toluene (5 mL), DIBAL-H 1.2 M in toluene (1.33 mmol, 1.60 mL) was added at 
0°C under argon atmosphere. The solution was stirred at reflux for 2 h. A TLC 
control (Hex/AcOEt 1:1) showed the disappearance of the starting material (Rf 
= 0.25) and the appearance of a new product (Rf = 0.01), then a saturated 
aqueous solution of Na2SO4 (0.7 mL) was added and the mixture was filtered 
over Celite® and evaporated under reduced pressure. Purification of the 
residue by flash column chromatography on silica gel 
(dichloromethane/methanol 15:1) afforded pure 98 (Rf=0.24, 33 mg, 0.07 
mmol, 44 % yield) as a colourless oil. [α]D
20 = - 10.0 (c 0.19, CHCl3). 
1H-NMR 
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(500 MHz, CDCl3) δ 7.35-7.25 (m, 10 H, Ar), 4.72-4.57 (m, 4 H, Bn), 4.06 (dd, J = 
7.0, 6.0 Hz, 1 H, H-2), 3.80 (t, J = 6.0 Hz, 1 H, H-1), 3.72 (dt, J = 5.5, 3.7 Hz, 1 H, 
H-7), 3.58-3.52 (m, 2 H, Ha,b-8), 3.38 (dd, J = 6.0, 3.4 Hz, 1 H, H-7a), 3.33 (s, 3 
H, H-Me), 3.10-3.05 (m, 1H, Ha-5), 2.80 (dt, J = 7.3, 3.6 Hz, 1 H, H-3), 2.76-2.71 
(m, 1H, Hb-5), 1.98-1.92 (m, 1 H, Ha-6), 1.84-1.79 (m, 1 H, Hb-6). 13C-NMR (125 
MHz, CDCl3) δ 138.2, 138.1 (s, Ar), 128.5-127.8 (d, 10 C, Ar), 86.5 (d, C-1), 85.9 
(d, C-7), 84.1 (d, C-2), 73.0 (t, Bn), 72.9 (d, C-7a), 72.0 (t, Bn), 69.4 (d, C-3), 60.6 
(t, C-8), 57.1 (q, C-Me), 51.7 (t, C-5), 30.1 (t, C-6). HRMS (ESI) for C23H30NO4 
[M+H]+ calculated: 384.2169; found: 384.2173. 
(1R,2R,3R,6S,7S,7aR)-1,2-bis(benzyloxy)-3-[(benzyloxy)methyl]-7-
methoxyhexahydro-1H-pyrrolizin-6-ol (99). To a stirred solution of 97 (149 mg, 
0.26 mmol) in dry THF (5 mL), LiAlH4 1M in THF (1.04 mmol, 1.04 mL) was 
added at 0°C under argon atmosphere. The solution was stirred at reflux for 2 
h. A TLC control (Hex/AcOEt 1:1) showed the disappearance of the starting 
material (Rf = 0.45) and the appearance of a new product (Rf = 0.06), then a 
saturated aqueous solution of Na2SO4 (0.4 mL) was added and the mixture was 
filtered over Celite® and evaporated under reduced pressure. Purification of 
the residue by flash column chromatography on silica gel (Hexane/ethyl 
acetate 1:3) afforded pure 99 (Rf=0.17, 102 mg, 0.22 mmol, 85 % yield) as 
colourless oil. [α]D
20 = + 4.5 (c 0.91, CHCl3). 
1H-NMR (500 MHz, CDCl3) δ 7.36-
7.25 (m, 15 H, Ar), 4.62-4.49 (m, 6 H, Bn), 4.19 (dt, J = 4.7, 3.5 Hz, 1 H, H-6), 
4.15 (t, J = 4.3 Hz, 1H, H-1), 4.06 (t, J = 4.3 Hz, 1 H, H-2), 3.64 (t, J = 3.4 Hz, 1 H, 
H-7), 3.52-3.47 (m, 2 H, Ha-8, OH), 3.43 (t, J = 4.2 Hz, 1 H, H-7a), 3.38 (s, 3H, 
Me), 3.40-3.34 (m, 3 H, H-3, Ha-5, Hb-8), 2.98 (dd, J = 12.0, 3.7 Hz, 1 H, Hb-5). 
13C-NMR (125 MHz, CDCl3) δ 138.5, 138.1, 137.7 (s, Ar), 128.5-127.6 (d, 12 C, 
Ar), 91.1 (d, C-7), 86.9 (d, C-1), 85.8 (d, C-2), 77.2 (d, C-6), 73.5 (d, C-7a), 73.3 
(t, C-8), 72.4, 72.1, 71.9 (t, Bn), 70.4 (d, C-3), 61.1 (t, C-5), 57.7 (q, Me). IR (KBr): 
3407, 3029, 2895, 2863, 1452, 1098, 1067, 733, 695 cm-1. HRMS (ESI) for 
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C30H36NO5 [M+H]
+ calculated: 490.2549; found: 490.2564. Anal. Calcd for 
C30H35NO5 (489.60): C, 73.59; H, 7.21; N, 2.86. Found: C, 73.59; H, 7.24; N, 2.88. 
(1R,2R,3R,6S,7S,7aS)-3-(hydroxymethyl)-7-methoxyhexahydro-1H-
pyrrolizine-1,2,6-triol (7-methoxy-casuarine, 94). To a stirred solution of 99 
(182 mg, 0.38 mmol) in MeOH (15 mL), 4-5 drops of conc. HCl and 304 mg of 
Pd (10% on C) were added. The suspension was stirred under hydrogen 
atmosphere for 4 d, then filtered through Celite® and washed with MeOH. 
Evaporation under reduced pressure afforded a vitreous solid that was 
transferred to a column of DOWEX 50WX8 and then washed with MeOH (15 
mL), H2O (10 mL) to remove non amine containing products and then with 7% 
NH4OH (25 mL) to elute 7-methoxycasuarine (94). Evaporation of the solvent 
afforded 7-methoxycasuarine as a yellow solid (52 mg, 0.24 mmol, 62%), m.p. 
146-148 °C. [α]D
20 = + 36.9 (c 0.18, H2O). 
1H-NMR (400 MHz, D2O, 25°C) δ 4.30 
(q, J = 4.4 Hz, 1 H, H-6), 4.12 (t, J = 8.4 Hz, 1 H, H-1), 3.84 (t, J = 3.3, 1 H, H-7) 
3.76 (t, J = 8.7 Hz, 1 H, H-2), 3.74 (dd, J = 11.7, 3.7 Hz, 1H, Ha-8), 3.58 (dd, J = 
11.7, 6.7 Hz, 1H, Hb-8), 3.41 (s, 3 H, Me), 3.17 (dd, J = 12.1, 4.8 Hz, 1 H, Ha-5) 
3.08 (dd, J = 8.4, 3.1 Hz, 1 H, H-7a), 3.03-2.99 (m, 2 H, H-3), 2.90 (dd, J = 12.4, 
4.3 Hz, 1 H, Hb-5). 13C-NMR (50 MHz, D2O, 25°C) δ 89.0 (d, C-7), 78.2 (d, C-1), 
77.2 (d, C-2), 76.1 (d, C-6), 70.8 (d, C-7a), 70.3 (d, C-3), 62.9 (t, C-8), 58.8 (t, C-
5), 57.3 (q, Me). IR (KBr): 3392, 3292, 3226, 2892, 1447, 1436, 1395, 1336, 
1332, 1323, 1133, 1106, 1095, 1030, 952 cm-1. MS (70 eV): m/z 205 (M+, 0.9), 
188 (M+-H2O, 0.2), 174 (M
+
-CH2OH, 100), 128 (15), 102 (17), 70 (40). Anal. 
Calcd for C9H17NO5 (219.24): C, 49.31; H, 7.82; N, 6.39. Found: C, 49.29; H, 
7.85; N, 6.43. 
4.5.5 Syntheses of casuarine and 7-epiaustraline 
(4aS,5R,6R,7R)-4,5,6-tris(benzyloxy)-7-[(benzyloxy)methyl]-4a,5,6,7-
tetrahydro-2H-pyrrolo[1,2-b][1,2]oxazine (86). To a stirred solution of 
benzyloxyallene (572 mg, 3.91 mmol) in dry THF (15 mL), a solution of BuLi 2.5 
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M in THF (1.44 mL, 3.61 mmol) was added at -40°C under argon atmosphere. 
The mixture was stirring at -40°C for 10 minutes under argon atmosphere, 
then a solution of nitrone 1 (860 mg, 2.10 mmol) in dry THF (15 mL) were 
added at -78°C. The mixture was stirring at -78°C under argon atmosphere for 
2 hours. A TLC control (DCM/AcOEt 8:1) showed the disappearance of the 
starting material (Rf = 0.11) and the appearance of a new product (Rf = 0.82) 
then H2O (30 mL) was added dropwise then the mixture was warm up to rt. 
The mixture was extracted with  AcOEt (3 x 20 mL) and the combined organic 
layers were dried over anhydrous Na2SO4, filtered and evaporated under 
reduced pressure. Purification of the residue by flash column chromatography 
on silica gel (Hexane/ethyl acetate 4:1) afforded pure 86 (Rf=0.26, 892 mg, 1.58 
mmol, 75 % yield) as a yellow oil. [α]D
20 = - 20.7 (c 1.4, CHCl3). 
1H-NMR (500 
MHz, CDCl3) δ 7.46-7.25 (m, 20 H, Ar), 4.93-4.87 (m, 3 H, H-3, Bn), 4.74-4.53 
(m, 6 H, Bn), 4.51-4.49 (m, 2 H, H-5, Ha-2), 4.42 (dd, J = 14.7, 3.3 Hz, 1 H, Hb-2), 
4.23 (t, J = 4.2 Hz, 1 H, H-6), 3.97 (d, J = 6.3 Hz, 1 H, H-4a), 3.78-3.74 (m, 2 H, H-
7, Ha-8), 3.66 (dd, J = 11.3, 7.7 Hz, 1 H, Hb-8). 13C-NMR (125 MHz, CDCl3): δ 
(ppm) 151.2 (s, C-4), 138.4-136.9 (s, 4 C, Ar), 128.7-127.7 (d, 16 C, Ar), 93.0 (d, 
C-3), 87.9 (d, C-5), 86.3 (d, C-6), 73.6, 72.4, 72.1 (t, Bn), 69.6 (t, C-8), 69.4 (t, 
Bn), 68.3 (d, C-7), 66.3 (d, C-4a), 63.6 (t, C-2). IR (KBr): 3029, 2897, 1673, 1496, 
1453, 1361, 1349, 1216, 1199, 1074, 732, 694 cm-1. HRMS (ESI) for C36H38NO5 
[M+H]+ calculated: 564.2705; found: 564.2742. Anal. Calcd for C36H37NO5 
(563.68): C, 76.71; H, 6.62; N, 2.48. Found: C, 76.76; H, 6.58; N, 2.50. 
(3S,4S,4aS,5R,6R,7R)-4,5,6-tris(benzyloxy)-7-[(benzyloxy)methyl]-
hexahydro-2H-pyrrolo[1,2-b][1,2]oxazin-3-ol (101). To a stirred solution of 86 
(410 mg, 0.73 mmol) in dry THF (15 mL), a solution of BH3
.THF 1M in THF (2.92 
mmol, 2.92 mL) was added at -30°C under argon atmosphere. The solution was 
stirred at -30°C for 5 minutes and then at rt for 2 h. A TLC control (Hex/AcOEt 
2:1) showed the disappearance of the starting material (Rf = 0.35) and the 
appearance of a new product (Rf = 0.63), then a solution of NaOH 2N (4.38 mL) 
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and H2O2 (1.46 mL) were added dropwise at -10°C and the mixture was stirring 
overnight. Then a saturated aqueous solution of Na2S2O3 (5 mL) was added 
dropwise and the mixture was stirring for few minutes. The mixture was 
extracted with Et2O (3 x 20 mL) and the combined organic layers were dried 
over anhydrous Na2SO4, filtered and evaporated under reduced pressure. 
Purification of the residue by flash column chromatography on silica gel 
(hexane/ethyl acetate 2:1) afforded pure 101 (Rf=0.16, 345 mg, 0.59 mmol, 81 
% yield) as a colourless oil. [α]D
20 = - 25.5 (c 0.41, CHCl3). 
1H-NMR (500 MHz, 
CDCl3) δ 7.38-7.21 (m, 20 H, Ar), 4.70-4.44 (m, 8 H, Bn), 4.31-4.25 (m, 1 H, H-5), 
4.06 (t, J = 2.8 Hz, 1 H, H-6), 4.03 (d, J = 3.3 Hz, 1 H, Ha-2), 3.77-3.69 (m, 4H, 
Hb-2, H-3, H-7, Ha-8), 3.59 (t, J = 6.1 Hz, 1 H, H-4), 3.54 (dd, J = 8.9, 7.4 Hz, 1 H, 
Hb-8), 3.35 (t, J = 6.5 Hz, 1 H, H-4a), 2.39 (bs, 1 H, OH). 13C-NMR (125 MHz, 
CDCl3): δ 138.3, 138.2, 138.0, 137.9 (s, Ar), 128.6-127.8 (d, 16 C, Ar), 85.4 (d, C-
6), 84.7 (d, C-5), 76.9 (d, C-4), 73.6, 73.1, 71.9, 71.7 (t, Bn), 69.0 (d, C-3), 68.9, 
68.8 (t, C-2, C-8), 67.9 (d, 2 C, C-7, C-4a). IR (KBr): 3432, 3029, 2910, 2864, 
1495, 1453, 1362, 1206, 1093, 750, 734 cm-1. HRMS (ESI) for C36H40NO6 [M+H]
+ 
calculated: 582.2811; found: 582.2861. Anal. Calcd for C36H39NO6 (581.69): C, 
74.33; H, 6.76; N, 2.41. Found: C, 74.17; H, 6.98; N, 2.42. 
(2’S,3’S)-3’-(benzyloxy)-3’-{(2R,3R,4R,5R)-3,4-bis(benzyloxy)-5-
[(benzyloxy)methyl]pyrrolidin-2-yl}-1’,2’-diol (103). To a stirred solution of 1,2-
diiodoethane (376 mg, 1.33 mmol) in dry THF (9 mL), Sm (232 mg, 1.54 mmol) 
was added at rt under argon atmosphere. The solution was stirred at rt for 2 h, 
then a solution of 101 (216 mg, 0.37 mmol) in dry THF (9 mL) was added and 
the mixture was stirring at rt for 2 h. A TLC control (Hex/AcOEt 1:1) showed the 
disappearance of the starting material (Rf = 0.55) and the appearance of a new 
product (Rf = 0.02), then a saturated aqueous solution NaHCO3 (6.5 mL) was 
added and the mixture was extracted with Et2O (3 x 20 mL) and the combined 
organic layers were dried over anhydrous Na2SO4, filtered and evaporated 
under reduced pressure. Purification of the residue by flash column 
Chapter 4 
134 
 
chromatography on silica gel (dichloromethane/methanol 20:1) afforded pure 
103 (Rf=0.38, 173 mg, 0.30 mmol, 81 % yield) as an orange oil. [α]D
20 = - 7.14 (c 
0.49, CHCl3). 
1H-NMR (500 MHz, CDCl3) δ 7.37-7.22 (m, 20 H, Ar), 4.66 (d, J = 
11.4 Hz, 1H, Bn), 4.54-4.42 (m, 7 H, Bn), 4.05-4.01 (m, 2 H, H-3, H-2’), 3.98 (dd, 
J = 5.7, 2.7 Hz, 1 H, H-4), 3.78 (d, J = 5.4 Hz, 2 H, Ha,b-1’), 3.68 (dd, J = 9.5, 3.8 
Hz, 1 H, H-3’), 3.57-3.56 (m, 1 H, H-2), 3.56 (d, J = 4.5 Hz, 2 H, Ha,b-6), 3.36 (dd, 
J = 10.0, 4.6 Hz, 1H, H-5). 13C-NMR (125 MHz, CDCl3) δ 138.2, 138.1, 137.9, 
137.8 (s, Ar), 128.6-127.8 (d, 16 C, Ar), 86.9 (d, C-3), 88.8 (d, C-4), 76.4 (d, C-3’), 
73.3, 72.9 (t, Bn), 72.2 (d, C-2’), 72.1, 71.5 (t, Bn), 68.7 (t, C-6), 64.4 (d, C-2), 
63.4 (t, C-1’), 62.4 (d, C-5). IR (KBr): 3312, 3029, 2862, 1495, 1452, 1070, 695 
cm-1. HRMS (ESI) for C36H42NO6 [M+H]
+ calculated: 584.2967; found: 584.3011. 
Anal. Calcd for C36H41NO6 (583.71): C, 74.04; H, 7.08; N, 2.40. Found: C, 73.61; 
H, 7.01; N, 2.33. 
(1R,2R,3R,6S,7S,7aS)-1,2,7-tris(benzyloxy)-3-[(benzyloxy)methyl] 
hexahydro-1H-pyrrolizin-6-yl methanesulfonate (104). To a stirred solution of 
103 (151 mg, 0.26 mmol) in dry DCM (20 mL), TEA (108 μL, 0.78 mmol) and 
MsCl (44 μL, 0.57 mmol)  were added at rt under argon atmosphere. The 
solution was stirred at rt for 1.5 h. A TLC control (DCM/MeOH 9:1) showed the 
disappearance of the starting material (Rf = 0.54) and the appearance of a new 
product (Rf = 0.88), then H2O (5.0 mL) was added and the mixture was 
extracted with DCM (3 x 20 mL) and the combined organic layers were dried 
over anhydrous MgSO4, filtered and evaporated under reduced pressure. 
Purification of the residue by flash column chromatography on silica gel 
(Hexane/ethyl acetate 1:1) afforded pure 104 (Rf=0.54, 158 mg, 0.25 mmol, 94 
% yield) as a colourless oil. [α]D
20 = - 7.08 (c 1.3, CHCl3). 
1H-NMR (500 MHz, 
CDCl3) δ 7.38-7.25 (m, 20 H, Ar), 5.17 (dt, J = 5.3, 3.1 Hz, 1 H, H-6), 4.69-4.46 
(m, 8 H, Bn), 4.22 (dd, J = 3.8, 3.5 Hz, 1 H, H-7), 4.04 (t, J = 5.2 Hz, 1 H, H-1), 
4.01 (dd, J = 12.2, 5.8 Hz, 1 H, H-2), 3.59 (dd, J = 9.5, 4.6 Hz, 1 H, Ha-8), 3.54-
3.49 (m, 3 H, Hb-8, H-7a, Ha-5), 3.37 (dd, J =13.2, 3.1 Hz, 1 H, Hb-5), 3.28 (td, J 
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= 6.4, 4.8 Hz, 1 H, H-3), 2.89 (s, 3 H, Ms). 13C-NMR (125 MHz, CDCl3) δ 138.4, 
138.2, 138.0, 137.5 (s, Ar), 128.6-127.7 (d, 16 C, Ar), 85.9 (d, C-7), 85.8 (d, C-1), 
85.3 (d, C-2), 85.3 (d, C-6), 73.5, 72.8 (t, Bn), 72.5 (t, C-8), 72.4, 72.1 (t, Bn), 
68.2 (d, C-3), 57.2 (t, C-5), 38.6 (q, Ms). IR (CDCl3): 3029, 2893, 2863, 1342, 
1175, 1090, 1071, 750, 696 cm-1. HRMS (ESI) for C37H42NO7S [M+H]
+ calculated: 
644.2637; found: 644. 2678. Anal. Calcd for C37H41NO7S (643.79): C, 69.03; H, 
6.42; N, 2.18. Found: C, 69.50; H, 6.03; N, 2.60. 
(1R,2R,3R,7R,7aR)-1,2-bis(benzyloxy)-3-[(benzyloxy)methyl]hexahydro-
1H-pyrrolizin-7-ol (105). To a stirred solution of 104 (67 mg, 0.10 mmol) in dry 
toluene (4 mL), DIBAL-H 1.2 M in toluene (0.83 mmol, 1.00 mL) was added at 
0°C under argon atmosphere. The solution was stirred at reflux for 2 h. A TLC 
control (Hex/AcOEt 1:1) showed the disappearance of the starting material (Rf 
= 0.64) and the appearance of a new product (Rf = 0.01), then a saturated 
aqueous solution of Na2SO4 (0.5 mL) was added and the mixture was filtered 
over Celite® and evaporated under reduced pressure. Purification of the 
residue by preparative TLC on silica gel (ethyl acetate/methanol 30:1) afforded 
pure 105 (Rf=0.50, 24 mg, 0.05 mmol, 50 % yield) as a colourless oil. [α]D
20 = - 
27.0 (c 0.33, CHCl3). 
1H-NMR (500 MHz, CDCl3) δ 7.36-7.25 (m, 15 H, Ar), 4.70-
4.48 (m, 6 H, Bn), 4.07 (dd, J = 6.9, 6.2 Hz, 1 H, H-2), 3.94 (dt, J = 5.2, 4.0 Hz, 1 
H, H-7), 3.78 (t, J = 5.9 Hz, 1 H, H-1), 3.60-3.56 (m, 2 H, Ha,b-8), 3.46 (dd, J = 
5.9, 3.5 Hz, 1 H, H-7a), 3.15-3.10 (m, 1 H, Ha-5), 2.79 (dt, J = 7.1, 3.6 Hz, 1 H, H-
3), 2.77-2.72 (m, 1H, Hb-5), 2.00-1.93 (m, 1 H, Ha-6), 1.91-1.86 (m, 1 H, Hb-6). 
13C-NMR (125 MHz, CDCl3): δ 138.3, 138.2, 138.1 (s, Ar), 128.5-127.8 (d, 12 C, 
Ar), 86.4 (d, C-1), 84.1 (d, C-2), 83.4 (d, C-7), 73.3 (d, C-7a), 73.0, 71.9, 71.3 (t, 
Bn), 69.3 (d, C-3), 60.6 (t, C-8), 51.7 (t, C-5), 30.5 (t, C-6). IR (KBr): 3029, 2922, 
2867, 1453, 1361, 1108, 734, 696 cm-1. HRMS (ESI) for C29H34NO4 [M+H]
+ 
calculated: 460.2443; found: 460.2495. 
(1R,2R,3R,7R,7aR)-3-(hydroxymethyl)hexahydro-1H-pyrrolizine-1,2,7-
triol (7-epiaustraline, 17). To a stirred solution of 105 (58 mg, 0.13 mmol) in 
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MeOH (6 mL), 4-5 drops of concentrated HCl and 104 mg of Pd (10% on C) 
were added. The suspension was stirred under hydrogen atmosphere 
overnight, then filtered through Celite® and washed with MeOH. Evaporation 
under reduced pressure afforded a viscous oil that was transferred to a column 
of DOWEX 50WX8  and then washed with MeOH (20 mL), H2O (20 mL) to 
remove non amine containing products and then with 7% NH4OH (30 mL) to 
elute 7-epiaustraline (17). Evaporation of the solvent afforded 7-epiaustraline 
as a yellow solid (24 mg, 0.13 mmol, 100% yield). [α]D
20 = - 6.3 (c 0.49, MeOH). 
1H-NMR (400 MHz, D2O) δ 4.25 (dt, J = 4.6, 2.6 Hz, 1 H, H-7), 3.69-3.59 (m, 3 H, 
H-1, H-2, Ha-8), 3.53 (dd, J = 11.7, 6.3 Hz, 1 H, Hb-8) 3.00 (dddd, J = 16.5, 11.4, 
7.7 Hz, 1 H, Ha-5), 2.95 (dd, J = 7.7, 1.7 Hz, 1H, H-7a), 2.80 (dddd, J =  11.1, 7.1, 
3.4 Hz, 1H, Hb-5), 2.60 (dddd, J = 9.2, 6.2, 3.7 Hz, 1 H, H-3), 2.02-1.93 (m, 1 H, 
Ha-6), 1.71-1.65 (m, 1 H, Hb-6). 13C-NMR (50 MHz, D2O): δ 77.1 (d, C-1), 75.5 
(d, C-2), 74.4 (d, C-7), 73.9 (d, C-7a), 68.2 (d, C-3), 61.5 (t, C-8), 51.8 (t, C-5), 
31.3 (t, C-6). IR (KBr): 3357, 3307, 3243, 2912, 1443, 1340, 1316, 1261, 1035, 
978, 530 cm-1. HRMS (ESI) for C8H16NO4 [M+H]
+ calculated: 190.1074; found: 
190.1087. 
(1R,2R,3R,6S,7S,7aR)-1,2,7-tris(benzyloxy)-3-[(benzyloxy)methyl] 
hexahydro-1H-pyrrolizin-6-ol (106). To a stirred solution of 104 (140 mg, 0.22 
mmol) in dry THF (4 mL), LiAlH4 1M in THF (0.88 mmol, 0.88 mL) was added at 
0°C under argon atmosphere. The solution was stirred at reflux for 2 h. A TLC 
control (Hex/AcOEt 1:1) showed the disappearance of the starting material (Rf 
= 0.44) and the appearance of a new product (Rf = 0.16), then a saturated 
aqueous solution of Na2SO4 (0.7 mL) was added and the mixture was filtered 
over Celite® and evaporated under reduced pressure. Purification of the 
residue by flash column chromatography on silica gel (Hexane/ethyl acetate 
1:3) afforded pure 106 (Rf=0.43, 105 mg, 0.19 mmol, 86 % yield) as a colourless 
oil. [α]D
20 = - 7.14 (c 0.14, CHCl3). 
1H-NMR (500 MHz, CDCl3): δ 7.36-7.25 (m, 20 
H, Ar), 4.60-4.48 (m, 8 H, Bn), 4.26 (q, J = 4.0 Hz, 1 H, H-6), 4.12 (t, J = 4.4 Hz, 1 
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H, H-1), 4.08 (t, J = 4.6 Hz, 1 H, H-2), 3.87 (t, J = 3.7 Hz, 1 H, H-7), 3.56-3.50 (m, 
3 H, H-7a Ha,b-8), 3.43-3.38 (m, 2 H, H-3, Ha-5), 2.98 (dd, J = 12.0, 3.9 Hz, 1 H, 
Hb-5). 13C-NMR (125 MHz, CDCl3): δ 138.5, 138.3, 138.2, 137.8 (s, Ar), 128.6-
127.6 (d, 16 C, Ar), 88.6 (d, C-7), 86.5 (d, C-1), 85.7 (d, C-2), 77.6 (d, C-6), 73.6 
(d, C-7a), 73.4, 72.4 (t, Bn), 72.2 (t, C-8), 71.8, 71.1 (t, Bn), 70.3 (d, C-3), 61.1 (t, 
C-5). IR (KBr): 3029, 2862, 1452, 1363, 1205, 1067, 732, 694 cm-1. HRMS (ESI) 
for C36H40NO5 [M+H]
+ calculated: 566.2901; found: 566.2904. Anal. Calcd for 
C36H39NO5 (565.69): C, 76.43; H, 6.95, N, 2.48. Found: C, 75.79; H, 7.00; N, 2.43. 
(1R,2R,3R,6S,7S,7aR)-3-(hydroxymethyl)hexahydro-1H-pyrrolizine-
1,2,6,7-tetrol (casuarine, 11). To a stirred solution of 106 (160 mg, 0.10 mmol) 
in MeOH (10 mL), 4-5 drops of concentrated HCl and 84 mg of Pd (10% on C) 
were added. The suspension was stirred under hydrogen atmosphere 
overnight, then filtered through Celite® and washed with MeOH. Evaporation 
under reduced pressure afforded a viscous oil that was transferred to a column 
of DOWEX 50WX8  and then washed with MeOH (20 mL), H2O (20 mL) to 
remove non amine containing products and then with 7% NH4OH (30 mL) to 
elute casuarine (11). Evaporation of the solvent afforded casuarine (11) as a 
white solid (21 mg, 0.10 mmol, 100% yield). [α]D
20 = + 13.6 (c 0.66, MeOH). 1H-
NMR (500 MHz, D2O) δ 4.20-4.17 (m, 2 H, H-6, H-7), 4.14 (t, J = 8.2 Hz, 1 H, H-
1), 3.79-3-74 (m, 2 H, H-2, Ha-8) 3.60 (dd, J = 11.8, 6.6 Hz, 1 H, Hb-8), 3.25 (dd, 
J = 12.3, 4.4 Hz, 1H, Ha-5), 3.06 (dd, J =  8.2, 3.3 Hz, 1H, H-7a), 3.04-3.01 (m, 1 
H, H-3), 2.91 (dd, J = 12.3, 3.8 Hz, 1 H, Hb-5). 13C-NMR (50 MHz, D2O) δ 79.3 (d, 
C-7), 78.2 (d, C-1), 77.9 (d, C-6), 77.1 (d, C-2), 72.7 (d, C-7a), 70.5 (d, C-3), 62.7 
(t, C-8), 58.6 (t, C-5). 
(1R,2R,3R,6R,7S,7aR)-6-azido-1,2,7-tris(benzyloxy)-3-[(benzyloxy) 
methyl]hexahydro-1H-pyrrolizine (110). To a stirred solution of 104 (81 mg, 
0.13 mmol) in dry DMF (4 mL), NaN3 (85 mg, 1.30 mmol) were added under 
argon atmosphere. The solution was stirred at 100°C for 2 days. A TLC control 
(Hex/AcOEt 1:1) showed the disappearance of the starting material (Rf = 0.53) 
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and the appearance of a new product (Rf = 0.78), then the suspension was 
cooled at rt, extract with AcOEt and the organic layers were washed with 
water and brine, dried on Na2SO4, filtered and evaporated. Purification of the 
residue by preparative TLC on silica gel (hexane/ethyl acetate 3:1) afforded 
pure 110 (Rf=0.38, 46 mg, 0.08 mmol, 62 % yield) as a colourless oil. [α]D
20 = - 
39.8 (c 0.43, CHCl3). 
1H-NMR (500 MHz, CDCl3) δ 7.38-7.21 (m, 20 H, Ar), 4.73 
(d, J = 11.9 Hz, 1 H, Bn) 4.63-4.44  (m, 7 H, Bn), 4.05-4.02 (m, 2 H, H-6, H-2), 
3.94 (dd, J = 7.4, 4.7 Hz, 1 H, H-7), 3.88 (t, J = 3.9 Hz, 1 H, H-1), 3.64 (dd, J = 7.4, 
3.7 Hz, 1 H, H-7a), 3.58 (dd, J = 9.4, 6.2 Hz, 1 H, Ha-8), 3.51 (dd, J = 9.4, 6.5 Hz, 
1 H, Hb-8), 3.36 (dd, J = 11.7, 3.0 Hz, 1 H, Ha-5), 3.09-3.02 (m, 2H, H-3, Hb-5). 
13C-NMR (125 MHz, CDCl3) δ 138.5, 138.2, 138.1, 137.5 (s, Ar), 128.7-127.6 (d, 
16 C, Ar), 85.9 (d, C-2), 85.7 (d, C-1), 82.9 (d, C-7), 73.4, 72.5 (t, Bn), 72.4 (t, C-
8), 72.2, 71.6 (t, Bn), 71.1 (d, C-7a), 70.1 (d, C-3), 61.6 (d, C-6), 57.8 (t, C-5). IR 
(KBr): 3031, 2864, 2129, 2102, 2077, 1496, 1452, 1311, 1255, 1116, 733, 692 
cm-1.HRMS (ESI) for C36H39N4O4 [M+H]
+ calculated: 591.2927; found: 591.2968. 
(1R,2R,3R,6R,7R,7aR)-6-amino-3-(hydroxymethyl)hexahydro-1H-
pyrrolizine-1,2,7-triol (7-epiaminocasuarine, 109). To a stirred solution of 110 
(86 mg, 0.15 mmol) in MeOH (6 mL), 4-5 drops of concentrated HCl and 80 mg 
of Pd (10% on C) were added. The suspension was stirred under hydrogen 
atmosphere for 2 days, then filtered through Celite® and washed with MeOH. 
Evaporation under reduced pressure afforded a viscous oil that was 
transferred to a column of DOWEX 50WX8  and then washed with MeOH (20 
mL), H2O (20 mL) to remove non amine containing products and then with 7% 
NH4OH (30 mL) to elute 7-epiaminocasuarine (109). Evaporation of the solvent 
afforded 7-epiaminocasuarine as a transparent oil (20 mg, 0.10 mmol, 67% 
yield). 1H-NMR (400 MHz, D2O) δ 3.94 (bd, J = 3.4 Hz, 1 H, H-7), 3.67-3.56 (m, 3 
H, H-1, H-2, Ha-8), 3.45 (dd, J = 11.6, 6.2 Hz, 1 H, Hb-8) 3.35-3.30 (m, 1 H, H-6), 
2.97 (d, J = 7.7 1H, H-7a), 2.80 (dd, J = 11.6, 6.8, 3.4 Hz, 1H, Ha-5), 2.61-2.53 
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(m, 2 H, Hb-5. H-3). 13C-NMR (50 MHz, D2O): δ 76.9, 75.2 (d, C-1, C-2), 74.1 (d, 
C-7), 72.3 (d, C-7a), 68.0 (d, C-3), 61.9 (t, C-8), 55.8 (t, C-5), 50.7. 
4-(benzyloxy)-4-{(4aS,5R,6R,7R)-5,6-bis(benzyloxy)-7-[(benzyloxy) 
methyl]pyrrolidin-4a-yl}prop-3-en-2-ol (111). To a solution of 86 (153 mg, 0.27 
mmol) in CH3CN/H2O 7/1 (4 mL), Mo(CO)6 (112 mg, 0.42 mmol) and NaBH4 (5 
mg, 0.14 mmol) were added. The reaction mixture was stirred at reflux for 3 h. 
The mixture was then filtered and concentrated under reduced pressure. The 
residue was purified by flash column chromatography on silica gel 
(EtOAc/hexane 2:3) to afford pure 111 (Rf=0.32) as a yellow oil (68 mg, 45%). 
[α]D
23 = + 14.6 (c 1.0, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ 7.34-7.22 (m, 20 H, 
Ar), 5.13 (t, J = 8.0 Hz, 1 H, H-3), 4.75-4.69 (AB system, J = 11.5 Hz, 2 H, Bn), 
4.59-4.48 (m, 6 H, Bn), 4.18-3.99 (m, 4 H, Ha-2, Hb-2, H-4a, H-5, H-6), 3.56-3.49 
(m, 2 H, Ha-8, Hb-8), 3.49-3.42 (m, 1 H, H-7). 13C-NMR (50 MHz, CDCl3) δ 156.7 
(s, C-4), 138.0, 137.4, 136.4 (s, Ar.), 128.4-127.5 (d, 20 C, Ar), 101.4 (d, C-3), 
87.1 (d, C-5), 86.6 (d, C-6), 73.4, 72.6, 72.1 (t, Bn), 71.4 (t, C-8), 69.4 (t, Bn), 
61.7 (d, C-7), 60.2 (d, C-4a), 57.2 (t, C-2). IR (CDCl3): 3450, 3350, 3066, 3031, 
2932, 2867, 2243, 1654, 1495, 1362, 1220, 1094, 1076 cm-1. MS (ESI) for 
C36H39NO5Na [M+Na]
+ calculated: 588.70; found: 588.45. Anal. Calcd for 
C36H39NO5 (565.7) C, 76.43; H, 6.95; N, 2.48; Found: C, 76.00 ; H, 7.47; N, 2.94. 
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5.1 Biological evaluation and modeling studies 
As previously mentioned, all the synthesized molecules were tested, or 
are currently under biological evaluation, towards a wide range of 
glycosidases. For some enzymes, molecular modelling studies have also been 
performed. 
5.1.1 Inhibition of glycosidases 
This study has been done in collaboration with Prof. Pierre Vogel of the 
University of Lausanne. In particular, we thank Dr. Claudia Bello for inhibition 
studies and mass spectrometry. 
Compounds 11, 14-16, 50-52, 57, 60 and 63 (Figure 5.1) were assayed 
toward a panel of fourteen commercially available glycosidases: α-L-fucosidase 
(EC 3.2.1.51) from bovine kidney; α-galactosidase (EC 3.2.1.22) from coffee 
bean; β-galactosidases (EC 3.2.1.23) from Escherichia coli, bovine liver and 
Aspergillus oryzae; α-glucosidases (EC 3.2.1.20) from yeast and rice; 
amylogucosidase (EC 3.2.1.3) from Aspergillus niger; β-glucosidase (EC 
3.2.1.21) from almond; α-mannosidase (EC 3.2.1.24) from jack bean; β-
mannosidase (EC 3.2.1.25) from snail; β-xylosidase (EC 3.2.1.37) from 
Aspergillus niger; β-N-acetylglucosaminidases (EC 3.2.1.30) from jack bean and 
bovine kidney with appropriate p-nitrophenyl glycoside substrates.135 
The errors were estimated to be around 20% on the measurements 
(statistical study carried out with model compounds) and around 10-15% on 
the concentrations (errors on sample weight). 
                                                            
135
 Brandi, A.; Cicchi, S.; Cordero, F. M.; Frignoli, R.; Goti, A.; Picasso, M.; Vogel, P. 
J. Org. Chem. 1995, 60,6806 and references therein. 
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Figure 5.1. Molecules tested 
Casuarine (11), Table 5.1, showed to be a potent and competitive 
inhibitor of amyloglucosidase from Aspergillus niger (IC50 = 1.9 ± 0.4 µM, Ki = 
2.0 ± 0.4 µM). It also inhibits α-glucosidases from yeast and from rice (91% and 
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94% at 1mM, respectively) and, to a lesser extent, β-glucosidase from 
almonds, α-mannosidase from jack bean, β-xylosidase from Aspergillus niger 
and β-N-acetylglucosaminidase from jack bean (46%, 21%, 24% and 16% at 
1mM, respectively). 
Casuarine-6-O-α-glucoside (50, Table 5.1) was slightly less potent, with 
IC50 and Ki in the same order of magnitude (IC50 = 4.4 ± 0.9 µM, Ki = 3.9 ± 0.8 
µM, mixed type inhibition), but more selective than casuarine: indeed at 1mM 
concentration it gave only 20% inhibition toward α-glucosidase from yeast and 
did not inhibit at all α-glucosidase from rice. Moreover it showed only 19% 
inhibition toward α-L-fucosidase from bovine kidney (1mM). 
Glucoside 51 (Table 5.1), 7-homocasuarine 16 and glucoside 52 (Table 
5.2) were good and selective competitive inhibitors of amyloglucosidase from 
Aspergillus niger (IC50 = 7.7 ± 1.5, 8.1± 1.6 and 24 ± 4.7 µM, respectively; Ki = 
7.4 ± 1.2, 11± 2.1 and 23 ± 4.6 µM, respectively). They inhibited α-glucosidase 
from yeast weakly (29%, 45% and 55% at 1mM, respectively) and did not 
inhibit α-glucosidase from rice.  
7-Deoxycasuarine (14), Table 5.1, was a very potent and selective 
inhibitor of amyloglucosidase from Aspergillus niger (IC50 = 4.5 ± 0.9 µM, Ki = 
3.5 ± 0.7 µM). Among the other glycosidases assayed, only α-glucosidase from 
rice was also inhibited weakly (36% at 1 mM). 
Lactam 15 (Table 5.2) exhibited weak (IC50 = 210 ± 43 µM) but very 
selective inhibitory activity toward amyloglucosidase from Aspergillus niger. 
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 Percentage of inhibition at 1mM 
Compound 
Enzyme (pH) 
11 50 63 14 51 
α-L-fucosidase  
EC 3.2.1.51  
1-bovine kydney (6) 
n.i. 1.9 n.i. n.i. n.t. 
α-galactosidase  
EC 3.2.1.22  
2-coffe bean (6) 
n.i. n.i. n.i. n.i. n.t. 
β-galactosidase  
EC 3.2.1.23  
5-Escherichia coli (7) 
 
8-Aspergillus oryzae(4) 
n.i. n.i. n.i. n.i. n.t. 
n.i. n.i. n.i. n.i. n.i. 
α-glucosidase  
EC 3.2.1.20  
10-yeast (7) 
 
11-rice (4) 
91 20 n.i. n.i. 29 
94 n.i. n.i. 36 n.i. 
amyloglucosidase 
EC 3.2.1.3 
13-Aspergillus niger(5) 
98 
IC50=1.9μM  
Ki=2.0μM 
97 
IC50=4.4μM  
Ki=3.9μM 
n.i. 
100 
IC50=4.5μM  
Ki=3.5μM 
97 
IC50=7.7μM  
Ki=7.4μM 
β-glucosidase  
EC 3.2.1.21  
15-almond (5) 
46 n.i. n.i. n.i. n.t. 
α-mannosidase  
EC 3.2.1.24  
16-jack bean (5) 
21 n.i. n.t. n.i. n.t. 
β-mannosidase  
EC 3.2.1.25  
18-snail (4) 
n.i. n.t. n.t. n.i. n.t. 
β-xylosidase  
EC 3.2.1.37  
19-Aspergillus niger(5) 
24 n.t. n.t. n.i. n.t. 
β-N-
acetylglucosaminidase  
EC 3.2.1.30  
21-jack bean (5) 
 
22-bovine kidney (4) 
16 n.i. n.i. n.i. n.i. 
n.i. n.t. n.i. n.t. n.t. 
Table 5.1. Inhibition for compounds 11, 50, 63, 14 and 51 toward commercially available 
glycosidases. n.i. = no inhibition,  n.t. = test not performed. 
 
Among the remaining compounds, 63 was not active toward all the 
glycosidases assayed, 60 and 57 showed weak and very selective inhibitory 
activity (25% and 76% inhibition at 1mM, respectively) toward 
amyloglucosidase from Aspergillus niger.  
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 Percentage of inhibition at 1mM 
Compound 
Enzyme (pH) 
15 16 52 60 57 
α-L-fucosidase  
EC 3.2.1.51  
1-bovine kydney (6) 
n.i. n.i. n.t. n.i. n.i. 
α-galactosidase  
EC 3.2.1.22  
2-coffe bean (6) 
n.i. n.i. n.t. n.i. n.i. 
β-galactosidase  
EC 3.2.1.23  
5-Escherichia coli (7) 
 
8-Aspergillus oryzae(4) 
n.i. n.i. n.t. n.i. n.i. 
n.i. n.i. n.t. n.i. n.i. 
α-glucosidase  
EC 3.2.1.20  
10-yeast (7) 
 
11-rice (4) 
n.i. 45 55 n.i. n.i. 
n.i. n.i. n.i. n.i. n.i. 
amyloglucosidase 
EC 3.2.1.3 
13-Aspergillus niger(5) 
91 
IC50=210μM  
99 
IC50=8.1μM  
Ki=11 μM 
92 
IC50=24μM  
Ki=23 μM 
25 76 
β-glucosidase  
EC 3.2.1.21  
15-almond (5) 
42 n.t n.t. n.i. n.i. 
α-mannosidase  
EC 3.2.1.24  
16-jack bean (5) 
n.i. n.t n.t. n.i. n.i. 
β-mannosidase  
EC 3.2.1.25  
18-snail (4) 
n.i. n.t n.t. n.t. n.i. 
β-xylosidase  
EC 3.2.1.37  
19-Aspergillus niger(5) 
n.i. n.t n.t. n.t. n.i. 
β-N-
acetylglucosaminidase  
EC 3.2.1.30  
21-jack bean (5) 
 
22-bovine kidney (4) 
44 n.t n.t. n.t. n.i. 
20 n.t n.t. n.t. n.i. 
Table 5.2. Inhibition of compounds 15, 16, 52, 60, 57 toward commercially available 
glycosidases.  n.i. = no inhibition,  n.t. = test not performed. 
As 50 is a glucoside, we verified whether amyloglucosidase was able to 
hydrolyze its glycosidic bond under the test conditions. Indeed, we had to 
consider the possibility that the inhibitory activities observed for 50 were due 
to the casuarine liberated by the hydrolytic reaction catalyzed by 
amyloglucosidase. 
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Thus, a series of mass spectra analyses using HR-ESI-TOF-MS (high 
resolution ESI mass spectrometry, positive ionization mode) were performed: 
as shown in Figure 5.2 the peak assigned to protonation of the glucoside (A), 
MW = 367.35, was detected in the solution when the measurement was 
performed immediately after the addition of the enzyme (C) as well as after 20 
minutes of incubation at room temperature (D) and after 20 minutes of 
incubation at 37 °C (E). We verified that the mixture of enzyme and buffer did 
not give similar signals (B). 
The spectra of the different assays performed with the buffered solution 
(phosphate) of the inhibitor in the presence of the enzyme neither showed 
peaks corresponding to the aglycone (MW = 205.21), nor to glucose (180.16) 
alone (Figure 5.3). This demonstrates that glucoside 50 is not hydrolyzed by 
the enzyme (amyloglucosidase from Aspergillus niger) under the conditions of 
our test. 
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Figure 5.2. (A): HR-ESI-TOF-MS of an aqueous solution of 50; (B): HR-ESI-TOF-MS of a 
phosphate buffer solution (pH = 5) of amyloglucosidase from Aspergillus niger; (C): HR-ESI-
TOF-MS of a phosphate buffer solution (pH = 5) of amyloglucosidase from Aspergillus niger in 
the presence of 50, measurement performed at t = 0 min and T = 25°C; (D): HR-ESI-TOF-MS of a 
phosphate buffer solution (pH = 5) of amyloglucosidase from Aspergillus niger in the presence 
of 50, measurement performed at t = 20 min and T = 25°C; (E): HR-ESI-TOF-MS of a phosphate 
buffer solution (pH = 5) of amyloglucosidase from Aspergillus niger in the presence of 50, 
measurement performed after 20 min incubation at 37°C. 
Chapter 5 
150 
 
 
Figure 5.3. (A): HR-ESI-TOF-MS of an aqueous solution of 50; (B): HR-ESI-TOF-MS of a 
phosphate buffer solution (pH = 5) of amyloglucosidase from Aspergillus niger; (C): HR-ESI-
TOF-MS of a phosphate buffer solution (pH = 5) of amyloglucosidase from Aspergillus niger in 
the presence of 50, measurement performed t = 0 and T = 25°C; (D): HR-ESI-TOF-MS of a 
phosphate buffer solution (pH = 5) of amyloglucosidase from Aspergillus niger in the presence 
of 50, measurement performed t = 20 min and T = 25°C; (E): HR-ESI-TOF-MS of a phosphate 
buffer solution (pH = 5) of amyloglucosidase from Aspergillus niger in the presence of 50, 
measurement performed after 20 min incubation at 37°C. 
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Compounds 13, 17 and 94 were assayed toward a panel of fourteen 
commercially available glycosidases: α-L-fucosidase (EC 3.2.1.51) from bovine 
kidney; α-galactosidase (EC 3.2.1.22) from coffee bean; β-galactosidases (EC 
3.2.1.23) from Escherichia coli and Aspergillus oryzae; α-glucosidases (EC 
3.2.1.20) from yeast and rice; amylogucosidase (EC 3.2.1.3) from Aspergillus 
niger; β-glucosidase (EC 3.2.1.21) from almond; α-mannosidase (EC 3.2.1.24) 
from jack bean; β-mannosidase (EC 3.2.1.25) from snail; β-xylosidase (EC 
3.2.1.37) from Aspergillus niger; β-N-acetylglucosaminidases (EC 3.2.1.30) from 
jack bean and bovine kidney with appropriate p-nitrophenyl glycoside 
substrates (Table 5.3). 
The errors were estimated to be around 20% on the measurements 
(statistical study carried out with model compounds) and around 10-15% on 
the concentrations (errors on sample weight). 
Hyacinthacine A2 (13), Table 5.3, showed to be a potent and non 
competitive inhibitor of amyloglucosidase from Aspergillus niger (IC50 = 1.9 ± 
0.4 µM). It also inhibits α-glucosidase from yeast (72% at 1mM). 
7-Epiaustraline (17) (Table 5.3) was slightly less potent and competitive 
inhibitor of amyloglucosidase from Aspergillus niger, with IC50 in the same 
order of magnitude (IC50 = 3.5 ± 0.9 µM, mixed type inhibition). It also inhibits 
α-glucosidase from yeast (80% at 1mM) and, to a lesser extent, β-N-
acetylglucosaminidase from jack bean and α-glucosidase from rice (38% and 
16% at 1mM respectively). 
7-Methoxycasuarine 94 (Table 5.3), was quite good and selective 
inhibitor of amyloglucosidase from Aspergillus niger (IC50 = 9.7 ± 1.5 µM, mixed 
type inhibition). It also inhibits β-glucosidase from almond (34% at 1mM) and 
did not inhibit α-glucosidase from rice or from yeast. 
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 Percentage of inhibition at 1mM 
Compound 
Enzyme (pH) 
13 17 94 
α-L-fucosidase  
EC 3.2.1.51  
1-bovine kydney (6) 
n.t. n.t. n.t. 
α-galactosidase  
EC 3.2.1.22  
2-coffe bean (6) 
n.i. n.i. n.i. 
β-galactosidase  
EC 3.2.1.23  
5-Escherichia coli (7) 
 
8-Aspergillus oryzae (4) 
n.i. n.i. n.i. 
n.i. n.i. n.i. 
α-glucosidase  
EC 3.2.1.20  
10-yeast (7) 
 
11-rice (4) 
72 80 n.i. 
n.i. 16 n.i. 
amyloglucosidase 
EC 3.2.1.3 
13-Aspergillus niger (5) 
97 
IC50=1.9μM  
95 
IC50=3.5μM  
97 
IC50=9.7μM  
β-glucosidase  
EC 3.2.1.21  
15-almond (5) 
n.i. n.i. 34 
α-mannosidase  
EC 3.2.1.24  
16-jack bean (5) 
n.i. n.i. n.i. 
β-mannosidase  
EC 3.2.1.25  
18-snail (4) 
n.i. n.i. n.i. 
β-xylosidase  
EC 3.2.1.37  
19-Aspergillus niger (5) 
n.i. n.i. n.i. 
β-N-
acetylglucosaminidase  
EC 3.2.1.30  
21-jack bean (5) 
 
22-bovine kidney (4) 
n.i. n.i. n.i. 
n.i. 38 n.i. 
Table 5.3. Inhibition of compounds 14, 17, and 94 toward commercially available glycosidases. 
n.i. = no inhibition, n.t. = test not performed. 
In summary, evaluation of the inhibitory activity of casuarine and its 
derivatives towards a wide range of commercially available glycosidases 
allowed us to discover several new inhibitors of glucoamylase from Aspergillus 
niger. 
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Glucoamylase (1,4-α-D-glucan glucohydrolase, GA; EC 3.2.1.3; glycoside 
hydrolase family GH15, www.cazy.org) is an exo-hydrolase that catalyzes the 
removal of glucose units from the non-reducing end of starch and related 
oligosaccharides. The hydrolytic reaction, which preferentially occurs at α-1,4 
linkages, proceeds with inversion of configuration. Glucoamylases are also able 
to hydrolyze α-1,6 linkages, but the specific activity is only 0.2% with respect to 
α-1,4 hydrolysis.136 The interest in glucoamylase is related to its use in the 
industrial production of bioethanol, glucose and fructose syrups.137 
Furthermore, given the presence of these enzymes in a wide variety of 
organisms and their quite simple obtainment in a pure form, GA have been 
extensively studied as a model for other glucosyl-hydrolase family members.138 
5.1.2 Modeling studies of the amyloglucosidase/inhibitors 
interactions 
This study has been performed in collaboration with Prof. Paola Gratteri 
(Department of Pharmaceutical Sciences, University of Florence). In particular, 
we thank Dr. Claudia Bonaccini and Matteo Chioccioli for docking studies. 
 For the discussion of the modeling, we report a more convenient 
numeration for the studied molecules (Table 5.4) together with their inhibition 
values towards glucoamylase from Aspergillus niger. 
Based on the inhibition results, our molecular study was focused on 
glucoamylase from Aspergillus niger, and it was aimed at correlating 
experimental affinity with binding energy predictions obtained through 
molecular docking and MM-GBSA rescoring techniques. 
 
 
                                                            
136
 Hiromi, K.; Hamauzu, Z. I.; Takahashi, K.; Ono, S. J. Biochem. (Tokio) 1966, 59, 
411. 
137Saha, B. C.; Zeikus, J. G. Starch/Staerke 1989, 41, 57.  
138
 Sauer, J.; Sigurskjold, B. W.; Christensen, U.; Frandsen, T. P.; Mirgrorodskaya, E.; 
Harrison, M.; Roepstorff, P.; Svensson, B. Biochim. Biophys. Acta 2000, 1543, 275. 
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Molecule Structure 
IC50  
(µM) 
Molecule Structure 
IC50 
(µM) 
I 
 
1.9 XII 
 
300 b 
II 
 
4.4 XIII 
 
420b 
III 
 
0%a XIV 
 
3.5 
IV 
 
4.5 XV 
 
1.9 
V 
 
7.7 XVI 
 
4.3c 
VI 
 
214 XVII 
 
2.7c 
VII 
 
8.1 XVIII 
 
108d 
VIII 
 
23.7 XIX 
 
9.8d 
IX 
 
25% a XX 
 
290d 
X 
 
76% a XXI 
 
63e 
XI 
 
28 b    
Table 5.4. Structures and inhibition activities (IC50) towards glucoamylase from Aspergillus 
niger for the compounds used in the molecular modeling study. aFor molecules with 
percentage of inhibition less than 90% IC50 values were not calculated 
 bValues from Ref. 58. 
cValues from Ref. 138. dValues from Ref. 139. eValues from Ref. 112g. 
                                                            
139
 Goti, A.; Cardona, F.; Brandi, A.; Picasso, S.; Vogel, P. Tetrahedron: Asymmetry 
1996, 7, 1659. 
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Furthermore, the docking/rescoring procedure tested on glucoamylase 
shows promising ability in discriminating active and inactive molecules, and 
thus it can be used for the rational design of new glucosidase inhibitors. 
5.1.2.a Docking studies 
As a first stage of this molecular modeling study we performed a series 
of docking runs using i) two available crystallographic structures of complexes 
of glucoamylase from Aspergillus awamori with ligands (PDB ID: 1DOG and 
1GAI)140,141 and ii) considering as part of the target one or two water 
molecules. The choice of using more than one structure has been made 
assuming that the structural alignment of the two complexes did not reveal 
any significant conformational difference and thus making it difficult to 
influence ligand posing. We experienced that such “invisible” differences could 
greatly influence the scoring of docked poses. As far as the presence of water 
molecules is concerned, the two solvent molecules considered here, Wat501 
and Wat534 in 1DOG structure, are located in close proximity to the ligands. In 
particular Wat501 is directly engaged in H-bonding interaction with ligands, 
while Wat534 seems to have a structural role, since it is coordinated by three 
residues, one of which (D55) has been demonstrated to be required for 
substrate binding and catalysis.142 Preliminary analysis of docking accuracy 
performances highlighted the need to consider at least Wat501 in order to 
reproduce the correct binding mode of co-complexed ligands, especially for 1-
deoxynojirimycin. Moreover, the comparison of the crystal structures of the 
complexes with acarbose and D-gluco-dihydroacarbose suggested a 
fundamental role of Wat501 in modulating the affinity of ligands, given that a 
                                                            
140
 Harris, E. M.; Aleshin, A. E.; Firsov, L. M.; Honzatko, R. B. Biochemistry 1993, 32, 
1618. 
141
 Aleshin, A. E.; Stoffer, B.; Firsov, L. M.; Svensson, B.; Honzatko, R. B. 
Biochemistry 1996, 35, 8319. 
142
 Itoh, T.; Sakata, Y.; Akada, R.; Nimi, O.; Yamashita, I. Agric. Biol. Chem., 1989, 53, 
3159. 
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0.2 Å shift of this water molecule induced by the presence of an additional 
hydrogen atom on C-7a of D-gluco-dihydroacarbose has been indicated as the 
most apparent cause for the 10000-fold drop in activity with respect to 
acarbose.141 For these reasons we performed docking calculations in the 
presence of both the only Wat501 and the two water molecules together. The 
selection of the best docked orientation for each ligand has been performed 
on the basis of either Gscore and Emodel values and the Gscore values for the 
selected poses have been compared to experimental pIC50 data. It is important 
to note that ligand affinity data refer to the inhibition of Aspergillus niger 
glucoamylase, whereas the available 3D structures were obtained with the 
Aspergillus awamori enzyme; nevertheless, the sequence comparison of the 
proteins from the two strains highlighted more than 95% of sequence identity, 
with all binding site forming residues completely conserved in the two 
proteins. This observation supported our choice of correlating Aspergillus niger 
experimental affinities with Aspergillus awamori calculated binding energies. 
Indeed, while this work was in preparation, the crystallographic structure of 
the catalytic domain of Aspergillus niger glucoamylase was solved (PDB ID: 
3EQA)143 and the structural comparison with Aspergillus awamori protein 
confirmed they are almost identical. We report the results from the visual 
inspection of selected docked poses. 
5.1.2.b Binding mode analysis 
For most of the molecules, almost coincident orientations were found 
independently on the protein structure, the number of water molecules 
considered as part of the target during docking and the kind of evaluation 
function used to select the poses. This observation confirms that Wat534 does 
not influence ligand posing during docking, but we cannot exclude its role in 
maintaining the structure of the binding site. 
                                                            
143
 Lee, J.; Paetzel, M. To be published. 
 For molecules I, IV
In this preferred orientation (Figure 5.4A
located in the inner part of the 
network in which the OH at C
(donor), the OH at C-2 is bonded to D55 (acceptor) and R54 (donor) and 
OH at C-1 is alternatively oriented toward Wat501 or the backbone carbonyl of 
L177 (Figure 5.4C) for donating an additional H
the positively charged nitrogen atom orients the hydrogen toward Wat501 and 
does not interact with any negatively charged res
contrast to finding obtained
dihydro-acarbose.141  
Figure 5.4. Docked orientation of casuarine 
shown as stick representation with green coloured carbon atoms. A) Interactions between 
molecule I and active site residues; the two water molecules considered during docking are 
also shown. H-bonds are indicated as dashed lines coloured in green or orange if involving the 
ligand or water molecules, respectively. B) Detailed inspection of steric repulsion (magenta 
dashed lines) between molecule 
(magenta dashed lines) between molecule 
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 and VII all the selected poses are almost coincident. 
) ring A of the pyrrolizidine nucleus is 
-1 subsite, finding an optimal H-bonding 
-8 is bonded to D55 (acceptor) and Wat501 
-bond. Given this orientation, 
idue of the protein, 
 for the imino group of acarbose and D-gluco
I and 7-modified derivatives; ligand molecules are 
I and E179. C) Detailed inspection of steric repulsion 
VII and E179, W317 and R305 
 
 
the 
in 
-
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Indeed, the docked orientation of casuarine and derivatives places the 
hydrogen atoms of C-5 and C-7 in close contact with E179 (Figure 5.4B). 
This could negatively contribute to the affinity of such compounds, but it 
is partly compensated by the additional H-bond that the OH at C-6 is able to 
donate to E179. Finally, as far as position 7 is concerned, no H-bond 
interactions are established by the OH at C-7 of I, in that resembling the 
behaviour of the deoxy-derivative IV. For molecule VII, instead, the OH at C-9 
can form two H-bonds with R305 (donor) and W178 (acceptor), but strong 
repulsive interactions between the methylene hydrogens and R305 and/or 
W317 are present, which could explain the relatively lower affinity of VII over I 
(Figure 5.4C). 
Comparing molecule IV and its lactam derivative VI, the assumption that 
repulsive interactions could have a very important role in decreasing binding 
affinity finds a confirmation: the docked orientations are very similar, but the 
limited conformational flexibility of VI results in stronger repulsive interactions 
with residues of the binding site, in accordance with the lower pIC50 value. 
The analysis of the selected poses for the corresponding glucoside 
derivatives II, V and VIII showed two possible binding modes which 
alternatively oriented the pyrrolizidine or the glucose moiety in the -1 site, 
which  are defined as CAS-IN and GLU-IN, respectively. Interestingly, the two 
orientations showed no significant differences in terms of associated Gscore. 
When the molecules adopt the GLU-IN orientation (Figure 5.5), which is 
the more frequently selected by our docking procedure, the glucose in -1 site 
overlaps to ring A of D-gluco-dihydro-acarbose but lacks the steric repulsions 
described for C-7a of the acarbose derivative,141 given the presence in the 
corresponding position of glucose of the endocyclic oxygen. In all the selected 
poses showing GLU-IN orientation the pyrrolizidine nucleus, which is able to 
completely fill the +1 site (Figure 5.5B), orients the N-H+ toward the aromatic 
ring of Y311, with a geometry compatible with NH-π interaction. Furthermore, 
 the OH at C-8 is able to donate one H
stabilization of this binding mode (Figure 
derivatives of glucosides 
could confirm the poor binding at 
pyrrolizidine and glucose. Also at the level of +1 site the results of docking 
converged to a unique solution for all the lactam molecules, which is almost 
coincident with the orientation of the pyrrolizidine moiety of glucoside 
derivatives except for the ring conformation clearly influenced by the presence 
of the lactam structure. Furthermore, the absence of the charge on nitrogen 
atom prevents lactam derivatives to reinforce the interaction at +1 site 
through NH-π interactions.
Figure 5.5. GLU-IN orientation of glucoside derivatives; ligand molecules are shown as stick 
representation with green coloured carbon atoms. A) Interactions between molecule 
active site residues; the two water molecules considered during doc
bonds are indicated as dashed lines coloured in green or orange if involving the ligand or 
water molecules, respectively. The distance between N
ring is also shown. B) Comparison between the GLU
and the docked orientation of 
between the GLU-IN orientation of glucoside derivatives and the docked orientat
maltose (yellow carbons) 
Biological evaluation & modeling studies
159
-bond to E180, thus contributing to the 
5.5A). Interestingly, all lactam 
III, IX, X adopt the same GLU-IN orientation and this 
-1 site of the lactam moiety with respec
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king are also shown. H
-H+ and the centroid of Y311 aromatic 
-IN orientation of glucoside derivatives 
D-gluco-dihydroacarbose (yellow carbons). C) Comparison 
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Apart from that, the visual inspection of selected docked poses for 
corresponding glucoside/lactam molecules in this orientation did not highlight 
any other significant difference in the interactions which could justify the 
complete absence of inhibitory properties for lactam compounds. 
Moreover, comparing the orientation of II with the docked orientation 
of the hydrolyzable maltose (Figure 5.5C), it is not clear how the casuarine 
glucoside could resist hydrolysis, as observed, since the nucleophile Wat501 is 
perfectly oriented toward the anomeric carbon. 
In the CAS-IN orientation (Figure 5.6A) the position of pyrrolizidine 
nucleus of glucoside molecules is almost coincident to the docked pose of the 
parent unglucosylated compounds, except for the conformation of ring B, 
which is influenced by the positioning of glucose moiety, and for the lack of 
the H-bond interaction between the OH at C-6 and E179. 
As a consequence, the same repulsive interactions previously described 
are present. Given that orientation of the pyrrolizidine portion, the glucose 
moiety is oriented in the outer part of the binding site, but it is not able to 
completely occupy the +1 site as is the case for ring B of acarbose and its D-
gluco-dihydro-derivative141 due to the longer C-2/C-6 distance of pyrrolizidine 
(4.9 Å) with respect to the C-1/C-4 distance of ring A of D-gluco-dihydro-
acarbose or glucose (2.9 Å) (Figure 5.6B). As a consequence, the C-6 atom of 
pyrrolizidine is more than 2 Å far from the C-1 atom of glucose in the docked 
pose of maltose (Figure 5.6C), which is the target of the nucleophilic attack 
during glucoamylase hydrolysis. With these observations in mind, we could 
hypothesize a different binding mode for glucosides (CAS-IN) and their lactam 
derivatives (GLU-IN); as a consequence of that, glucosides strongly bind and 
resist to hydrolysis, while lactam derivatives are hydrolyzed by glucoamylase 
soon after binding releasing the corresponding lactam and glucose, that are 
not good inhibitors. 
 Figure 5.6. CAS-IN orientation of glucoside derivatives; ligand molecules are shown as stick 
representation with green coloured carbon atoms. A) Interactions between molecule 
active site residues; the two water molecules considered during docking are also sh
bonds are indicated as dashed lines coloured in green or orange if involving the ligand or 
water molecules, respectively. B) Comparison between the CAS
derivatives and the docked orientation of 
C6 distance of pyrrolizidine and the C1
also shown as dashed lines coloured in blue and red, respectively C) Comparison between the 
CAS-IN orientation of glucoside derivatives and 
carbons) 
Molecules XI-XV, the inhibitory activities of which towards glucoamylase 
were reported previously (See Table 
differ from casuarine (I
configuration of stereogenic centres
same ring A substitutions of casuarine but different substituents at C
of ring B. Interestingly, docking results for 
(the 6,7-di-deoxy analog of 
with the previously described orientation of casuarine derivatives. Molecule 
XI, instead, which lacks the 
at C-7 with respect to I, showed also a seco
is oriented toward D179 (Figure 
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own. H
-IN orientation of glucoside 
D-gluco-dihydroacarbose (yellow carbons). The C2
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preserves the same H
described for casuarine derivatives, allowed the molecule to better fill the 
site, placing the unsubstitued C
It is quite interesting to note that this binding mode is
casuarine given the presence of the hydroxyl 
different configuration of 
repulsions. The lack of 
configuration in molecule 
and Wat501, is probably the reason why this second binding mode is not 
observed for these two molecules. 
Figure 5.7. Docked orientations of molecule 
as stick representation with carbon atoms coloured in green (orientation I) or yellow 
(orientation II); the two water molecules considered during docking are also shown. H
are indicated as dashed lines coloured in orang
yellow if involving ligand orientation I or II, respectively
Molecules XII and 
different configuration at C
both the two binding modes described for 
epi modification determined ring A distortion and the loss of several 
favourable interactions. Molecule 
-bonds with R54, D55, L177 and Wat501 already 
-6 close to the aromatic rings of Y48 and W52. 
 not possible for 
substituent at C-6 and the 
the OH at C-7 which are not tolerated by steric 
the OH at C-7 in molecule XV or its different 
XIV, which results in the loss of H-bonds with D55 
 
XI (A) and XVI (B). The ligand molecules are shown 
-bonds 
e if involving water molecules and in green or 
 
XIII present the same ring B substitutions of XI, but 
-1 or C-3 on ring A, respectively. Molecule XII shows 
XI, although the presence of the 1
XIII, instead, shows always the second 
-1 
 
-
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binding mode which is however characterized by the presence of strong 
repulsive interactions which could justify the very low affinity of this 
compound. 
Finally, indolizidines XVI-XXI, the inhibitory activities of which towards 
glucoamylase were reported previously (See Table 5.4), present a 6-membered 
ring B with a similar stereochemical arrangement (molecule XVI) or a low 
degree of hydroxylation with respect to ring A of I and different substitutions 
on C-1 and C-2 of ring A. Most of the selected poses for XVI oriented ring B in a 
very similar way as ring A of pyrrolizidine, with C-6, C-7 and C-8 of XVI almost 
coincident to C-1, C-2 and C-3 of XI, respectively (Figure 5.7B). Contrarily to 
pyrrolizidines, given the presence in C-6 position of compound XVI of a 
hydroxy group instead of the C-3 hydroxymethyl group of pyrrolizidine 
derivatives, XVI is unable to H-bond both D55 and Wat501. Anyway, in that 
pose both N-H+ and the OH at C-1 orient toward E179 establishing strong H-
bonding interactions. The second binding mode which we observed for this 
molecule is very similar to orientation II of pyrrolizidine XI, with the full H-
bonding network involving Wat501, D55 and R54, but orienting N-H+ toward 
Wat501. 
Molecules XVII-XXI present a low degree of hydroxylation and, 
interestingly, very different activities associated to quite small structural 
variations. The two enantiomers of lentiginosine, XVII and XVIII, showed a 
different binding mode with respect to XVI given the total absence of hydroxyl 
groups on ring B. In fact, all the selected poses for the two compounds orient 
ring A in the inner portion of -1 site; for molecule XVIII, probably due to the 
stereochemical arrangement of ring A substituents, all the selected poses 
converged to a unique orientation in which the OH at C-2 is always engaged in 
H-bonding interactions with R54 and D55, the positively charged nitrogen 
orients the hydrogen toward E179 with the possibility of charge-reinforced H-
bond formation and the OH at C-1 alternatively orients toward Wat501 or the 
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Figure 5.8. Docked orientations of molecule 
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yellow if involving ligand orientation I or II, respectively
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-bonds with R54, D55 and 
y groups, but alternatively orient N-H+ toward 
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XIX, but with a very distorted geometry 
XXI always showed the same 
etween C-7 and C-8. 
XVIII (A) and XVII (B). The ligand molecules are 
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In conclusion, docking experiments performed on pyrrolizidine and 
indolizidine derivatives allowed one to hypothesize preferential binding modes 
for all the studied compounds. It is evident that an optimal network of H-
bonding interaction at the level of the inner -1 site has to be found for a ligand 
to bind, but also interactions at the level of +1 site seem to have an important 
role in modulating the affinity of more extended molecules. Furthermore, 
another important contribution to the stability of protein-ligand complexes 
could be represented by steric repulsions which are especially found for 
analogues with reduced flexibility (lactam derivatives).  
5.1.3 Inhibition of a human maltase glucoamylase 
This study has been performed in collaboration with Prof. David Rose 
(University of Toronto, Canada). In particular, we thank Lyann Sim for the 
inhibition tests and X-ray analysis. 
Human maltase-glucoamylase (MGAM, EC 3.2.1.20) falls into family 
GH31 of the Carbohydrate Active enZyme (CAZy) classification.144 It is one of 
the two enzymes (together with sucrase-isomaltase SI, EC 3.2.1.48 and 
3.2.1.10) responsible for catalysing the last step in starch digestion, by 
hydrolyzing mixtures of dextrins, at the non-reducing end, into glucose with 
net retention of anomeric configuration.145 Inhibitors of enzymes involved in 
the starch-digestion pathway are used to delay glucose production and thus 
aid in the treatment of type II diabetes.84b This therapeutic potential would be 
encouraged by an in-depth study of their mode of action.146 Rose et al. 
                                                            
144
 Coutinho, P. M.; Henrissat, B. in Recent Advances in Carbohydrate Bioengineering 
(Eds.: H. J. Gilbert, G. J. Davies, B. Henrissat, B. Svensson), Royal Society of 
Chemistry, Cambridge, 1999, pp. 3. 
145
 a) Nichols, B. L.; Eldering, J.; Avery, S.; Hahn, D.; Quaroni, A.; Sterchi, E. E. J. 
Biol. Chem. 1998, 273, 3076; b) Nichols, B. L.; Avery, S.; Sen, P.; Swallow, D. M.; 
Hahn, D.; Sterchi, E. E. Proc. Natl. Acad. Sci USA 2003, 100, 1432. 
146
 For reviews on glycosidase mechanisms, see: a) Heightman, T. D.; Vasella, A. T. 
Angew. Chem. 1999, 111, 795; Angew. Chem. Int. Ed. 1999, 38, 750; b) Zechel, D. L.; 
Withers, S. G. Acc. Chem. Res. 2000, 33, 11; c) Ref. 2. 
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recently reported147 the first crystal structure of the human N-terminal subunit 
of MGAM (NtMGAM) in its apo form and in complex with acarbose (113) 
(Figure 5.9), a tetrasaccharide analogue currently on the market as an 
antidiabetic drug (Glucobay, Precose). 
NtMGAM inhibition studies revealed that casuarine (11), with a Ki of 
0.45 µM, displayed over 600 fold greater inhibition against NtMGAM 
compared to its glucoside 50, which inhibited with a Ki of 280 µM. 
 
Figure 5.9. Acarbose (113), casuarine (11) and its glucoside 50 
These results are similar to the inhibition profile of rat intestinal maltase 
where 11 and 50 inhibit with IC50 values of 0.7 µM and 260 µM, respectively, 
but are in contrast to the inhibition profile of fungal glucoamylases where 11 
and 50 display similar and potent inhibitory activities.58 
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 Sim, L.; Quezada-Calvillo, R.; Sterchi, E. E.; Nichols, B. L.; Rose, D. R. J. Mol. 
Biol. 2008, 375, 782. 
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The similarity in inhibition profiles between NtMGAM and the rat 
intestinal maltase is consistent with previous kinetic studies,147,148 which 
proposed that the N-terminal NtMGAM domain of human maltase-
glucoamylase displays maltase activity whereas its C-terminal catalytic domain 
displays glucoamylase activity. 
The crystal structure of NtMGAM in complex with 11 was solved to 2.1 Å 
(see Experimental Section for details and data processing and refinement 
statistics). The electron density clearly revealed one molecule of 11 (Figure 
5.10) bound in the –1 subsite and one glycerol molecule (originating from the 
cryoprotection solution) bound in the +1 subsite. 
Figure 5.10. Stereo (divergent) ball-and-stick representation of casuarine (11) in complex with 
NtMGAM. Observed electron density for the maximum likelihood weighted 2Fobs-Fcalc map is 
contoured at 1σ. Figure were drawn using BOBSCRIPT149 
 
The two pyrrolidine rings, named ‘A’ and ‘B’ in Figure 5.9, both adopt an 
envelope configuration; ring A is in a 2E conformation, and ring B in an E6 
conformation. 
With its heavily hydroxylated rings, 11 binds tightly to the NtMGAM 
active site primarily through hydrogen bonding interactions with the side 
chains lining the –1 subsite (Figure 5.11). 
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 Quezada-Calvillo, R.; Sim, L.; Ao, Z.; Hamaker, B. R.; Quadroni, A.; Brayer, G. D.; 
Sterchi, E. E.; Robayo-Torres, C. C.; Rose, D. R.; Nichols, B. L. J. Nutr. 2008, 138, 
685. 
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Figure 5.11. Interactions between 11 and NtMGAM (D443 is the catalytic nucleophile, D542 
the catalytic acid/base). Hydrogen bonds are shown by dashed lines 
These include hydrogen bonding between D327 and the hydroxyl groups 
at C-8 and C-2, H600 with the OH at C-1 and the OH at C-2, D443 with the OH 
at C-7 and the pyrrolidine nitrogen, R526 with the OH at C-7 and D542 with the 
OH at C-6. The weaker inhibition of 50 compared to 11 leads us to believe that 
the addition of glucoside group of 50 makes unfavourable interactions with 
the +1 subsite, or weakly competes with the casuarine group to occupy the –1 
subsite, both of which may decrease the inhibition properties of the casuarine 
group. 
Indeed, molecule 50 is a mimic of a α-1,1-glucoside while the enzyme 
hydrolyses 1,4-glucosides. Work is underway in our laboratory in order to 
synthesize mimetics of 1,4-glucosides based on casuarine (Figure 5.12). 
 
Figure 5.12. 1,4-Glucoside based on casuarine 
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5.1.4 Inhibition on trehalases 
5.1.4.a Trehalase inhibition 
Trehalose (α-D-glucopyranosyl α-D-glucopyranoside) (114, Figure 5.13) 
has a multifunctional physiological role in various organisms ranging from 
bacteria and fungi to invertebrates and higher plants. Many of these lower 
organisms produce and store trehalose, sometimes in amounts as high as 10% 
to 20% of their dry weight.75b Trehalose is particularly important for insects (it 
constitutes the major blood sugar of most insects)150 as it is hydrolysed into 
glucose, which is vital for insect flight. Inhibition of the hydrolysis of trehalose 
is thus an interesting target for novel insecticides. 
 
Figure 5.13. Trehalose (114) and trehalase inhibitors 
In order to utilise trehalose, insect tissues have the enzyme α-trehalase 
(EC 3.2.1.28), which promotes the irreversible hydrolysis of one of the two 
glycosidic bonds in trehalose with inversion at the anomeric 
configuration.150,151 Trehalose does not occur in mammalian cells, although 
                                                            
150
 Becker, A.; Schlöder, P.; Steele, J. E.; Wegener, G. Experientia, 1996, 52, 433. 
151
 Defaye, J.; Driguez, H.; Henrissat, B. Carbohydr. Res., 1983, 124, 265. 
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humans have the enzyme trehalase in intestinal villae cells and in kidney brush 
border cells, probably to handle ingested trehalose.75b 
Although insects possess two types of treahalases, a soluble one 
(localized in haemolymph) and a membrane-bound trehalase (localized in 
tissues), very little is known about this latter and the difference in function 
about soluble and membrane-bound trehalases.152,153  
Trehalases inhibitors are valuable tools for studying the molecular 
physiology of trehalase function and sugar metabolism in insects.154 The 
evaluation of the enzymatic activity helps in ensuring clarification of the key 
role of this class of enzymes in insects and in vertebrates. Together with the 
selection of new potential insecticides, inhibition studies have been proved 
useful for elucidating structural features of the active site.155  
Among the most powerful inhibitors of trehalases there are some 
natural pseudodisaccharides, such as validoxylamine A (115),156 trehazolin 
(116),156 and casuarine-6-O-α-D-glucoside (50) (Figure 5.13).58 
5.1.4.b Inhibition of trehalase from Escherichia coli (Tre37A) 
Structural determination of complexes of enzymes with strong inhibitors 
is able to provide molecular insights into enzyme mechanism and features of 
the active site. Davies et al. recently presented the first three-dimensional 
structure of a periplasmic trehalase from Escherichia coli (Tre37A), which 
belongs to family GH37 of the CAZy classification, in complex with some potent 
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 Lee, J.-H.; Saito, S.; Mori, H.; Nishimoto, M.; Okuyama, M.; Kim, D.; 
Wongchawalit, J.; Kimura, A.; Chiba, S. Biosci. Biotechnol. Biochem., 2007, 71, 2256. 
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 Tang, B.; Chen, X.; Liu, Y.; Tian, H.; Liu, J.; Hu, J.; Xu, W.; Zhang, W. BMC Mol. 
Biol., 2008, 9, 51. 
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inhibitors, 1-thiatrehazolin (116) and validoxylamine A (115, Figure 5.13).157 
Casuarine (11) and its glucoside 50 are known to inhibit porcine kidney 
trehalase (IC50 = 12 μM and IC50 = 0.34 μM, respectively);
5 consequentially, the 
measurement of their inhibitory activity towards Tre37A was of high interest. 
Kinetic data were collected on Tre37A using an assay where glucose was 
detected by glucose oxidase/peroxidase linking enzymes following trehalose 
hydrolysis (see Experimental Section for details). Ki values for 11 and 50 were 
determined at 37 °C and pH 5.5, and included a 20 minute pre-incubation of 
the inhibitor with the enzyme to prevent any complications in the data analysis 
from slow onset inhibition. Compound 50, with a Ki = 12 nM, was shown to be 
around a thousand fold more potent than 11 (Ki = 17 μM), indicating that the 
glucose moiety in the +1 subsite (see below) contributes considerably to 
binding. This fits with the fact that Tre37A hydrolyses disaccharide substrates 
and therefore presumably has evolved to optimise interactions in both the –1 
and +1 subsites.157 
Figure 5.14. Stereo (divergent) ball-and-stick representation of casuarine-6-O-α-glucoside (50) 
in complex with Tre37A. Observed electron density for the maximum likelihood weighted 
2Fobs-Fcalc map is contoured at 1σ. Figures were drawn using BOBSCRIPT.
148  
 
X-ray data for Tre37A in complex with 50 were collected to 1.9 Å (see 
Experimental Section for details and data processing and refinement statistics). 
                                                            
157
 Gibson, R. P.; Gloster, T. M.; Roberts, S.; Warren, R. A. J.; de Gracia, I. S.; García, 
A.; Chiara, J. L.; Davies, G. J. Angew. Chem. 2007, 119, 4193; Angew. Chem. Int. Ed. 
2007, 46, 4115. 
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There was clear electron density in each of the four molecules of the 
asymmetric unit corresponding to a molecule of 50, Figure 5.14. 
The casuarine moiety of 50 is bound in the –1 subsite of Tre37A (Figure 
5.15). 
Figure 5.15. Interactions between 50 and Tre37A (E496 is the catalytic base, D312 the catalytic 
acid). Hydrogen bonds are shown by dashed lines 
 
The two pyrrolidine rings are both found in an envelope conformation; 
ring A is in an 2E conformation, and ring B in an 5E conformation. The glucose 
moiety of 50, in the +1 subsite, is bound in a relaxed 4C1 conformation. The 
majority of the interactions between the glucose and the active site residues 
of Tre37A are as described previously;157 the exception to this is the hydroxyl 
group at the C-6 position, which hydrogen bonds with a sulfate group from the 
crystallisation conditions, and appears to cause a large movement of E511 
away from the active site. 
The hydroxyl group at C-8 of the casuarine moiety hydrogen bonds with 
D160 and a water molecule, the OH at C-2 interacts with D160 and the oxygen 
of Q207 and the OH at C-1 with W159 and the backbone carbonyl of G310. 
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The nitrogen atom in the pyrrolizidine ring interacts with the same 
water molecule. In ring B, the hydroxyl group at C-7 interacts with W447 and a 
different water molecule (not shown). 
In order to generate highly potent trehalase inhibitors with potential 
insecticide activity, we studied the inhibition activity of two casuarine-6-O-α-D-
glucoside analogues 51 and 52 (Figure 5.13). Compounds 51 and 52 bear a 
hydrogen atom and a hydroxymethyl group in place of the hydroxy group at C-
7 of casuarine-6-O-α-D-glucoside, respectively. We analysed the inhibitory 
potency of the compounds towards Tre37A and commercial porcine kidney 
trehalases, obtaining the Ki values in Table 5.5. Moreover, we succeeded in 
crystallizing and solving the structure of Tre37A in complex with 52 to gain 
insights into the interactions important for binding. 
 Porcine Kidney Ki E. coli Tre 37A Ki 
50 11 nM 12nM 
51 138 nM 86 nM 
52 >10 µM 2.8 μM 
Table 5.5. Inhibition of porcine kidney trehalase, and Tre37A by compounds 50, 51 and 52 
The potency of 50, 51 and 52 towards the two trehalases showed a 
similar trend, with the strongest inhibition obtained using compound 50. These 
direct comparisons demonstrate that the functional group at the C-7 position 
has a significant effect on the inhibition of the casuarine-6-O-α-D-glucoside 
analogues; a hydroxyl group appears to be preferential to a hydrogen atom, 
which in turn are both more potent than a hydroxymethyl group.  
Molecular insights into casuarine-6-O-α-D-glucoside analogue inhibition 
can be obtained from the three-dimensional structure of the trehalase in 
complex with the inhibitor. Although it would be ideal to obtain both the 
structure of studied trehalase to demonstrate the basis for selectivity, to date 
only the trehalase from E. coli has been amenable to crystallization. We solved 
the structure of Tre37A in complex with 52, with the aim of dissecting which 
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features make the inhibitor less favourable to this trehalase compared to 50. 
X-ray data for Tre37A in complex with 52 were collected to 2.1 Å (see 
Supplementary Material for data collection and refinement statistics). Electron 
density clearly showed the presence of a molecule of 52 bound in the -1 
(casuarine analogue moiety) and +1 (glucose) subsites of each molecule of 
Tre37A in the asymmetric unit (Figure 5.16a). 
Compound 52 and active site residues overlap perfectly with Tre37A in 
complex with 50 (Figure 5.16b). 
 
Figure 5.16. (a) Ball-and-stick representation of Tre37A in complex with 52. Glu496 (above), 
the catalytic acid and Asp312 (below), the catalytic base are shown. Observed electron 
density, contoured at 1σ (0.44 electrons /Å3) for the maximum likelihood weighted 2Fobs-Fcalc 
map is shown. (b) Overlap between Tre37A in complex with 52 (green) and 50 (yellow) 
As observed with the Tre37A complex with 50, both pyrrolidine rings 
were found in an envelope conformation. The majority of the interactions with 
active site residues are the same as described previously and can be seen in 
Figure 5.17. 
The only differences lie with the hydroxymethyl group at C-7. Whereas 
previously 50 was observed to make a weak (3.1 Å) hydrogen bond interaction 
with Trp447 and with a water molecule, 52 forms two hydrogen bonds with 
active site residues: Trp447 (at a distance of 2.7 Å) and the peptide carbonyl 
group of Asp312 (which incidentally is the catalytic base). The observation of 
the formation of additional interactions with active site residues with 52 
compared to 50 makes it difficult to rationalize why it binds more weakly. 
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Figure 5.17. Active site interactions between Tre37A and 52 
5.1.4.c Inhibition of trehalase from Chironomus riparius 
This study has been performed in collaboration with Prof. Paolo Parenti 
(University of Milano-Bicocca). In particular, we thank Dr. Matilde Forcella for 
biological evaluation. 
As with the design of any inhibitor, specificity is a significant concern. 
The design of a viable insecticide which targets a trehalase would therefore 
require it to be “mammal-safe” and thus only specific for insect trehalases. 
A membrane-bound isoform of trehalase from midge larvae 
(Chironomus riparius) has been recently purified.158 C. riparius represents a 
good model for biochemical studies and it was demonstrated that its 
resistance to stress factors is highly dependent on trehalose catabolism.159 
These studies revealed that trehalase from C. riparius is specific for trehalose 
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 Forcella, M.; Cardona, F.; Goti, A.; Parmeggiani, C.; Cipolla, L.; Gregori, M.; 
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and is competitively inhibited by known trehalase inhibitors. It can be 
considered a target for new and specific molecules having insecticide activity. 
Compound 50 is the most potent trehalase inhibitor described to date 
with a Ki value against C. riparius of 0.66 nM, more potent than that displayed 
by validoxylamine A156,160 and an order of magnitude lower than determined 
for trehazolin in other insect species.154,156 However, compound 51 display a Ki 
value of 22 nM and in terms of selectivity, as well as potency, it is perhaps 52, 
Ki = 157 nM, that is the most interesting compound of this set of inhibitors, as 
far their selectivity with respect to mammals trehalases and to other 
human/mammals glycosidases, is taken into account. Indeed, 52 displays 
nearly 20-fold selectivity for the insect trehalase over the E. coli enzyme, and is 
at least 100-fold selective over the porcine kidney trehalase (see Table 5.5). 
Additionally and more importantly, it is essentially inactive towards relevant α-
glucosidases, such as NtMGAM and HPA. 
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5.2 Conclusion 
In conclusion, the biological tests described in this chapter showed that 
several new inhibitors of glucoamylase from Aspergillus Niger were discovered 
and new potent and selective inhibitors of trehalases were synthesized. 
The study toward commercially available glycosidases shows an 
interesting selective inhibitory activity of several molecules towards 
amyloglucosidase from Aspergillus Niger, and only a slightly diminished activity 
between casuarine (11) and its methoxy derivative (94) which opens the way 
to the synthesis of a new class of glycosidases inhibitors. The modelling study 
gave us useful suggestions for the rational design of new glucosidase 
inhibitors. 
The study on NtMGAM and Tre37A, demonstrates that among glycoside 
hydrolase enzymes that belong to different families and clans, and which differ 
in mechanism of action, there is a degree of conservation of the analogous 
active site residues reflecting the convergent evolution of optimised non-
covalent interactions. The binding of inhibitors 11 and 50 were investigated 
with NtMGAM and Tre37A by kinetic and structural methods, which provided 
information on the relevant interactions in the active site and could form the 
basis for the synthesis of analogues. This study shows that casuarine can be 
envisaged as a lead compound for the construction of novel disaccharide and 
polysaccharide type glycoside hydrolase inhibitors, the syntheses of which are 
currently ongoing in our laboratories. 
Comparison of the inhibitor activity of target molecules on different 
trehalases showed that compounds 50 and 52 are at least one order of 
magnitude more potent towards the C. riparius trehalase than both the E. coli 
and porcine trehalases (Table 5.6). 
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 Porcine Kidney, Ki E. coli Tre37A, Ki C. riparius, Ki 
50 11 nM 12nM 0.66 nM 
51 138 nM 86 nM 22 nM 
52 >10 µM 2.8 μM 157 nM 
Table 5.6. Inhibition of porcine kidney trehalase, Tre37A and C. riparius trehalase by 
compounds 50, 51 and 52 
As promiscuous inhibition is a potential problem for agricultural 
applications of trehalase inhibitors, the specificity of these compounds for 
trehalases towards other glycosidases was also addressed. The inhibition of 50, 
51 and 52 towards two human glycosidases, N-terminal human maltase 
glucoamylase (NtMGAM)147 and human pancreatic amylase (HPA) was 
assessed.161,162 All compounds were found not to inhibit HPA at a 
concentration of 100 μM. Of the three compounds, only 50 inhibits NtMGAM 
to any significant extent, with a Ki of 280 μM;
72 a value that is around 20,000-
fold less than with the insect trehalase. 
For all these reasons the tested compounds are especially attractive 
since they bind only weakly to relevant human enzymes displaying significant 
selectivity for the insect enzyme. 
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5.3 Experimental section 
5.3.1 Inhibition of glycosidases 
The experiments were performed essentially as follows:0.01-0.5 unit/mL 
of enzyme (1 unit = 1 mol of glycoside hydrolyzed/min), preincubated for 5 min 
at 20 °C with the inhibitor, and increasing concentration of aq. sol. of the 
appropriate p-nitrophenyl glycoside substrates (buffered to the optimum pH of 
the enzyme) were incubated for 20 min at 37 °C. The reaction was stopped by 
the addition of 100 µL of 0.3 M sodium borate buffer pH 9.8. The p-
nitrophenolate formed was quantified at 405 nm and IC50 values were 
calculated. Double-reciprocal (Lineweaver-Burk) plots were used to determine 
the inhibition characteristics and the Ki of each compound. 
5.3.2. Modeling studies of the amyloglucosidase/inhibitors 
interactions 
The ligand structures (Table 5.4) were built using Maestro v8.5.163 All the 
molecules were subjected to conformational search and clusterization with 
Macromodel 9.6164 in order to sample the most accessible conformations for 
both the aglyconic and glucose moieties. The bridgehead nitrogen atoms were 
treated as ionized to better simulate the physiological conditions, except for 
lactam intermediates. 
5.3.3 Inhibition of a human maltase glucoamylase 
Inhibition assays of NtMGAM were carried out in 96-well microtitre 
plates containing 100 mM MES buffer, pH 6.5, inhibitor and p-nitrophenol-D-
glucopyranoside (pNP-glucose, Sigma) as substrate (2.5-30 mM). The reaction 
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was allowed to proceed for 50 minutes at 37 °C before quenching with 0.5 M 
sodium carbonate and measuring the release of the p-nitrophenolate ion at 
405 nm. 
The Ki values of 11 and 50 against NtMGAM were calculated by 
determining the reaction rates of the enzymes in the absence and presence of 
inhibitor. Concentrations of 0.2-0.6 µM 11 or 0.4-1.2 mM 50 were used to 
inhibit NtMGAM Rates were determined and the data fitted to the Michaelis-
Menten equation in GRAFIT (Erithacus Software Ltd., Horley, UK) to obtain a 
KM (in absence of inhibitor) or apparent KM (KM
app) (in presence of inhibitor). Ki 
values were determined using the equation KM
app = KM (1+[I]/Ki). 
The crystallization of NtMGAM was previously reported by Sim et al.147 
The complex of NtMGAM with 11 was obtained by soaking NtMGAM crystals 
for ~12 hrs in mother liquor supplemented with 200 µM 11. X-ray diffraction 
data were collected on an ADSC Quantum-4 CCD detector at beamline F1 at 
the Cornell High Energy Synchrotron Source (CHESS) and were processed with 
HKL2000.165 Since the crystal of NtMGAM in complex with 11 was isomorphous 
to the crystal of NtMGAM in complex with acarbose,147 this structure was used 
as an initial model to calculate Fo-Fc maps. These difference maps clearly 
revealed the position of casuarine in the NtMGAM active site. Inhibitor 
topologies and restraints were generated using the PRODRG server 
(http://davapc1.bioch.dundee.ac.uk/programs/prodrg/) and the model was 
subsequently modified and refined using COOT166 and REFMAC.167  
                                                            
165
 Otwinowski, Z.; Minor, W. Methods Enzymol. 1997, 276, 307. 
166
 Emsley, P.; Cowtan, K. Acta Crystallogr. D Biol. Crystallogr. 2004, 60, 2126. 
167
 Murshudov, G. N.; Vagin, A. A.; Dodson, E. J. Acta Crystallogr. D Biol. 
Crystallogr. 1997, 53, 240. 
Biological evaluation & modeling studies 
181 
 
5.3.4 Inhibition of trehalases 
5.3.4.a Inhibition of trehalase from Escherichia coli (Tre 37A) 
Inhibition of Tre37A were determined using a stopped assay, where 
glucose was detected using glucose oxidase/peroxidase linking enzymes 
(Megazyme, Bray, Eire) in the same way as described previously.156 
Measurements were made at trehalose concentrations between 0.05 and 6 
mM and Tre37A was present at a final concentration of 0.7 nM.  
The Ki values of 11 and 50 against Tre37A were calculated by 
determining the reaction rates of the enzymes in the absence and presence of 
inhibitor. Concentrations of 10-40 µM 11 or 10-20 nM 50 were used to inhibit 
Tre37A. Rates were determined and the data fitted to the Michaelis-Menten 
equation in GRAFIT (Erithacus Software Ltd., Horley, UK) to obtain a KM (in 
absence of inhibitor) or apparent KM (KM
app) (in presence of inhibitor). Ki values 
were determined using the equation KM
app = KM (1+[I]/Ki). 
Gene expression and purification of Tre37A was carried out as described 
previously.157 Protein, at a concentration of 10-12 mg/mL, was co-crystallized 
with 5 mM 2 from 1.7 M ammonium sulfate and 0.1 M citric acid buffer, pH 
3.5. Crystals were cryoprotected in the mother liquor supplemented with 25% 
ethylene glycol and flash frozen. Data were collected on beamline ID29 at the 
European Synchrotron Radiation Facility (ESRF), and were processed with the 
HKL2000 suite.165 As the cell dimensions differed from previous complexes of 
Tre37A, structure solution required molecular replacement in PHASER168 using 
a monomer of 2JF4 as the search model. The model was refined with manual 
building in COOT166 interspersed with refinement of geometric restraints in 
REFMAC.167 
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5.3.4.b Inhibition of trehalase from Chironomus riparius 
Activity for the trehalases from C. riparius and porcine kidney was 
measured using a coupled assay with glucose-6-phosphate dehydrogenase and 
hexokinase according to the methods used by Wegener et al.169 Enzyme assays 
were performed in triplicate at 30 °C using a Cary3 UV-Vis spectrophotometer. 
Enzyme activity was analyzed by Cary Win UV application software for 
Windows XP. The effect of compounds 50-52 on enzyme activity was evaluated 
at a fixed substrate concentration in the presence of increasing inhibitor 
concentrations. Substrate concentrations were 0.5 mM and 2.5 mM for C. 
riparius trehalase and porcine kidney trehalase, respectively: these values are 
the corresponding Km values as determined by kinetic studies. The assay was 
performed in sodium acetate buffer at pH 6.5 as described by Wegener et al.169 
Previous studies158 revealed that the optimum pH is 6.5. Enzyme concentration 
in the text tube was 4 nM and 37 nM for C. riparius and pig kidney trehalase, 
respectively. Initial rates as a function of inhibitor concentration were fitted in 
Sigma Plot (Jandel, CA) to the following equation: 
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where vi and v0 are the initial rates in the presence and in the absence of 
inhibitor, respectively, [I] the inhibitor concentration, and IC50 the inhibitor 
concentration producing half-maximal inhibition. Enzyme activities were 
determined in the presence of 1-1000 nM 50, 0.01-100 μM 51 and 0.1-1000 
μM 52. Ki values were calculated using the Cheng-Prusoff relationship: 
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assuming competitive mechanism of inhibition. Competition was 
assessed by measuring enzyme activity at fixed inhibitor concentration and 
increasing trehalose concentrations. As the estimated IC50 values of 50 and 51 
approached the enzyme concentration (ET), to calculate the corresponding Ki 
values data were fitted to the Morrison equation for tight binding inhibition:170 
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where 
app
iK is equivalent to the IC50. 
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6.1 Summary and Conclusion 
In this work we accomplished the total syntheses of a variety of natural 
and unnatural pyrrolidine alkaloids (Figure 6.1), pyrrolizidine alkaloids (Figure 
6.2) and their glucosyl derivatives (Figure 6.3). 
 
 
Figure 6.1. Pyrrolidine alkaloids synthesized 
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Figure 6.2. Pyrrolizidine alkaloids synthesized 
 
 
Figure 6.3. Glucosidic derivatives synthesized 
Conclusions 
189 
 
The targets were obtained by two different synthetic strategies: the first 
one is based on a highly regio- and totally stereoselective 1,3 dipolar 
cycloaddition of suitable substituted alkenes to a carbohydrate-derived 
nitrone; and the second one is based on a nucleophilic addition of 
organometallic reagents or allenes to the same carbohydrate-derived nitrone. 
All the target molecules were tested towards a wide range of 
glycosidases (see Chapter 5) like commercially available glycosidases, 
trehalases and human maltase-glucoamylase and many of them showed 
interesting inhibition properties. 
The synthesis of other natural pyrrolizidine alkaloids such as australine 
and 6,7-diepicasuarine underway in our research group, as well as the 
synthesis of other unnatural derivatives. 
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